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Abstract  
 
There is limited research in Australia focusing on C. trachomatis infection at a population 
level utilising systematic non-random recruitment methodologies. In addition, little is known 
in the Australian Defence Force (ADF) about the prevalence of C. trachomatis and of risk 
behaviours that may impact on sexual health.   This study utilised an existing process in 
the ADF, the Annual Health Assessment, to source new information about C. trachomatis 
infection and about sexual risk and behaviour. The outcomes of this research may assist 
the ADF to maintain the health of personnel and consequently a high degree of operational 
preparedness, and may contribute to the understanding of C. trachomatis prevalence in 
Australia and across the world.  
 
The aims of this study were to determine the prevalence of C. trachomatis infection and to 
identify potential high risk populations in the ADF with a view to discussing secondary 
prevention interventions for the control of C. trachomatis infection within the ADF.  
 
Seven hundred and thirty-three ADF personnel were recruited into the study over a 24 
month period.   Participants were asked to complete an 8 page comprehensive survey 
about sexual behaviour and to provide a urine sample to be tested for C. trachomatis.  
Ethics approval was received from both the Australian Defence Human Research Ethics 
Committee and the University of Queensland Medical Research Ethics Committee.  
 
The study examined ADF personnel on deployment and on base in order to provide a 
comparison of populations across varying work environments.  Similarly, this study 
examined ADF personnel who had recently taken a course of doxycycline for malaria 
prophylaxis as part of deployment and those who had not in order to assess whether the 
prophylactic use of antibiotics for other purposes may have had an effect on the 
acquisition of C. trachomatis. This study enrolled participants from the three services in the 
ADF, the army, navy and air force, across 10 sites in Australia and four deployments to 
obtain a wide cross section of the ADF population. The findings from this study provide a 
profile of ADF sexual health and sexual behaviour that is comparable to the Australian 
population and identifies, in some instances, greater levels of safe practice and lower 
levels of risk behaviour.  Additionally, the ADF has a lower prevalence of C. trachomatis 
(1.87% age and gender adjusted ) than other comparable military populations as well as a 
healthier sexual health and behaviour profile.  
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C. trachomatis positivity was associated with the number of sexual partners. Those who 
had two or more partners were almost five times more likely to test positive than those who 
had one or less partners in the previous 12 months (p=0.026; OR, 4.71 95% CI 1.04-
21.21).  Presence of an STI in the previous 12 months was also associated with  the 
number of sexual partners (p=0.0002; OR, 4.35 95% CI 1.90-9.90) and relationship status, 
(p=0.041; OR, 2.22 95% CI 1.01-4.87);  casual partners in the previous 12 months, 
(p=0.007; OR, 5.79 95% CI 1.37-24.40); condom use with casual partners, (p=0.067; OR, 
3.32 95% CI 1.33-8.31);  unsafe sex practice (p=0.0003; OR, 3.05 95% CI 1.62-5.75); and 
was trending toward being associated with use of doxycycline in the previous 12 months 
(p=0.054; OR, 2.06 95% CI 0.97-4.35).        
 
This study sample was frequently deployed. While 26% of the sample surveyed were 
currently on deployment (n=190), 42% (n=309) indicated they had been deployed at some 
stage over the previous 12 months.   Those who had been deployed at any time during the 
previous 12 months (including those on deployment when participating in the study) were 
less likely to be C. trachomatis positive (1.67% vs 2.34%; p=0.54; OR, 0.71); and were as 
likely to have self-reported an STI as their colleagues who had not been deployed at any 
stage in the previous 12 months (5.82% vs 5.94%; p=0.95; OR, 0.98).   
 
This study examined rates of attendance at health services for sexual health concerns.  
18.12% (age and gender adjusted) of participants indicated they attended a health service 
for a sexual health concern in the previous 12 months. Females were significantly more 
likely to attend a health service than males (26.45% vs 16.52%; p=0.005; OR 1.81 95% CI 
1.19-2.76) for a sexual health matter.    Participants were three times more likely to attend 
an ADF health service for testing and treatment of an STI than to attend a civilian health 
service (16.4% vs 5.61% p<0.0001).  Those who engaged in some unsafe sex were 
significantly more likely to attend a health service for a sexual health matter (30.67% vs 
13.86%; p<0.0001; OR 2.75 95% CI 1.87-4.04).   
 
Support for sexual health screening already occurs in the ADF implicitly through the 
encouragement of operational preparedness and explicitly through the Comprehensive 
Preventive Health Examination (CPHE). Further utilisation of existing mechanisms for 
education and screening such as the CPHE and pre- and post-deployment health checks 
is warranted.  
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Chapter 1: Introduction 
 
1.1 Overview and Scope of Thesis 
 
1.1.1 Background 
 
The research in this thesis was undertaken between 2007 and 2013.  The researcher’s 
interest in this area was two-fold: working in medical education in sexual health and an 
association with the Centre for Military and Veterans’ Health. The overall aim of this study 
was to determine the prevalence of C. trachomatis infection and to identify potential high 
risk populations.  For this purpose, the following research questions were developed: 
1. Is the prevalence of C. trachomatis infection in the ADF different from the 
general population of Australia? 
2. Are there differing prevalences within subpopulations of the ADF? 
3. What factors determine varying prevalences among various subpopulations 
in the ADF? 
4. What are the risk determinants for C. trachomatis infection in the ADF? Can 
these risk determinants be addressed through secondary prevention 
measures? 
 
Even though the approval processes through the various levels of the ADF hierarchy were 
complex, much good will existed in many areas of the ADF for this study to proceed and 
reach its conclusion.   
 
The initial aspects of this study grew out of the Chlamydia Targeted Grants Program that 
were offered by the Commonwealth Department of Health and Ageing in 2007.   These 
grants were made available because of the wider concerns about C. trachomatis rates in 
the Australian community and to investigate simple and accessible systems for testing.  
 
The concept for the study originated with the Centre for Military and Veterans’ Health 
(CMVH). The research candidate developed the original concept into a PhD proposal and 
assisted CMVH personnel in the application for funding.  The final study design was the 
combined work of the research candidate and the supervisory team.  The candidate led all 
aspects of the research, including participant recruitment.  
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The findings from this study in C. trachomatis prevalence, STI diagnosis and safe sex 
practice were compared to the general Australian population and to other similar military 
populations.   
 
1.1.2 Organisation of the Thesis 
 
This thesis is structured in traditional format with much of the background arising from a 
comprehensive literature review.  The literature review in the background chapter (Chapter 
Two) focussed on sexual risk and behaviour and on education interventions. Because the 
role of this review was to provide context, it did not attempt to adhere to PRISMA 
guidelines for systematic reviews and meta-analyses. The methodology chapter (Chapter 
Three) describes the processes undertaken in the development of the study and 
throughout the study itself. The results chapter (Chapter Four) is divided into six sections.  
The first provides a description of the findings from the urine screen and from all questions 
in the survey, the second provides an analysis of C. trachomatis prevalence and of self-
reported STIs, the third section analyses safe sex practices among the subpopulations of 
the ADF, the fourth section analyses access to health services and provides and 
examination of utilisation of ADF health services and of civilian health services.   The final 
two sections compare the findings and analysis noted above to the broader ADF 
population and to the Australian population.  The discussion (Chapter Five) presents an 
interpretation of the results and includes debate about each of the topics that emerged 
from the study.  As the organisation of the study was complex, the discussion contains a 
comprehensive section examining methodological considerations.  
 
An attempt has been made to standardise the terminology used for C. trachomatis. 
Variance exists when direct quotes are used or when the vernacular ‘chlamydia’ is more 
appropriate.  
 
The last two sections of this thesis describe future research directions and presents the 
study’s conclusions (Chapter Six). There is more to be undertaken in analysis of 
components of the data collected through this study. The researcher did not attempt to 
publish findings while completing this thesis as this involved discussion and approval 
processes with the ADF that impacted on time dedicated to completion of the study itself.   
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Chapter 2: Background   
 
2.1 C. trachomatis Biology, Natural History and Clinical Spectrum  
 
C. trachomatis has been recognised as a microorganism that causes disease in humans 
since Egyptian times (Schachter et al. 1978). Chlamydiae are obligatory intracellular 
parasites that kill their host cell at the end stages of their growth cycle (Schachter & 
Stephens 2008).  The disease process and clinical manifestations of chlamydial infections 
probably represent the combined effects of tissue damage from C. trachomatis replication 
and from inflammatory responses to chlamydiae (Schachter & Stephens 2008). C. 
trachomatis is considered a pathogen as its replicative cycle results in the death of the 
host cell (Paavonen 1999) which are preferentially squamocolumnar epithelial cells.   
 
The lifecycle is about 72 hours beginning with infection by an elementary body entering the 
host cell, that over the next hours transforms intracellularly to a reticulate body and begins 
to multiply.  Within 18–24 hours some reticulate bodies reorganise into elementary bodies 
and in the process break down the host cell walls.  These elementary bodies are released 
to infect adjacent cells and potentially other hosts (Shaw et al. 2000; Paavonen 1999).  
 
C. trachomatis can be differentiated into 19 serovars.  Of the principal variants, serovars A, 
B, Ba and C cause ocular trachoma. Serovars L1, L2 and L3 cause lymphogranuloma 
venereum. Serovars D to K are associated with genital infection (Schachter & Stephens 
2008). 
 
Although acute infection may manifest as vaginal/urethral discharge, pain on urination, or 
pelvic inflammatory disease, 85-90% of cases are asymptomatic (SHSV 2008) and this is 
reinforced by Sutton, suggesting 90% are asymptomatic (Sutton et al. 2003).  The majority 
of infections with C. trachomatis are “difficult to diagnose clinically and elude detection 
because they produce few or no symptoms” (Stamm 2008).  There is evidence that a 
percentage of C. trachomatis asymptomatic infection will clear over time (Molano et al. 
2005; Morre et al. 2002) however infection in some asymptomatic individuals may last for 
years (Fairley et al. 2007).  
 
In women, untreated C. trachomatis is known to cause Pelvic Inflammatory Disease (PID), 
ectopic pregnancy, infertility and perinatal morbidity (Stamm 2008; Chen et al. 2005, 
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Haggerty et al. 2003, Cohen & Brunham 1999, Hills et al. 1996).  The Australian National 
Guidelines for the Management of STIs indicate that 60-80% of PID in women under 25 
may be “caused by sexually transmitted chlamydia or gonococci mixed with other 
commensals and anaerobic genital flora” (SHSV 2008). Long-term complications may 
include infertility (Moore et al. 1990) and ectopic pregnancy (Wolner-Hanssen et al. 1990). 
Guy et al. (2011) found “limited high quality evidence regarding the association between 
chlamydia infection and reproductive sequalae". However, they calculated that the 
proportion of PID in young Australian women that was attributable to C. trachomatis 
infection was between 17% and 24%.  
 
In men, untreated C. trachomatis (and gonorrhoea) represent the most important causes 
of urethritis (SHSV 2008) which may have consequences for partners such as PID and 
tubal factor infertility (SHSV 2008). C. trachomatis is also known to cause epididymitis and 
proctitis. (Stamm 2008) and possible long term complications including arthritis, prostatitis, 
and epididymitis (Stamm  & Cole 1986).  Trei et al. (2008) in their retrospective cohort 
study involving 17,764 men from the US Air Force that examined reproductive tract 
complications associated with C. trachomatis infection found a significant association 
between previous diagnosis of C. trachomatis and any reproductive tract complication 
(hazard ratio 1.37). 
 
Infection can also increase the risk of transmission and acquisition of other STIs, most 
notably HIV (Wasserheit, 1992; Eron et al. 1996).   Wasserheit (1992) suggested a 
synergy between some STIs and HIV where the STIs assist in both the acquisition of HIV 
and in HIV progression (although this latter point was inconclusive). In addition, HIV 
assists in the acquisition and progression of some STIs.  Wasserheit noted that the 
number of exposures to an STI pathogen rather than the categorical presence or absence 
of the STI may be a factor in HIV progression.  
 
C. trachomatis infection is easily detected and can be rapidly eradicated with a single 
course of oral antibiotics (Stamm 2008; Ginige et al. 2006).  The standard treatment in 
Australia is a single dose of azithromycin 1 g orally stat however a 7 day course of 100mg 
twice daily of doxycycline may also be prescribed (SHSV 2008). There is evidence that C. 
trachomatis  may, and has, become resistant to some antibiotics (Somani et al. 2000). 
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2.2 C. trachomatis Epidemiology  
   
2.2.1 Worldwide  
 
The World Health Organisation (2012) estimated that in 2008 there were 105.7 million new 
cases of C. trachomatis. There is limited national C. trachomatis prevalence data available 
in many locations across the world.  Where data exists, it often concentrates on 
subpopulations and within this subset, is often limited by sample bias due to recruitment 
procedure. 
 
A systematic review of C. trachomatis studies in the United Kingdom (Adams et al. 2004) 
showed that among those who attended GP practices, those under 20 year old age group 
had an estimated prevalence of 8.1% 20–24 year olds 5.2% and 25 –29 year olds 2.6%.  It 
was acknowledged that in this study, the prevalence would most likely be higher among 
those who seek health services, than in the general population.   
 
An early systematic review of the prevalence of C. trachomatis among European women 
(Wilson et al. 2002) reported prevalences between 1.0% and 17%. The majority of such 
studies involved earlier testing methodologies and particular study populations. In the 
Netherlands, a study by van Bergen et al. (2005) revealed an overall prevalence of 2.0% 
comprising 2.5% in women and 1.5% in men. In Portugal, prevalence among women aged 
14 to 30 was found to be 4.6% (Brito de Sa et al. 2002). A study involving 19,773 
individuals (aged 16–39) in Denmark found a C. trachomatis prevalence rate of 2.8% in 
men and 3.6% in women. Among individuals younger than 25, the rate was 5.1% for men 
and 6.2% for women (Anderson et al. 2002). 
 
In the US, studies reported an overall C. trachomatis prevalence rate of 6.5% among 
1,933 grade 7 to 12 students (Cohen et al. 1998) and 4.19% among 14,322 young adults 
aged 18 to 26 (Miller et al. 2004). Additionally, it was estimated that the C. trachomatis 
prevalence rate among 15–24 year olds in 2000 was 2.54%; this was based on a C. 
trachomatis prevalence estimate by Weinstock et al. (2004) of 1 million in this age group 
and correlated to the census data (US Census Bureau 2000) indicating there were 
39,357,000 individuals in this age group in 2000. Torrone et al. (2013) reported an overall 
C. trachomatis prevalence rate of 1.2% among women in the US, with a prevalence rate of 
2.9% among those with more than two sex partners in the previous 12 months. 
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The prevalence of C. trachomatis in African countries is estimated at 2.6% for females and 
2.1% for males (WHO 2012). In Kenya, a study of women attending outpatient clinics 
found a prevalence rate of 6% (Kohli et al. 2013). A study of men and women attending a 
Gabonese public health clinic for a sexual health matter found a prevalence rate of 53.6% 
(Fleury & Siawaya 2014).  
  
2.2.2 Australian General Population  
 
The Australian Chlamydia Control Effectiveness Pilot (ACCEPt) trial reported a C. 
trachomatis prevalence of 4.6% (M 5.2%, F 4.4%) among 4,284 16-29 year olds who were 
recruited at the time of attendance (for any reason) at the GP practice or Aboriginal 
Medical Service.  
 
A meta-analysis and systematic review of the prevalence of C. trachomatis infection in 
Australia was published by Lewis et al. in 2012. Studies conducted after 2005 were eligible 
for inclusion. Seventy-six studies were included and the C. trachomatis prevalence 
(pooled) for women under 25 was 5.0% and for men under 30 was 3.9%.   An earlier 
analysis by Guy et al. (2011) for the NSW Department of Health found a prevalence 
between 3 and 12% in community and clinic based studies involving young people.  Both 
research projects concluded that heterogeneity of the studies included and the non- 
random sampling methodologies of many studies reduced the capacity for accurate 
estimations of C. trachomatis prevalences.  
 
The meta-analysis conducted by Lewis et al. (2012) found a trend toward higher C. 
trachomatis prevalence among younger populations and this was reinforced by Guy et al. 
(2011). Hocking et al. (2006) found higher prevalences among younger women and Chen 
et al. (2004) found that adolescents and females less than 25 years were more at risk of C. 
trachomatis infection.  
 
Lewis et al. (2012) noted that the pooled prevalence estimates for Indigenous women less 
than 25 years was 22.1% and for Indigenous men less than 25 years was 14.6%.  
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2.2.3 Defence Populations  
 
A first glance suggests a higher prevalence of C. trachomatis in defence populations than 
in non-defence populations (Gaydos et al. 2000; Gaydos et al. 1998; Brodine 2003; Stary 
et al. 1991). Sena et al. (2000) reported an age- and race-adjusted higher incidence of C. 
trachomatis among both male and female active duty soldiers at Fort Bragg, one of the 
largest defence force sites in the US, and Brodine and Shafer (2003) wrote an article on 
combating chlamydia in the military, asking “Why aren’t we winning the war?” Stary et al. 
(1991) reported a C. trachomatis infection rate of 12.2% among Austrian male military 
personnel compared to 1–7% among asymptomatic males in civilian studies. However, a 
closer examination of sample populations, testing methodology and recruitment methods 
demonstrates confounding variables that affect the overall prevalence.  
 
Tables 2.1, 2.2 and 2.3 provide a summary of reported prevalences of C.trachomatis by 
gender and sample type.  Where ‘pre’ is stated in the year of study this notes that the 
study occurred prior to the listed year as the actual year of the study was not reported in 
the published paper. The age range is not stated in all papers.  The tables further group 
studies into those where the test performed utilised cultures or immunoassays or where 
the test performed utilised Nucleic Acid Amplification Tests (NAATs). 
 
Table 2.1 C. trachomatis among female military personnel 
Year 
of 
study 
Sample 
Prevalence 
Sample 
Size 
Reference 
Population 
Recruitment 
Method 
Country 
Age 
Range 
Test performed using culture or immunoassays 
1991 
pre 
Serving 
personnel 
Attendance at 
health service 
USA 
Not 
stated 
12% 620 
Demaio 
1991 
1991 Active duty 
Attending for pap 
smear 
USA 18-38 8.2% 476 
Catterson 
1993 
 
Test performed using Nucleic Acid Amplification Tests 
1995 
Active navy 
personnel 
Volunteer within 
cohort 
USA 18-45 4.7% 299 
Thomas 
2001* 
1997 Recruits At time of entry  USA 17-39 9.2% 13204 
Gaydos 
1998 
1998 
Serving 
personnel 
shore based 
cohort 
USA 
Mean 
27.2 
6.9% 131 
Brodine 
1998* 
1998 
Serving 
personnel 
submarine tender USA 
Mean 
25.4 
2.7% 183 
Brodine 
1998* 
1998 
Serving 
personnel 
Attendance at 
STD clinic 
USA 
Not 
stated 
11.6% 793 
Gaydos 
2002 
1998 
Serving 
personnel 
Hospitalization USA 
Not 
stated 
9.1% 7053 
Clark 
2002 
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Table 2.1 C. trachomatis among female military personnel (Continued) 
Year 
of 
study 
Sample 
Prevalence 
Sample 
Size 
Reference 
Population 
Recruitment 
Method 
Country 
Age 
Range 
1998 
Serving 
personnel 
 
Requesting pap 
smear 
USA 17-47 7.3% 480 
Gaydos 
1998 
1999 Recruits 
at time of entry 
physical 
examination 
USA 17-39 8.5 – 9.9% 23013 
Gaydos 
2003 
1999 Active duty 
attending medical 
clinic  
USA 
Not 
stated 
19.1% 822 
Zenilman 
2002 
2000 Recruits 
Controls for an 
intervention study 
USA 17+ 13% 332 
Shafer 
2008 
2003 Soldiers 
Seeking medical 
care 
Israel 18-45 3.2% 708 
Bamberger 
2003 
2004 
deployment in 
Iraq 
Annual 
gynaecological 
exam 
USA 19-53 0.52% 1737 
Buller 
2006* 
2009 
serving 
personnel 
Medical records USA 18+ 3.5% 66 
Aldous 
2011* 
* Study populations pooled to provide an overall C. trachomatis prevalence 
 
Table 2.2 C. trachomatis among male military personnel 
Year 
of 
study 
Sample 
Prevalence 
Sample 
Size 
Reference 
Population 
Recruitment 
Method 
Country 
Age 
Range 
Test performed using culture or immunoassays 
1979 
Serving 
personnel 
Attending medical 
clinic 
USA 19-28 11.3% 97 
Podgore 
1982 
1990 
Serving 
personnel 
Attending hospital 
for check up 
Austria 
Not 
stated 
12.2% 335 
Stary 
1991 
1992 
Conscripts at 
recruit 
2 mths after 
recruitment to test 
assays 
Denmark 19-23 7.9% 392 
Jensen 
1992 
1992 
Serving 
personnel 
Attendance at a 
medical clinic as 
part of a broader 
study (inc younger 
people) 
USA 12-35 7% 42 
Shafer 
1993 
1992 
pre 
Recruits 
health assessment 
at recruitment as 
part of testing 
method study 
Sweden 
Mean 
19.5 
9.3% 279 
Genc 
1992 
1993 
pre 
recruits On first day Norway 19-21 6.1% 392 
Scheel 
1993 
1993 Recruits 
Recruited for 
testing sensitivity 
study 
Austria 
Mean 
18 
1.3% 224 
Domeika 
1994 
1996 
Serving 
personnel 
Attending for 
urethritis 
USA 18-43 36% 400 
McKee 
2000 
2000 
Serving 
personnel 
Clinical attendance 
for urethritis 
Brazil 
Not 
stated 
23.3% 
unknow
n 
Castro 
2000 
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Table 2.2 C. trachomatis among male military personnel (Continued) 
Year 
of 
study 
Sample 
Prevalence 
Sample 
Size 
Reference 
Population 
Recruitment 
Method 
Country 
Age 
Range 
Test performed using Nucleic Acid Amplification Tests 
1994 
Serving 
marines 
Random cohort 
from another study 
USA 18-43 4.1% 1028 
Schafer 
2002* 
1994 Recruits 
at time of health 
assessment at 
recruitment 
Austria 
Not 
stated 
4.1% 705 
Stary 
1996 
1998 
Serving 
marines 
Volunteer on 
deployment 
USA 
Mean 
21.3 
5.2% 406 
Brodine 
1998* 
1998 
Serving 
personnel 
Volunteer from 
shipboard cohort 
USA 
Mean 
22.4 
3.4% 618 
Brodine 
1998* 
1998 Recruits 
at time of health 
assessment at 
recruitment 
Denmark 18-29 4.6% 388 
van den 
Brule 
2002 
1999 Active duty 
attending medical 
clinic  
USA 
No 
stated 
14.1% 2038 
Zenilman 
2002 
2000 Recruits 
at time of health 
assessment at 
recruitment as part 
of testing method 
study 
USA 
Not 
stated 
3.3% 1438 
Wood 
2007 
2000 Recruits 
at time of health 
assessment at 
recruitment 
USA 
Not 
stated 
4.7% 3911 
Arcari 
2004 
2001 
Officer 
training 
cadets 
Attending advanced 
training 
USA 18-32 2.48% 1443 
Sutton 
2003 
2001 Recruits  
Present on base at 
time of study 
USA 17-35 5.3% 2245 Cecil 2001 
2001 
pre 
Serving 
personnel 
Volunteers from 2 
bases 
New 
Zealand 
17-35 4.0% 200 
Cole 
2001* 
2002 recruits 
at time of health 
assessment at 
recruitment 
UK 
16-25 
approx 
9.8% 798 
McKay 
2003 
2004 
Serving 
soldiers 
Seeking medical 
care 
USA 18-25 8.0% 138 
Greene 
2007 
2005 Recruits 
Full cohort enlisted 
to study 
Brazil 17-24 5% 627 
Fioravante 
2005 
2007 Recruits 
at time of health 
assessment at 
recruitment 
Switzerland 18-26 1.2% 517 
Baud 
2008 
2009 
US Army 
serving 
personnel 
Medical records USA 18+ 6.6% 124 
Aldous 
2011* 
* Study populations pooled to provide an overall C. trachomatis prevalence 
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Table 2.3 C. trachomatis among military personnel where gender is not differentiated 
Year 
of 
study 
Sample 
Prevalence 
Sample 
Size 
Reference 
Population Recruitment Method Country 
Age 
Range 
Test performed using Nucleic Acid Amplification Tests 
2001 Recruits 
at time of health 
assessment at 
recruitment 
Slovenia 18-28 2.75% 1272 
Skaza 
2003 
 
Studies involving recruits and studies focusing on particular subpopulations (e.g. 
attendance at a health clinic) found higher C. trachomatis prevalence rates, which may 
have resulted from sample bias. Additionally studies utilised outdated testing 
methodologies provided mixed prevalence rates and may also have confounded results. 
Only 10 studies (highlighted with an asterisk in the reference column) had utilised NAAT 
testing methodology, had a sample population of serving personnel and a random 
component in the recruitment. These 10 studies had a pooled sample of 4,792 
participants, with 139 positive results, revealing a pooled prevalence rate of 2.9% overall 
and 1.6% for females and 4.2% for males.   
 
These studies did not account for recurrent diagnoses. Research suggests that the 
incidence of recurrent C. trachomatis is high, especially in younger age groups (Barnett & 
Brundage 2001; Fung et al. 2006). 
   
2.3.4 Australian Defence Populations  
 
Peacock, Debattista and Mortlock (2006) reviewed the evidence of C. trachomatis 
prevalence in the ADF in the literature. The exploratory study found a prevalence rate of 
1.9%; however, the study was too small to generate significant findings. Writing in the 
same year, Nisyrios (2006) advocated for the introduction of a C. trachomatis screening 
program in the ADF.  
 
Reports examining C. trachomatis in the ADF are limited. In O’Keefe’s (1994) discussion 
of medicine in Southeast Asian conflicts, non-specific urethritis is listed as a common STI; 
however, rates are not disclosed. Based on his experience as Regimental Medical Officer 
for the 4th Field Regiment in Vietnam in 1967, Bradford (2005) reported that non-specific 
urethritis was the second most common STI after gonorrhoea. 
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2.3 Sexual Health and the Defence Forces  
   
2.3.1 History of Sexual Health and the Defence Forces 
 
Sexual health and the military have a long history (Greenberg 1972; Adler 1980). As early 
as the Peninsular War (1804–1814), a General noted that he had seen more syphilis “than 
had been found in the hospital of England in the whole of the previous century” (Brandt 
1988). During the Boer War, the rate of admission to army hospitals for STIs rose to over 
500 per 1000 men and represented 37% of all admissions (Brandt 1988). 
 
In Australia World War I was seen as the catalyst for the introduction of significant efforts 
to control the spread of STIs (Temple-Smith & Gifford 2005). In 1915, the large number of 
Army recruits with STIs prompted the Commonwealth Government to consider legislation 
for treatment.  The need to combat STIs became as important as the war effort itself as it 
was viewed as necessary to keep the military fit for duty rather than restricted or 
incapacitated by syphilis and gonorrhoea (Cutler and Arnold 1988).  Anti-sex messages as 
a form of STI prevention and designed to instil fear and loathing, reached its peak during 
World War 1 when American soldiers were told, “A German bullet is cleaner than a whore”. 
(Brandt AM 1988)  
 
Between the two world wars, the STI problem became less urgent and retreated from 
public consciousness (Vonderlehr & Heller 1946). However, World War 2 again brought 
about national recognition of the adverse effects of STIs (Cutler & Arnold 1988; Adler 
1980). Paradoxically, the advances in penicillin therapy which arose out of World War 2 
permitted a single injection cure of syphilis and gonorrhoea, and saw the loss of both 
public concern about and medical and political interest in STIs (Cutler & Arnold 1988; 
Korzeniewski 2012). 
 
Before truly effective treatments were available for STIs, many methods were employed by 
the military to control transmission. The first official approach of the US Army to 
discourage soldiers from putting themselves at risk of STIs was a financial penalty. A 
regulation in 1778 established fines of $10 and $4 for officers and enlisted soldiers, 
respectively, who were diagnosed with an STI. In 1814, another regulation required 
soldiers infected with STIs to pay for their treatment and forego wages for the period of 
time in which they were absent from duty (Emerson 1997).  
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Another mechanism in the attempt to control STI transmission was the utilisation of shame 
and associated punitive measures. By the end of World War 1, the US military was using 
shame as a means of punishment for contracting an STI. In an attempt to change 
behaviour, General Order No. 215 was issued requiring a physical exam for signs of STIs 
in troops returning to the US. Those soldiers found to be infected would be detained while 
their units went home (Brandt 1985). This did not only apply to the soldiers themselves but 
also, on some occasions, to their superiors. A more effective punitive approach came in 
the form of holding commanding officers responsible for the incidence of STIs among their 
men. When first implemented during World War 1, this policy halved the STI rates in some 
companies (Emerson 1997). This shame and punishment approach was also adopted by 
moral reformers of the time (Greenberg 1972), of whom Florence Nightingale is the best 
known example. The control of STIs was seen as a “moral” as much as a “medical” 
problem, and moral considerations loomed large in traditional notions of discipline and 
military honour (Harrison 1995).  
 
Shapiro et al. (1974) argued that the Vietnam War was also accompanied by an increase 
in the incidence of STIs. In a review of clinical cases presented to a major military hospital 
in the war zone in Vietnam from November 1970 to October 1971, new cases of gonorrhea 
were diagnosed on average 292 times per month (Shapiro et al. 1974). 
Historically, war and STIs have always been interrelated.   
 
2.3.2 Contemporary  picture of Sexual Health and Defence Forces  
 
Until recently, epidemiological surveys conducted in defence forces have consistently 
revealed elevated rates of STIs among their serving members, compared with the general 
population. The UN estimated that peacetime infection rates among military forces were 
typically two to five times greater than rates found in civilian populations (UNAIDS 1998a). 
The UN report also noted that, in times of conflict, the military may have infection rates up 
to 50 times higher than civilian populations (UNAIDS 1998b). Further, STI infection rates 
tended to be higher among military units stationed away from home (Foreman 2002). An 
example was offered by McKee et al. (1998) who examined syphilis among active duty 
soldiers at Fort Bragg and a non-military population during a 9 year period, a total of 762 
cases of primary and secondary syphilis were recorded, 27% of which occurred in the 
soldiers.  
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Larsen et al. (2004) suggested a reason for this continued higher prevalence of STIs 
among military personnel was that conflict settings often stimulated an increase in 
transactional sexual activity. Military personnel, especially those on peacekeeping 
missions, often have more disposable income than the surrounding populations and thus 
have the financial means to purchase sex (Larsen et al. 2004). Shafer et al. (2002) 
suggested that young military men are at high risk of acquiring STIs because they are 
often deployed to foreign countries with high endemic rates of chlamydial, gonococcal and 
HIV infections and that STIs not only place these young men and their partners at risk of 
negative health outcomes, they also pose a threat to military readiness.  
 
Recent evidence suggests that this pattern may be changing in some military populations. 
In a study of the rates of gonorrhoea and C. trachomatis in US military personnel deployed 
to Iraq and Afghanistan between 2004 and 2009, the investigators suggested that, overall, 
the rates of gonorrhoea and chlamydia were the same or lower than age- and year-
matched rates in the US as reported by the Center for Disease Control and Prevention 
(CDC) (Aldous et al. 2011). 
 
Complications that may arise from C. trachomatis infection have also been documented in 
Defence Forces.  In the USA, army and navy recruits reported a crude incident rate of PID 
of 13.6 and 8.3 per 1000 person years respectively (Bloom et al. 2008). Clark et al. (2002) 
noted that women who were screened for C. trachomatis were less likely to be hospitalised 
than those that weren’t however, specific hospitalisation for PID was similar in both 
groups. Trei et al. (2008) reported that C. trachomatis infection was associated with 
increased reproductive tract complications in their study of 17, 764 US Air Force males.  
 
2.4 Sexual Risk and Behaviour in Australian Populations 
 
The majority of Australians are in heterosexual regular relationships (85% of men and 89% 
of women) and those in a regular relationship indicated they had sex, on average, 1.84 
times per week in the four weeks prior to the study of almost 20,000 16-59 year old 
Australians (Rissel et al. 2003b).  Younger people had sex more often.  Only 4.9% of men 
and 2.9% of women in heterosexual regular relationships reported having concurrent sex 
with another person in the last 12 months. Again, younger people were more likely than 
older people to report this.    
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The median age of first sexual encounter for males and females in Australia is sixteen 
(Rissel et al. 2003a).   
 
8.6% of females and 5.9% of males reported some homosexual experience throughout 
their life and 1.5% of females and 1.9% of males reported homosexual activity within the 
previous 12 months (Grulich et al. 2003).  
 
15.6% of Australian men reported ever having paid for sex and 1.9% had done so in the 
previous 12 months.  The vast majority of this (97%) had been with a female. 10% of men 
who had paid for sex had done so only overseas.   Very few women had ever paid for sex 
(0.1%).   Men were more likely to indicate that they had been paid for sex (0.9% vs 0.5%) 
than women and two thirds of this was by other men.   
 
Among all the ASHR respondents, 41% indicated they always used condoms with casual 
partners (in the last six months) and approximately 20% used condoms during their last 
occasion of vaginal intercourse (de Visser et al. 2003). 
 
Australians engage in sex while on overseas travel (Brown et al. 2012; Streeton 2006), 
and sex while travelling is considered a risk behaviour as it is more likely to be unsafe and 
is more likely to be in circumstances not totally familiar to the individual (Memish & Osoba 
2006).  
 
Sexual behaviour in itself is complex and Donovan (2000a; 2000b) suggested the 
repertoire of human efforts to avoid STIs is not only complex but idiosyncratic and variable. 
Individuals employ a complete cross-section of strategies before (or instead of) sex and 
during sex. Examples of these strategies include: partner selection whereby potential sex 
partners are viewed in terms of their likelihood to carry STIs; inspection of genitals before 
sex; and esoteric sex where the chance of transmission of STIs may be reduced. A full 
understanding of the behavioural aspects of STI avoidance is required to develop effective 
public health measures and campaigns.  
 
There is no contemporary available data on sexual behaviour amongst members of the 
ADF. 
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2.5  Risk Determinants for C. trachomatis  
 
2.5.1  Definitions  
 
Since the 1980s safe sex has been defined in the context of HIV transmission (Kippax et 
al. 1992; DilOrio et al. 1992) and more broadly as prevention of acquisition of STIs (DilOrio 
et al. 1992; Warner et al. 2006).  Prior to this it was used in the context of avoidance of 
pregnancy (DilOrio et al. 1992).  Regarding HIV acquisition, safe sex has been defined as 
consistent condom use (Connell & Kippax 1990). This definition has been translated into 
prevention of other STIs, especially gonorrhoea and C. trachomatis.  Inconsistent condom 
use is an associated factor with STI acquisition (Warner et al. 2006; Chen & Donovan 
2004; Gaydos et al. 1998).  
 
The definition used by Moskowitz et al. (2006) includes the four characteristics of safe sex 
- condom use; abstinence; monogamy; and safe partners and is suitable for a definition of 
risk behaviour for C. trachomatis infection. When examining risk determinants in this study, 
these four characteristics were considered. 
 
2.5.2 Risk Determinants for C. trachomatis Infection in Australia  
 
2.5.2.1 Number of partners 
 
The number of partners is a well-documented risk determinant for C. trachomatis infection 
across the world (Finer et al. 1999; Miller et al. 2004; Adams et al. 2004; Fung 2006) and 
in Australia (Yeung et al. 2014; Chen et al. 2005; Heal et al. 2002; Chen & Donovan 2004; 
Grulich 2003a). From the ACCEPt trial, Yeung et al. (2014) found that increasing partner 
numbers over the previous 12 month period increased the odds ratio for C. trachomatis 
infection. Heal et al. (2002) reported that, in a study of 508 patients aged 18–24 where 5% 
were infected with C. trachomatis, the only factors associated with increased risks of 
infection were attendance at a youth clinic and a recent change in sexual partner. Williams 
et al. (2003) reported that there was a greater risk for those who had recent partner 
change (OR 4.6). Kang et al. (2014) reported that a risk factor for having a history of any 
STI was three or more sexual partners ever or six or more in the past 12 months.  
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2.5.2.2 Age   
 
Williams et al. (2003) reported that those in their study from an inner city clinic who were 
under 25 were 5.4 times more likely to be diagnosed with C. trachomatis infection than 
those 25 and over.  Hocking et al. (2006) reported higher C. trachomatis infection rates 
among younger women than older women and Lewis et al. (2011) in their meta-analysis of 
C. trachomatis infection concluded that those under 25 (in all subpopulations) were more 
likely to be diagnosed with C. trachomatis.   
 
However, Kang et al. (2014) reported in a study involving 856 15–25 year olds that being 
20 years or older was a risk factor for having a history of STIs. This is in contrast to the 
above findings however the age range of this study is narrow compared to the above 
studies.  The complete sample of this study would fit into the younger subset of the above 
studies.  
 
2.5.3 Risk Determinants for C. trachomatis Infection in the Defence Forces 
 
Considering that a high rate of STIs in military populations was generally accepted as a 
fact in historical times, some researchers have attempted to provide insight into the 
possible reasons for the STI prevalence. A paper published by Watts and Wilson (1945) 
described a survey of 292 men and noted that the main predisposing personality traits 
among the patients with STIs were: 
1. Unstable men who do not control themselves in any aspect of their lives 
(psychopathic personalities); 
2. Habits of heavy drinking which are related to instability; 
3. Promiscuous men who are immature in their attitude and behaviour; 
4. Men who are too dull to be good soldiers and avoid venereal disease. 
A more contemporary scrutiny is presented in the following sub-sections.  
 
2.5.3.1 Defence Force Membership as an enabler of sexual risk 
 
A recent study by Anastario et al. (2013b) examined the impact on sexual risk behaviour 
from defence force membership itself (labelled the “military occupational habitus”). The 
research argued that the higher STI rates noted in military populations may be due to 
intrinsic factors of the occupation. They concentrated on two areas: firstly, the cyclical 
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nature of military work and rest (based on evidence of sexual encounters during historical 
rest and recuperation rotations); and secondly, the hazardous and risky nature of defence 
work itself. The latter concept suggests that defence personnel are trained to work within a 
risk environment and therefore do not necessarily view risk as negative. The researchers 
argued that this may lead to taking greater risk in sexual behaviours. It was noted that the 
paper was theoretical and conceptual; however, the concept has also been raised when 
discussing HIV prevention in several studies (Hendrix & Daniell 1999).  
 
A further argument in favour of defence force membership as an enabler of sexual risk 
was posited by Nordvik et al. (2007). Their research suggested that certain individuals act 
as “spatial bridgers” in the spread of C. trachomatis as STIs are spread through contact 
networks. Spatial bridgers were described as individuals who move among different circles 
are likely to be vectors of broader spread. In Nordvik et al.’s study, approximately 8% of 
people were spatial bridgers. In the discussion, members of military organisations were 
noted as possible spatial bridgers.  
 
2.5.3.2 Number of sexual partners 
 
In studies focusing on sexual activity in defence forces, a commonly discussed behaviour 
is the number of sexual partners (Anastario 2010; Korzeniowski et al. 2003; Shafer 2002; 
Bing 2008; Crutcher & Papdimos 1992; McCeary 1980; Eitzen 1997). Shafer et al. (2002) 
reported that marines who had more than one sexual partner were 1.56 times more likely 
to have had a recent STI (including C. trachomatis) and Skaza et al. (2003) and van den 
Brule et al. (2002) indicated that the greater the number of sexual partners, the more likely 
an individual was to have tested positive for C. trachomatis. Arcari et al. (2004) found that 
more than one sexual partner in the past three months was a significant factor in C. 
trachomatis infection, as did Thomas et al. (2001) for the previous six month period and 
Fioravante et al. (2005) for the previous two month period.  
 
Bing et al. (2008) examined HIV-related risk behaviour among military men in a post-
conflict African country. They found that the factors that independently predicted the 
number of sexual partners included younger age, younger age of sexual debut, being 
away from home, higher military rank, higher education, alcohol before sex, and problem 
alcohol use.   
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Sutton et al. (2003), however, indicated that the number of sexual partners did not present 
a risk factor for C. trachomatis among a study of 1,443 male college cadets. The risk 
determinants found in their study were race (African American); partner with a previous 
history of STIs; and self-reported symptoms.  
 
A recent study by Stahlman et al. (2014) examined differences in gender and sexual risk. 
10,250 personnel were included in the study and its main finding was that the number of 
sexual partners was the main factor associated with reporting an STI. When specifically 
examining more or less than five partners in the previous 12 months, the adjusted odds 
ratio for women was 4.78 and for men it was 5.87. Individuals who engaged in sex with 
partners who had other partners were also found to have a higher chance of having had a 
recent STI (OR 1.35) (Shafer et al. 2002).  
 
2.5.3.3 Age 
 
Studies into C. trachomatis infection in military populations demonstrate inconsistent 
findings regarding age as a risk determinant (Shafer et al. 2002).  The primary reason is 
that many of the sample populations only include younger individuals.  Where a broader 
age range is included, younger age becomes a risk determinant (Gaydos et al. 1998a; 
Adib et al. 2002). Additionally, Gunderson et al. (2001) found young women in the US 
Navy were more likely to have an STI than older women.  While not relating to military 
populations, Kang et al. (2014) found in a study of Australian 15-25 year olds, that being 
over 20 was a risk factor within this narrow sample rather than comparing this age range to 
older age ranges.   
 
2.5.3.4 Condom use 
 
Studies among defence force populations reinforce the finding by Warner et al. (2006) that 
condom use may be associated with recent or current C. trachomatis infection but that 
study results are inconsistent. Shafer et al. (2002) found an odds ratio of 1.07 between 
frequency of condom use and recent STI, and Thomas et al. (2001) and Gaydos et al. 
(2003) found a significant protective association between the use of condoms and C. 
trachomatis infection. Fioravante et al. (2005) found that individuals who failed to use 
condoms were 5.3 times more likely to be diagnosed with C. trachomatis.  
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Sutton et al. (2003) found no relationship between condom use and C. trachomatis 
infection. Arcari et al. (2004) and Baud et al. (2008) also found no association between 
condom use and C. trachomatis infection. The study by Baud et al. found a prevalence 
rate of 1.2% and indicated that this low rate may have affected the ability of the study to 
determine associations. The study by Arcari et al. focused on education interventions and 
found that the intent to use condoms and confidence in using condoms both increased 
significantly as a result of education; however, they found no significant relationship 
between the use of condoms and C. trachomatis infection. 
 
2.5.3.5 Alcohol consumption 
 
Alcohol use is considered to be high in many military populations (Bianchi & Popper 2000; 
Shafer et al. 2002; Bing 2008; Cook et al. 2006; Anastario 2013; Stahlman 2014; Eitzen 
1997; MacQueen 1995). Studies that have examined the relationship between alcohol use 
and safe sex practice and/or STI prevalence report mixed relationships. Shafer et al. 
(2002) reported a correlation between alcohol disinhibition and recent STIs (OR 1.14) as 
did Bing et al. (2008). Among US Air Force recruits, a study by Cooper et al. (2008) 
reported an association between binge drinking and the likelihood of not practising safe 
sex, as did Thomas et al. (2001). However, Baud et al. (2008) found no association in a 
study of Swiss recruits.  
 
A comprehensive study by Thompson et al. (2005) comprising a sample of 17,264 military 
personnel through the US Department of Defense ‘Survey of Health Related Behaviors 
Among Active Duty Military Personnel’ found that higher frequency of alcohol intoxication 
was associated with having more than one sexual partner in the previous 12 months. This 
was a dose response for both men and women. Additionally, among males, frequent 
episodes of intoxication impacted on condom use with casual partners.  
 
2.5.3.6 Deployment 
 
Historically deployment was seen to increase risk of STIs however in modern defence 
forces, deployment has been argued as a protection against STIs. Anastario et al. (2013) 
argued in their conceptual paper that deployment leads to less sexual behavioural risk. 
This is supported by an early study by Palmer (2003) reporting that deployment acted as a 
mechanism to diminish the libido. Hyams et al. (1995) found that infectious diseases were 
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not a major cause of lost manpower during the two Iraq wars. However, historically, 
deployment has been seen as a risk determinant for STIs (Bradford 2005; Deller & Smith 
1982; White 1967). 
 
2.5.3.7 Sex with sex workers 
 
Sex with sex workers is reported in many military populations (Boyer et al. 2001; Malone et 
al. 1993; Shafer et al. 2002; Anastario et al. 2010; 2013b; Crutcher & Papdimos 1992; 
Kitsiripornchai et al. 1998); however, few contemporary studies have examined the 
relationship between sex with a sex worker and STI rates. Even though, historically, sex 
with sex workers while on deployment has translated to STI infections (Sun 2005; Bradford 
2005; Deller & Smith 1982; White 1967), contemporary studies illustrate there is little 
relationship between sex with sex workers and STI acquisition. Shafer et al. (2002) noted 
an odds ratio of 0.96 in their study of US marines. 
 
2.5.3.8 Length of time in the military 
 
Some studies suggest a correlation between the length of time in the service and the 
likelihood of reporting STIs. Early in this line of enquiry, McCreary (1980) reported that 
individuals who had been in the service for less than three years were more likely to report 
urethritis aboard ships on deployment. He noted this was confounded by age but that 
length of service was also a contributing factor.  
 
2.5.3.9 Mental Health 
 
An emerging area of enquiry is the relationship between mental health (specifically PTSD 
and depression) and sexual risk behaviour (Murdoch 2007). Harbertson et al. (2013) found 
a correlation between PTSD and the reporting of STI symptoms, and Stahlman et al. 
(2014) reported that women in psychological distress were almost twice as likely to report 
an STI. Stahlman et al. suggested that a possible explanation is that women face high 
levels of sexism or “unwanted gender-related behaviours” which may predispose them to 
risky sexual behaviours. Anastario et al. (2011) found a correlation between self-reported 
STIs and a major depressive episode (AOR 2.5) among their sample of 334 defence force 
personnel in Belize.  
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2.6 Sexual Health Policy and Education Responses in Defence Forces  
 
The primary focus of policy relating to sexual health in defence forces has been to 
maintain operational preparedness and, as such, has concentrated on the elimination of 
the impact of ill-health on the ability of the soldier to undertake duties (Jordan et al. 2011; 
Kamenov et al. 2000; Meynard et al. 2008). STIs have previously impacted on military 
capability (Adler; 1980; Anonymous 1916; Arcari et al. 2004; Kamenov et al. 2000) and 
measures for the avoidance and prevention, detection and treatment of STIs are evident in 
modern defence force operations (Arcari et al. 2004; Kaldmae et al. 2000; Gaydos et al. 
1998a; 2000). 
 
2.6.1 Prevention 
 
Studies consistently show that personnel in the military are highly sexually active (Chao et 
al. 2010; Bing 2008a; 2008b; Celentano et al. 2000; Sun 2004) and policy aimed at the 
avoidance and prevention of STIs has evolved from focusing on punishment and 
stigmatisation to focusing on personal responsibility and operational preparedness.  
 
Early strategies to encourage military personnel to avoid STIs, using financial and 
administrative punishment and stigmatisation, have proven to be ineffective and are no 
longer in use in many military organisations around the world (Adler 1980; Emerson 1997; 
Greenberg 1972; Editor, British Medical Journal 1944). As an example of previous 
approaches, an anonymous contributor to The Lancet in 1916 opined that punishment for 
venereal disease was important and wrote “If this policy seems to be punishing one 
partner only for the sin of the two it must be remembered that a poisonous woman [i.e. a 
sex worker] can poison a regiment” (Anonymous 1916). 
 
Wallace (1994) reported that one of the prevention activities undertaken by the US Navy 
was to review the ports of call for STI and HIV rates: “With these estimates of STDs, 
decisions are made whether to take a battle group into port”. 
 
Personal responsibility has always been a component of STI prevention and education 
campaigns in military organisations (Kaldmae et al. 2000; Surgeon General ADF Health 
Directive 242; Vidmar et al. 1996); however, personal responsibility campaigns have 
moved from stigmatisation approaches with emphases on family values and morals 
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(Wallace 1994) to personal protection and operational readiness (Arcari et al. 2004). 
Education in STIs in the US Navy and Marine Corps is coordinated through the Sexual 
Health and Responsibility Program. This is a comprehensive prevention, education and 
health promotion effort covering STIs, HIV and unplanned pregnancies (MacDonald 2013) 
that has personal responsibility at the heart of its strategies.  
 
2.6.2 Education  
 
Sexual health education responses in the defence forces are implemented at three levels: 
among military personnel, among the military personnel involved in delivering the training, 
and among the staff working in military health services. Education at each of these levels 
is discussed in the following sub-sections, followed by a brief discussion of the importance 
of evaluating educational interventions.  
 
2.6.2.1 Education of military personnel 
 
Within the personal responsibility framework, education and skilling on STIs among 
serving personnel has become a strong focus in defence force strategies. Yearly 
educational updates are usually compulsory (Booth-Kewley 2001; 2002) and are often 
accomplished through dedicated face-to-face group sessions (Yaren et al. 2004; Bing 
2008b; Celentano et al. 2000). In a case-control study, Booth-Kewley et al. (2001) reported 
that education interventions resulted in a significantly higher proportion of the targeted 
individuals using condoms to prevent STIs than those in the control group, one year after 
the education activity.  
 
In the US, from 1999 to 2010, all sailors were required to complete a course about the 
prevention of STIs, HIV or unplanned pregnancy as part of their general military training. 
This training was completed via the web (Navy Knowledge Online) or in a classroom 
setting, as determined by their organisational leadership (Navy and Marine Corps Public 
Health Center [NMCPHC] 2012). 
 
As well as face-to-face group education, cognitive behavioural interventions have also 
been shown to be effective in reducing behavioural risk and preventing STIs (Boyer et al. 
2005). The randomised controlled study by Boyer et al. (2005) used a variety of education 
methods, including lectures, group discussions and exercises presented to recruits at the 
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time of recruit training. Those in the control group (n=1095) were 1.41 times more likely to 
have a post-intervention STI than the study group (n=1062). 
 
Studies suggest that the content of education interventions needs to include the 
transmission routes of STIs (Ortiz et al. 2005; Yaren et al. 2004; Bing 2008a; Kamenov et 
al. 2000), situational awareness and understanding of local STI epidemiology (Kaldmae et 
al. 2000; Nwokoji & Ajuwon 2004), effectiveness of condoms (Ortiz et al. 2005; Celentano 
et al. 2000; Nwokoji & Ajuwon 2004); impact of alcohol consumption (Celentano et al. 
2000) and risk factors for STIs (Bing 2008a; Jenkins 2000), with the latter focusing 
primarily on the number of partners.  
 
Timing of education has also been examined. Anastario et al. (2013b) recommended that 
education be conducted in the phase immediately following operations, while Vidmar et al. 
(1996) reported that an education and screening intervention for STIs aboard an aircraft 
carrier to deployed populations was effective.  
 
2.6.2.2 Education of personnel involved in providing training 
 
As well as the education of serving personnel, studies have focused on the education of 
those who will provide training (train the trainer) (Yaren et al. 2004). Yaren et al. (2004) 
noted that it should not be assumed that trainers are cognisant of all aspects of STIs, and 
their skills should be upgraded both in content and in training methodology.  
 
Education of Popular Opinion Leaders in Defence establishment has been trialled in the 
Barbados Defence Force (Anastario et al. 2013).  This trial focussed on education about 
condom use.  The intervention was successful in changing short term behaviour.  
 
2.6.2.3 Education of the health workforce 
 
Some military organisations have begun looking at the knowledge and practices of their 
own health services.  An example of the importance of educating the health workforce is 
presented by Tong et al. (2013) who studied the knowledge of sexual health guidelines 
(especially the guidelines for men who have sex with men) among health staff in Centers 
for Disease Control and Prevention (CDC) in the US. They found that the majority of the 
health professionals were not able to correctly identify correct screening guidelines. 
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2.6.2.4 Evaluation 
 
Booth-Kewley (2001; 2002) argued that strong evaluation is essential to build on 
interventions that work, and demonstrated in yearly follow-ups that education interventions 
are able to have an effect on risk behaviours, including condom use. Bing (2008a) 
suggested that monthly “boosting” sessions that evaluate the acquisition of knowledge and 
skill over time was an effective mechanism. 
 
Linking education to screening protocols and timing was shown to be effective by Arcari et 
al. (2004) and by Jenkins et al. (2000). 
 
2.6.3 Screening 
 
Screening for STIs occurs in most defence forces (Valkengoed et al. 2004; Schafer et al. 
2002; Nevin et al. 2008; Surgeon General ADF Health Directive 242). Defence forces 
across the world have developed comprehensive surveillance systems for infectious 
diseases (including STIs) in recent years (Meynard et al. 2008). These systems are 
designed to provide early detection of outbreaks in on-duty areas. Sanchez et al. (2013) 
called for expanded STI surveillance efforts in light of published data on STI rates in the 
military.    
 
The types of subpopulations that are screened and the STIs that are targeted vary among 
defence forces. For C. trachomatis, age and gender are the strongest delineators of 
screening programs, and screening that utilises a symptom-based approach is not 
supported (Cecil et al. 2001). 
 
In the US, the Navy and Marine Corps Public Health Center is responsible for (among 
other things) screening strategies for STIs. C. trachomatis screening is undertaken at 
Periodic Health Assessments and, for women, during an annual gynaecological exam 
(NMCPHC 2012). The US military has mandatory annual screening of women up to 25 
years for C. trachomatis (Jordan et al. 2011; Buller et al. 2006) based on the development 
of a model (Howell et al. 2000) that screening this population in the US military would be 
cost-effective. Schafer et al. (2002) suggested that age is the best criterion on which to 
base a screening program for chlamydia infection in women military recruits. Their study, 
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of 13,204 women recruits, reported that a screening program for all women 25 years of 
age or younger would have identified 95.3% of infected women.  
 
In Australia, the Comprehensive Preventive Health Examination (CPHE) conducted every 
five years remains the primary screening mechanism in the ADF (Surgeon General ADF 
Health Directive 242). Sexual behaviour, STIs and contraception are included in the health 
questionnaire which ADF members are asked to complete as part of the CPHE, and STIs 
including C. trachomatis are tested if thought necessary by the attending health worker; 
however, no routine screening of C. trachomatis is undertaken for existing personnel or for 
newly recruited personnel (Department of Defence 2012).  
 
Many defence forces screen for STIs in all new recruits (Nevin et al. 2008; Walleser et al. 
2006; Arcari et al. 2004; Cecil et al. 2001; Fioravante et al. 2005) at entry, and Howell et 
al. (1999) advised that this has cost savings for the military. There is evidence that 
screening for C. trachomatis infection in the broader serving military population is cost-
effective (Honey et al. 2002; Hu et al. 2004). 
 
In Australia, a call for the screening of C. trachomatis in the ADF can be traced as far back 
as 2006 (Nisyrios 2006); however, there has been an equally strong call in Australia that 
screening for C. trachomatis infection needs to involve both males and females (Chen et 
al. 2003) due to re-infection cycles. 
 
A word of caution about screening programs was highlighted by van Valkengoed et al. 
(2004) who argued that many of the complication rates for C. trachomatis were 
exaggerated and that this may in turn exaggerate the cost effectiveness of screening 
programs. They argued that the decision models in many studies relied on assumptions 
about the risk of complications and that those assumptions were, on occasion, 
overestimated.  As an example, they pointed out that the assumed rates of PID after C. 
trachomatis infection ranged from 15% to 80%.   
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2.7 Validity and Reliability of Methodology  
   
2.7.1 Polymerase Chain Reaction Technology  
 
In Australia, the National Guidelines for the Management of STIs (SHSV 2008) 
recommend the polymerase chain reaction (PCR) test (or other form of nucleic acid 
amplification test [NAAT]) for C. trachomatis detection. The combined C. trachomatis and 
gonorrhoea PCR assay is validated in Australia for use in women in endocervical, urethral 
and first void urine specimens and in men in urethral and first void urine specimens (SHSV 
2008). Although NAATs do not provide information about antimicrobial sensitivities, this is 
not of concern for C. trachomatis as sensitivity to recommended treatment regimens is 
reliable. Verkooyen et al. (2003) reported the reliability of NAAT methods based on the first 
international collaborative quality control study utilising 96 laboratories. This was 
reinforced by Jalal et al. (2006) who reported the superiority of PCR technology for the 
detection of C. trachomatis over other methodologies. As early as 1996, Stary et al. 
reported that PCR technology performed better in military populations than the then-
contemporary standard enzyme immunoassay for first void urine, and this was reinforced 
by Gaydos et al. (2002). Wood et al. (2007) designed a study of military recruits to 
compare NAAT testing with leukocyte esterase testing and concluded that the former was 
well suited to military purposes and the latter was not warranted for use in screening. PCR 
is now used as the standard for C. trachomatis testing in the US military (Lee et al. 2010). 
 
2.7.2 Urine Sampling   
 
A comprehensive study into attitudes toward the acceptability of urine screening among 
asymptomatic men and health providers was undertaken by Marrazzo et al. (2007) with a 
sample of over 23,000 men. There was overall general acceptance of providing a urine 
sample. This study reinforced findings by others (Gaydos et al. 1998; Domeika 1994) that 
provision of a urine sample is acceptable by military personnel. The National Guidelines 
for the Management of STIs (SHSV 2008) in Australia recommend the sample be acquired 
through first catch urine, of between 10 and 20 mls at least 1 hour after previously passing 
urine.  
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2.7.3 Collection Process  
 
The transport of urine specimens for STI testing has long been a barrier to effective 
screening in defence forces. Hsieh et al. (2003) acknowledged that the transport of 
specimens, especially urine, is an issue for the military. Postal services have been 
proffered as a method for urine transportation for many years for C. trachomatis infection 
screening (Macleod et al. 1999) and have been utilised by large-scale studies in Denmark 
(Anderson et al. 2002) and Australia (Martin et al. 2009) with no limitations found in the 
methodology.  
 
A gel that allows the mailing of urine samples through postal services was developed in 
Queensland in 2008 (Bialasiewicz et al. 2009). Overall, the sensitivity of the gel-based 
method ranged from 94.6–100% compared with neat urine, with a specificity of 100%. No 
PCR inhibition or decrease in analytical sensitivity was observed using the gel-processed 
extracts (Bialasiewicz et al. 2009).   
 
2.7.4 Current Gold Standard Treatment for C. trachomatis  
 
The National Guidelines for the Management of STIs (SHSV 2008) recommend 1 g of 
azithromycin by mouth immediately or, this if this is not suitable or available, 100 mg of 
doxycycline twice a day by mouth for seven days (SHSV 2008). Doxycycline is also an 
approved prophylactic treatment for malaria with a recommended dosage of 200 mg per 
day for seven days (Kitchener 2005). Kong et al. (2014) compared the use of doxycycline 
with azithromycin for C. trachomatis infection through a meta-analysis of randomised 
controlled trials and concluded that doxycycline may have a small increased efficacy with 
the fixed effects pooled efficacy for azithromycin being 96.2% and for doxycycline being 
97.4%.  
 
2.7.5 Survey Tool  
 
This study employed an eight page paper-based questionnaire to be self-administered by 
the participant. Self-administered surveys have been used with success in sexual health 
research in many military organisations (Todd et al. 2012; Baud 2008; Shafer et al. 2008; 
Greene et al. 2007; Palmer 2003; Fioravante et al. 2005; Skaza et al. 2003; Crutcher & 
Papdimos 1992). Lessons to enhance success drawn from previous research include the 
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maintenance of confidentiality (Todd et al. 2012; Baud 2008; Fioravante et al. 2005); use 
of language familiar to the participants (Greene et al. 2007); dedicated time to complete 
the survey (Anastario 2013; Shafer et al. 2008; Skaza et al. 2003); and awareness by the 
participant of the purpose and value of the study (Baud 2008; Shafer et al. 2008; Skaza et 
al 2003; Crutcher & Papdimos 1992). 
 
Anastario et al. (2013) examined the effect of the modality of a questionnaire on response 
rates and levels of missing data prior to undertaking a large scale survey of sexual risk 
behaviour among Peruvian uniformed services. They studied three modalities: face-to-face 
interview; self-administered paper-based interview; and audio computer-assisted self-
interview. Even though they concluded that the latter of these three was the method that 
generated the least amount of missing data, it was resource intensive and expensive and 
that the self-administered paper-based interview was completed by more personnel 
because of time constraints.  That is, more of those who started the survey, completed it 
and returned it through the paper-based method.  
 
2.8   Research Questions and Hypotheses 
 
The review of the literature demonstrates that sexual risk, behaviour and health have 
played an important role in the success of the activities of defence establishments 
worldwide. Historically, this role has been of major concern. In contemporary times, sexual 
health education and management that is in line with accepted public health and health 
promotion principles has become a core feature of most defence forces. This includes the 
ADF. However, researchers and practitioners continue to debate the risks of sexual 
behaviours, the differences between defence populations and civilian populations, and the 
need for strong public health measures in defence forces.   
 
This study attempts to fill a gap in contemporary knowledge about sexual risk and 
behaviour in the ADF, about C. trachomatis prevalence and about attempts to extend the 
evidence on education and prevention of STIs in the ADF. The contemporary defence 
force is very different to its predecessors, in its demographic profile, in its training and 
education, in its career structures and personnel management, and in its approach to the 
health and wellbeing of its members. It is expected that sexual behaviour, STIs including 
C. trachomatis and health promotion practices will also have changed.  
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To examine this, the following research questions were developed: 
1. Is the prevalence of C. trachomatis infection in the ADF different from the general 
population of Australia? 
2. Are there differing prevalences within subpopulations of the ADF? 
3. What factors determine varying prevalences among various subpopulations in the 
ADF? 
4. What are the risk determinants for C. trachomatis infection in the ADF? Can these 
risk determinants be addressed through secondary prevention measures? 
 
The hypotheses to be proven, or otherwise, by this research were developed as follows: 
1. The prevalence of asymptomatic genitourinary C. trachomatis infection, as 
determined by urine-based polymerase chain reaction (PCR) assay, is higher in ADF 
members compared with existing community data of the (age and sex matched) 
Australian population. 
2. The prevalence of asymptomatic genitourinary C. trachomatis infection is higher in 
ADF members returning from overseas deployment than those not deployed 
overseas. 
3. Sexual risk behaviour, as determined by self-administered questionnaire, is higher in 
those ADF members with genitourinary C. trachomatis infection than those without.  
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Chapter 3: Methodology 
 
3.1 Rationale  
 
A review of the literature demonstrates there is limited research in Australia focusing on C. 
trachomatis infection at a population level where participants are recruited randomly. In 
addition, little is known in the ADF about the prevalence of C. trachomatis and of risk 
behaviours that may impact on sexual health. This study utilised existing processes in the 
ADF, namely, the Annual Health Assessment (AHA), to source new information about C. 
trachomatis infection and about sexual risk and behaviour. In doing so, it provides 
essential information to the ADF and contributes to the understanding of C. trachomatis 
prevalence in Australia and across the world. The results of this study will provide 
assistance to the ADF in maintaining the health of ADF personnel and thereby assists the 
ADF to maintain a high degree of operational preparedness.  
 
Two particular factors were considered in establishing the scope of this study. A cohort of 
ADF personnel on deployment were included in the sampling and compared with those on 
base, given the literature describing sexual behaviours in military populations and the 
literature suggesting that deployment may be a risk factor in the acquisition of STIs. 
Similarly, this study examined a subgroup of ADF personnel who had recently taken a 
course of doxycycline for malaria prophylaxis as part of their deployment, given the 
evidence of other studies suggesting that the use of antibiotics may have an effect on the 
acquisition of STIs.  
 
This study enrolled participants from the three services in the ADF, namely, the army, navy 
and air force, across 10 sites in Australia and four deployments in order to obtain a broad 
cross-section of the ADF population. Given the effects of convenience sampling, the 
population of those recruited into the study was weighted in order to be able to generalise 
the results of this study to the ADF population. 
 
The results of the ADF population were compared to the Australian population, utilising 
findings from the ASHR. The purpose of the comparison was to determine any risk factors 
that may be particular to the ADF and that may be utilised in the development of effective 
screening and education programs.  
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3.2 Aims and Objectives 
 
The aims of this study were to determine the prevalence of C. trachomatis infection and to 
identify potential high-risk populations in the ADF with a view to recommending secondary 
prevention interventions for the control of C. trachomatis infection within the ADF.  
 
By the end of this research the following were to be achieved: 
 Determination of the prevalence of C. trachomatis infection among a sample of ADF 
personnel serving with the navy, army and air force. 
 Identification of potential behavioural or demographic factors that may contribute to 
the risk of acquiring and transmitting C. trachomatis infection. 
 Identification of particular subpopulations within the ADF that may represent cost-
effective targets for ongoing, routine screening. 
 
3.3 Study Design 
 
This was an epidemiological prevalence study of C. trachomatis infection using systematic 
non-random sampling. Potential participants, namely, males and females aged 18–29 
years, were invited to volunteer for the study when they presented to a site health facility 
for their AHA or similar routine health check. As the AHA is performed on (or near) the 
ADF member’s birthday, this approach provided a systematic sample for the study.   
 
Potential participants were invited to consent to the provision of a urine sample and to 
participate in the sexual behaviour survey. Potential participants were able to choose to be 
involved in either or both activities. Where a potential participant agreed to provide a urine 
sample, they were further invited to consent to some of the urine sample remaining 
identifiable and being tested for C. trachomatis within Defence Health Pathology so they 
may have access to treatment if needed. This process is detailed in the information and 
consent documentation presented in Appendix 1.  
 
Where informed consent was obtained, the member was invited to provide a first catch 
urine sample for analysis by PCR, and to complete a short self-administered, confidential 
and coded survey for the purpose of assessing sexual risk behaviour.  
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3.4 Setting 
 
The original design of this study involved four settings: 
- one large Australian Regular Army (ARA) facility that has a health service 
- one large Royal Australian Air Force (RAAF) facility that has a health service 
- one large Royal Australian Navy (RAN) facility that has a health service 
- two formations returning from overseas deployment.  
This setting was expanded to include additional land-based sites and deployments in order 
to maximise recruitment potential and because of interest generated in the pilot phases of 
the study.  
 
Fourteen ADF sites agreed to be involved in the study. Ten of these sites were land-based 
sites in Australia and four were ADF personnel on deployment with recruitment into the 
study while on active deployment. Of the 10 land-based sites, one was a RAAF site, one 
was an ARA site, seven were RAN sites and one was a combined RAN and ARA site. 
Land-based sites were located in five of the seven states and territories of Australia. The 
four deployment sites were with the RAN. The deployments visited undisclosed locations 
around the world.  
 
Two sites (one land-based RAN site and one deployed site) did not return any surveys or 
urine screens and were not included in further analysis. The reasons provided for lack of 
involvement were operational priorities (the deployed site) and staffing requirements (the 
land-based site). Actual ADF bases and deployment groups involved in the study were not 
recorded as this study is not able to report on site-specific or service-specific data.  
 
3.5 Study Population 
 
The study population were members of the ADF aged between 18–29 years who 
presented for an AHA or similar routine health screen.   
 
3.6 Study Sample 
 
A study sample of 936 was sought. This was divided into 468 deployed personnel (within 
the last 12 months) and 468 non-deployed personnel. These calculations were based on a 
power of 90% and a significance level of 5% in an analysis of differences between 
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deployed and non-deployed populations. This originally proposed sample size was based 
on an assumed infection rate of 7% in the deployed population and 2.5% in the non-
deployed population as a systematic review outlining the prevalence of genital C. 
trachomatis infection in Australia from 1997–2004 indicated a mean overall prevalence of 
4.6% (95% CI 4.4–4.8%) of the population (Vajdic et al. 2005). The difference in 
prevalence between the deployed arm and the non-deployed arm was based on the 
available literature at the time that suggested a higher prevalence in deployed populations 
(compared to non-deployed populations).  
 
3.7 Instrument Design 
 
3.7.1 Survey 
 
The survey was designed and submitted for ethical approval in 2006. It was resubmitted 
and approved after amendments arising from the focus test (see section 3.7.1.1 below). A 
literature review was conducted to assist the development of the survey. This literature 
review comprised the following strategies: 
1. Source existing documentation from CMVH research on sexual health and 
chlamydia in the ADF 
2. Source ADF Health Directives and General Instructions, through the CMVH 
intranet, on the topics of sexual health, AHA, privacy and health promotion 
3. Source existing data on STI and chlamydia trends, risk behaviour and risk 
populations in the Australian population from the journal ‘Sexual Health’ and from 
the Kirby Institute website 
4. Conduct research using the Queensland Health and University of Queensland 
research databases through the following steps: 
a. Use the keywords ‘sexual health and military’, ‘chlamydia and military’ 
(including the phrasing Chlamydia trachomatis; CT), ‘sexual risk behaviour 
and military’, ‘health, primary prevention, secondary prevention and military’ 
b. Substitute ‘military’ with the following words: defence; defence force; defence 
service; navy; air force; army; RAN  
c. On collection of articles, review relevant sections and source the references 
from those relevant sections  
d. Source similar articles by authors that emerged as key researchers 
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e. Source similar articles by journal title that emerged as key journals (e.g. 
Sexual Health; Journal of Military and Veterans’ Health; ADF Health and 
Military Medicine). 
 
The survey, presented in Appendix 2, was eight pages in length and contained 47 items 
that were divided into the following 12 themes: general demographic; ADF demographic; 
alcohol consumption; sexual activity with regular partners; sexual activity with casual 
partners; most recent sexual contact; history of STIs; access to health services; 
deployment; sex while on deployment; sex while overseas; and sex work.  
 
Twelve questions in the survey originated from the ASHR conducted in 2001–2002. La 
Trobe University and the Central Sydney Area Health Service were funded by the 
Commonwealth Department of Health and Aged Care and the National Health and Medical 
Research Council (NHMRC) to undertake the ASHR and utilised a validated survey 
instrument designed for the purpose (Smith et al. 2003b). The ASHR was a general 
population study of men's and women's sexual health behaviour and attitudes with the 
main aim of finding out more about the sexual health and behaviour of people living in 
Australia. Over 19,000 randomly selected people aged between 16 and 59 were 
interviewed by telephone. The items in the survey in the present study that originated from 
the ASHR (and were later used for comparative purposes) were Questions 3a, 11, 12a, 
12b, 12c, 12d, 12e, 13a, 13b, 13c, 14b and 15. 
  
Additionally, three questions in the survey were taken from the Alcohol Use Disorders 
Identification Test (AUDIT). This is the most widely used screen for alcohol use in Australia 
and has been extensively validated (Reinert & Allen 2007). ADF health providers also use 
the AUDIT to measure alcohol use and make decisions about appropriate treatment 
options for members using alcohol in excess of low risk levels. The questions in the survey 
that originated from the AUDIT were Questions 9a, 9b and 9c.  
 
The remaining questions were developed to provide evidence for the null hypotheses and 
were drawn from the literature. All questions and instruments were piloted, as discussed in 
the following sub-sections. 
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3.7.1.1 Pilot of the survey 
 
The first land-based site that agreed to be involved in the study provided personnel for 
focus testing. This was a large RAN site in a capital city. From the focus test, the survey 
was updated. The updated survey was included in resubmissions to the Australian 
Defence Human Research Ethics Committee (ADHREC), and approved. Details of the 
changes made to the survey are presented in Appendix 8.  
 
The inclusion criteria for the focus test comprised being between 18 and 29 years of age 
and being a member of the RAN. Nineteen RAN personnel participated in the face-to-face 
focus test and were recruited from the crews of four Admiral Class Patrol Boats in port at 
the time. The focus test was conducted by the researcher and Dr Joe Debattista, who 
participated as an enlisted officer.  
 
These 19 volunteers comprised 6 females and 13 males; the age range was from 18 to 32 
years, with the mean age being 24. The median age was 24 years. Females were, on 
average, slightly older than males (F=24.7 to M=23.7). One person present did not meet 
the age criteria for the study (18–29); however, this person was still included in the focus 
testing. Length of time in the RAN ranged from 1 year to 13 years, with the mean being 
5.2 years. Length of time posted at that particular site ranged from 3.5 months to 5 years, 
with the mean being 1 year and 4 months.  
 
The survey took participants between 6 and 10 minutes to complete. Overall, the survey 
was well understood by the participants. As well as minor changes, the participants 
indicated that the answers to the group of questions could narrow down the potential 
person who completed the survey to one, causing the respondent to be potentially 
identifiable, and the participants felt this would prevent personnel from completing the 
survey honestly as anonymity may be compromised.  
 
3.7.2 Urine Screen  
 
The methodology for urine PCR screening was developed in the second half of 2006 in 
anticipation of submission to the ADHREC. The process was first agreed by the steering 
committee (see section 3.16) and then discussed with key stakeholders, including those 
from whom approvals to conduct the project were sought.   
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Where informed consent was obtained, the volunteer participant was asked to provide a 
first catch urine sample for analysis by PCR for the detection of C. trachomatis (and to 
complete a short self-administered, confidential and de-identified survey as noted in the 
previous section). Where authorised by the participant, urine specimens were divided into 
two samples. The first sample remained de-identified using the coding format provided by 
the NHMRC ( an individual direct numerical code) and the results of this sample were 
matched with the de-identified coded survey. This sample was sent for testing to the Royal 
Brisbane and Women’s Hospital (RBWH) laboratories.   
 
If consent was provided by the participant, the second sample remained identifiable and 
was tested within Defence Health Pathology Laboratories for the local health facility within 
the ADF. The purpose of the second sample was to facilitate treatment. If an identified 
sample tested reactive for C. trachomatis, treatment was offered by the local ADF health 
facility with a single dose of azithromycin 1 g orally stat. An audit of 5% of cases was 
undertaken utilising one site to assess whether or not the standard operating procedure for 
treatment was followed, and it was followed 100% of the time.  
 
The RBWH testing laboratory agreed to test C. trachomatis samples and the first sample 
was sent on 8 April 2008. Agreement with RBWH laboratory personnel allowed the 
samples to carry one item of identifying information, that is, the code approved through the 
ethical screening process. Appendix 9 presents the consultation flowchart provided to 
clinicians at each site.  
 
3.7.2.1 Use of anhydrous gel composed of superabsorbent polymer and buffering agent 
 
Of note was the decision to utilise a recently developed gel (Bialasiewicz et al. 2009) that 
allowed the mailing of urine samples through Australia Post. The gel was the only 
mechanism by which urine was able to be sent through the post, and utilising this service 
was essential for the participation of the deployed sample. The gel was validated at the 
Royal Brisbane Hospital in 2008 (Bialasiewicz et al. 2009). A superabsorbent polymer and 
buffering agent desiccates the urine into a dry granulous state, which is subsequently 
reconstituted upon arrival at the laboratory. DNA is then extracted from the reconstituted 
solution using the Roche MagNA Pure protocol for the detection of C. trachomatis by PCR. 
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This study did not identify any technical or methodological problems with the use of this 
gel.  
 
3.7.2.2 Pilot of the urine screen 
 
The urine collection methodology was piloted at the same time and location as the survey 
instrument, using the same personnel described above in Section 3.7.1.1. Details of the 
changes made are contained in Appendix 8. For the urine collection pilot, the participants 
were divided into two groups. The demographics of each group were mixed. One group 
was asked to return samples for anonymous testing only and the other group was asked 
to return samples for both the anonymous study and for an identified test so they could be 
informed if they had C. trachomatis. Participants were then asked to read the instruction 
sheet and go to the bathroom to gather the sample.  
 
All the participants correctly handed in the appropriate samples. This indicated that the 
participants understood the instruction sheet and did not need prompting as to how to 
provide the sample.   
 
3.7.2.3 Use of Australia Post 
 
Approval was received from Australia Post to send the gelled urine through standard mail if 
it was packed according to set instructions. This included placing the tube inside a 
cardboard sleeve which was in turn placed inside a sealed plastic bag. The sealed bag 
was then placed inside the supplied standard Australia Post packaging. At the same time 
as the focus testing, four test packs were sent interstate through Australia Post, from a 
capital city to the RBWH testing laboratory. Two packs were placed in the Defence Health 
Service internal mail at the local site and two were placed in an Australia Post mailbox. All 
four packs arrived safely and intact within one week of original posting.  
 
3.7.2.4 Longevity of the gel medium 
 
An unexpected consequence of the design of this study was the assessment of the length 
of time in which the gel medium is able to store a viable DNA sample. The longest time any 
sample took from provision to testing was eight weeks. This was a set of samples sent 
from a deployed ship berthed in San Diego. At least one of these samples tested positive.  
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It was expected that the gel medium would allow the transport of urine for an extended 
period of time. The RBWH testing laboratory agreed to cover the cost of a proposed side 
study into the longevity of the gel. Personnel from the Sir Albert Sakzewski Research 
Laboratory (where the gel originated) helped with this sub-study design. The steps 
undertaken were: 
1. Thirty-eight known positive C. trachomatis samples were obtained from the RBWH 
testing laboratory. The strength of the samples was variable.   
2. Each of the 38 samples was decanted into 9 standard 10 ml tubes that each 
contained the gel.     
3. The first set of 38 samples (Week 0) were processed by the RBWH laboratory 
immediately and used as the baseline.  
4. The 38 x 8 tubes were stored at the University of Queensland School of Medicine, 
Brisbane, in room temperature conditions. 
5. On the Friday of each subsequent week, the next batch of 38 samples was delivered 
to the RBWH with the code written on the tube.  
6. The samples were analysed according to the standard protocol previously described. 
7. The result was recorded on a results page by laboratory personnel and sent to the 
CMVH at the end of the project.  
 
The null hypothesis of this sub-study was that “the ability to extract DNA from a urine 
sample stored in the anhydrous gel composed of superabsorbent polymer and buffering 
agent to test for C. trachomatis decreases over time to the extent that the sample is not 
viable after eight weeks”. This research activity was undertaken between November 2009 
and February 2010. 
 
3.7.2.5 Recording complications  
 
The Principal Epidemiologist and Manager of the Surveillance and Research Unit in the 
Communicable Diseases Branch of Queensland Health contacted the researcher at the 
end of August 2008. Samples that were reactive for C. trachomatis by the RBWH testing 
laboratory were automatically sent to Queensland Health through an online system. This 
online system—the first in Australia—automatically flagged the reactive results from this 
study because the results had insufficient identifying information. This study was the first to 
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be scrutinised in this way as it was the first study to use de-identified data within a 
Queensland Health laboratory since the online data transfer system was commissioned.    
 
Consequently, this study highlighted both the research limitations of the newly instigated 
data collection and analysis system and the proficiency of the system in targeting results 
with missing data. From discussions with Queensland Health it emerged there were three 
areas of concern.  
 
Firstly, the samples were non-identifiable and therefore notification of a positive result and 
contact tracing were unable to be undertaken. This was of concern for Queensland Health 
as the Public Health Act (2005) indicates that all positive results would be notified and 
contact tracing undertaken. The resolution of this issue was twofold: 
a. When a positive result from this study was entered into the Queensland Health online 
system, an additional sentence noting that this result was part of an anonymous study 
would be included. This would highlight to data analysis personnel that this result did 
not require pursuing for more detailed information. This became standard practice. 
b. When the Public Health Act is next reviewed, possible changes would be made to 
include research as a rationale for not fulfilling the requirement of notification and 
contact tracing.  
 
Secondly, the study raised the dilemma of positive results originating from other 
jurisdictions. For example, a sample that tested positive may have originated from Darwin; 
this positive sample should not have been included in Queensland notifications but in 
Northern Territory notifications. The resolution of this dilemma in the short term was not to 
include any positive results in any state’s notification data.  
 
Thirdly, the study design raised the possibility of dual notification of positive results. The 
study design allowed for an individual to request a portion of their supplied urine sample to 
be identified and processed through the local health service. This opened the possibility 
that: 
a) The de-identified sample was tested at the RBWH in Queensland; if positive, the 
result would be notified to Queensland Health which in turn would notify the relevant 
jurisdiction.  
b) The identified sample was tested locally; if positive, the result would be notified to the 
local jurisdiction. 
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Hence, one sample may have provided two positive results due to the study design. Given 
the very small number of positive samples received through the study, there was 
agreement to continue with the current processes.  
 
The contact with personnel from the Queensland Health Surveillance and Research Unit 
highlighted the mismatch between common study design and notification requirements. No 
long-term effects on the study were anticipated.  
 
3.7.3 Information and Consent Form 
 
The information and consent form was developed in parallel with the survey. The 
University of Queensland template for consent forms was utilised as the basis for this 
document. The survey was designed by members of the steering committee in 2006 and 
submitted for ethical approval in late 2006. It was piloted alongside the survey with the 
same group of defence personnel, and the outcome of this pilot suggested the information 
was easily understandable and the consent process clear. Appendix 8 contains the details 
of the pilot.  
 
3.8 Defence Organisational Clearance 
 
Defence organisational clearance was provided in an ADF Minute of December 2006 for 
the land-based sites. Securing approval for the ship-based screening of personnel 
returning from deployment was more difficult. However on 27 April 2008, approval was 
received from the Director of Naval Health and the Deputy Fleet Medical Officer began 
sourcing appropriate ships. It was noted at the time that further approval from the ship’s 
captain and from the person in charge of the health service on the ship was also required. 
Unfortunately on 5 September 2008, the Deputy Fleet Medical Officer informed the 
researcher that no ship had been secured for this purpose and it would need to be deferred 
to 2009. By June 2009, the involvement in the study of four ships was secured with 
approvals from both the ships’ captains and from personnel in charge of the health service 
on each ship.   
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3.9 Ethics Approval 
 
Ethics approval was received from the ADHREC on 19 February 2007 (Protocol 469/06) 
(Appendix 4) and subsequent approval from the University of Queensland Medical 
Research Ethics Committee (MREC) was received on 23 March 2007 (Protocol 
2007000532) (Appendix 5).  
 
Additional approvals were sought and received for three variations to the study (Appendix 
6). Firstly, in June 2007, it was noted that the study was, at that stage, only being 
conducted from RAN sites and therefore the title and wording of the protocol was changed 
to reflect this. Consequently, the title was changed to “A study of C. trachomatis: Sexual 
risk behaviour, infection and prevention in the Royal Australian Navy”. This was reverted to 
the original title in March 2009 after RAAF and ARA sites agreed to be involved. 
 
Secondly, changes were sought following the focus testing of the survey and the screening 
methodology. Changes sought to both of these were submitted in January 2008 and 
approved on 26 March 2008. This included the utilisation of on-site screening programs 
other than the AHA at particular sites. These were the 5-yearly assessment and the yearly 
cervical screening appointment. Both of these provided the desired systematic non-random 
pool of potential participants and consequently the integrity of the recruitment process was 
not comprised.  
 
Thirdly, as part of the revised screening methodology undertaken at two RAN sites, new 
materials were developed. These included: 
- Briefing page for participants (both sites) 
- Posters advertising the study to be placed in the health services (both sites) 
- Business card-sized reminder cards for clinicians (one site only). 
The use of this material was approved in August 2008.  
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3.10 Site Recruitment 
 
The study was advertised through ADF health networks and sites were recruited on the 
basis of operational feasibility and willingness to participate. Sites expressed interest 
through the Officer-in-Charge, were agreed by the steering committee and then discussed 
with the Director of Navy Health in Canberra. Following this process, a meeting was 
organised with the Fleet Medical Officer for further discussion and clarification.  
 
3.10.1 Health Staff Briefing and Training 
 
Briefing and training of health staff occurred prior to any site becoming involved in the 
study. The exact content and methodology of the briefing and training was dependent on 
the site and the personnel in attendance. The following topics were covered: 
1. Rationale and history of the project 
2. Discussion of current STI and sexual health screening 
3. STI update as needed (not required in most instances) 
4. Step-by-step guide to the process of recruitment, including informed consent 
5. Examination of physical layout of premises 
6. Discussion of screening protocol 
7. Detailed examination of survey questions and discussion of what to do if asked 
about the survey 
8. Record keeping and data storage. 
Training involved the key staff from the health service that would be involved in the study 
and/or would be impacted by the study being undertaken at the facility. This included 
medical practitioners (both ADF and civilian), nurses and administration staff. At each site 
the Officer-in-Charge of the health facility was also present. The training was delivered 
face-to-face on each occasion and involved three phases: 1) background to the study; 2) 
update on knowledge about STIs and sexual behaviour (detail dependent on the 
audience); and 3) logistics of the study being undertaken at that particular site. The 
training ended with general discussion and questions. The average time devoted to this 
activity was 45 minutes.  
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3.11 Participant Recruitment 
 
Involvement in the study was voluntary. Apart from the pilot phase of the study (see 
below), participants were recruited at the time of their AHA or a similar routine health 
screen. Other routine health screens included the five-yearly comprehensive health 
assessment, the pre-deployment health check, the post-deployment health assessment, 
and the annual cervical screen for women. Each of these recruitment processes adhered 
to the systematic non-random sampling methodology as potential participants attended for 
these screens and checks according to set criteria (e.g. their birthday) that affected all 
ADF members.   
 
3.11.1 Piloting Methodologies 
 
The most appropriate method of initial contact with potential participants was piloted at 
three sites. (Detail about the three sites and the full process is contained in Appendix 12.) 
Three methods of potential recruitment were devised. The first method was attaching the 
study solely to the AHA whereby the medical practitioner who provides the AHA invites 
those who present for the AHA to participate in the study. This was piloted at two sites at 
the beginning of the recruitment period. Feedback from the Officer-in-Charge was that the 
recruitment rate varied from 40–60%. 
 
The second method was utilising external personnel (the researcher) to invite participation 
in the study of all who attended a health service within a particular timeframe (one week) 
for any health matter and who conformed to the study inclusion criteria (i.e. aged 18–29). 
This was undertaken as a ‘test of process’ in August 2008. The recruitment rate was 
between 12% and 15% each day of those who satisfied the study criteria (based on a 
count of personnel accessing the health service at the time). It was estimated that 50% of 
those attending the health service fell within the study’s age range.  
 
This recruitment method proved to be both resource-intensive (two personnel were 
required to be present at all times—one at the front entrance of the site responsible for 
recruitment and one in the screening/survey room) and ineffectual in terms of a low 
recruitment rate. In addition, this method of recruitment compromised the study design by 
recruiting those who were attending the health service for a health concern. 
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The third method was utilising health service administration personnel to invite participation 
in the study of all who arrived at a health service who conformed to the study inclusion 
criteria (i.e. aged 18–29). This method was piloted for three weeks at a fourth site. Two 
health service staff were involved in this pilot. One staff member (Leading Seaman Medic 
Reservist) was tasked specifically with recruiting participants for the study on arrival at the 
reception counter of the site, and a second (full-time staff member of the service) acted as 
the backup when the first person was not available. This method netted 12 samples over 
the three weeks (estimated to be less than 10% of the eligible population that attended the 
health service during this period).  
 
Within these three pilot sites, different methodologies were compared for the personnel 
responsible for recruitment:  
i. Recruitment by persons in uniform or not in uniform 
ii. Recruitment by persons who were male or female 
iii. Active or passive recruitment (that is, leaving the briefing pages where 
visitors to the health service were able to retrieve them without being 
approached by study personnel). 
 
3.11.2 Agreed Methodology 
 
Piloting the different methodologies outlined above identified those factors which enabled, 
inhibited or did not impact the recruitment of participants.  
 
Enablers: 
1. Individual contact by an enthusiastic health worker. 
2.  Integrating the study with the AHA  
3. The use of the gel for transport and storage. There were nil reported misuses of this 
medium. 
 
No impact: 
1. Being in uniform or not in uniform – for the process of recruitment, consent and; 
survey and urine screening tools – did not impact on recruitment rates.  
2. The gender of the person recruiting had no effect.  
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Inhibitors: 
1. Passive recruitment; distributing briefing notes in clinic waiting areas for passive 
‘pick up’ did not result in any recruitment.  
2. Using personnel from the health service / base known to the base community was 
not effective; potential participants were reluctant to return completed surveys to 
people they knew even though assurances and practices of confidentiality were 
noted and carried through. The participants thought the health personnel ‘may take 
a peek’. 
 
The piloting recruitment processes showed that the original methodology of recruiting, 
survey and screening as part of the AHA was the most efficient and effective means to 
undertake the study. This method recruited 40–60% of eligible personnel, whereas the 
other methods recruited 12–15% and less than 10%. In addition, participants placing their 
completed survey in a sealed envelope and immediately posting it ensured that 
confidentiality concerns were addressed. The original approach of recruitment at the 
presentation for the AHA was utilised for all land-based sites for the remainder of the 
study. Data that was collected during this pilot that satisfied the inclusion criteria and was 
amassed through attendance for the AHA or similar routine screens was included in the 
full dataset of the study.  
 
3.11.3 Recruitment Timeline  
 
Recruitment occurred over a 30 month period with different sites undertaking recruitment 
for varying lengths of time as shown in Figure 3.1. 
 
Land-based recruitment Site 
1 01/04/08                     30/12/09   
2  01/05/08                30/11/09     
3    18- 22/08/08                     
4         08-26/09/08                
5                  14/04/09   30/12/09   
6                 01/03/09 30/06/09       
7                   01-30/06/09       
8                     01/11/09 30/12/09   
9                      01/12/09      31/07/10 
Deployment based recruitment site 
10                      01/06/09 30/10/09   
11                      01/06/09 30/10/09   
12                      01/06/09 30/10/09   
Month J F M A M J J A S O N D J F M A M J J A S O N D J F M A M j 
Figure 3.1: Timeline of recruitment 
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3.12 Completion of Survey and Provision of Urine Sample 
 
Participation in the study was entirely voluntary. This was explained to the participants 
verbally at the point of recruitment, and was stressed in the provided written information 
sheet which was read prior to consenting to participation. The information sheet outlined 
the project in sufficient detail so that the participant was able to make an informed decision 
about whether or not to participate. Any uncertainties were invited to be raised prior to 
consent being granted, and participants were re-assured that they could withdraw from the 
study at any point.   
 
Where informed consent was obtained, the participant was asked to provide a urine 
sample for analysis by PCR, and to complete a short self-administered, confidential and 
de-identified survey for the purpose of assessing sexual risk behaviour. The participant 
was further asked if they would like the urine sample to be divided into two samples, with 
the second remaining identified for local testing and potential treatment. Data relating to 
the identified sample was kept by the local health service and was not included in this 
study analysis.  
 
3.12.1 Confidentiality  
 
Information collected through the survey was anonymised through coding. This was made 
clear to participants both verbally and in writing. Particular behaviours and responses to 
any questions were not able to be linked to particular participants. This ensured 
anonymity. As noted above in Section 3.7.2, urine specimens were divided into two 
samples and one sample was de-linked to identifying information (though linked to the 
survey through a coding mechanism). Care was taken to ensure that participants were 
aware of the options to either provide an anonymous test or an additional pathology test 
that was identifiable.  
 
Members of the ADF work in a hierarchical system, and as such can be seen to be in a 
dependent relationship with the investigators. With this in mind, the investigators took all 
possible precautions to emphasise to potential participants that participation was 
voluntary, anonymous, and that no penalty was imposed for non-participation. 
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3.12.2 Land-Based Site Processes 
 
Testing kits were delivered to each site at the time of initial briefing and training by the 
researcher. Kits were sent from the screening site to the researcher through Australia Post 
or in person (if local). Kits sent through Australia Post were sent individually.  Kits 
delivered in person were delivered in bulk.  Returned kits containing the sealed envelope 
with the completed survey inside it and the packed gelled urine were opened only by the 
researcher. The researcher recorded the date of receipt of the kit, checked the codes on 
the survey, the urine container and the pathology slip and entered the code into an Excel 
spreadsheet. The gelled urine and pathology slip were physically taken to the RBWH 
testing laboratory by the researcher. Results were sent via internal mail to the researcher 
and entered into the Excel spreadsheet. 
 
3.12.3 Deployment-Based Site Processes 
 
Kits were delivered to the Medic in charge of the health facility on board the ship at the 
time of briefing and training. Participants recruited while on deployment were invited to 
volunteer to participate in the study at the time of a usual health assessment.  This 
occurred on ships returning from, or on, active deployment.  As well as the AHA, 
participants were asked to volunteer for the study when they presented for their pre and 
post deployment health checks which were sometimes undertaken while in transit.  
 
On arrival at a port, sealed kits were placed in the diplomatic mail bags along with the 
ships’ usual mail and sent to Fleet Base East in Sydney.  From there, the kits were sent to 
the University of Queensland through Australia Post.  The longest period of time from 
screen to test was 8 weeks.  
  
3.12.4 Sampling Bias 
 
Sampling bias was minimised through the extensive use of the AHA as the point of 
recruitment into the study. The AHA was conducted on, or close to, the individual’s 
birthday and offered a means of effective systematic sampling. Health staff, including 
medical practitioners, who recruited participants into the study were aware to ask all 
personnel within the age range to become involved in the study. Some volunteer bias may 
have been present due to the unknown differences between those who chose to 
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participate and those who chose not to participate. For example, individuals may have 
chosen not to participate because they did not think that sexual health was a topic of 
interest (or concern) for them. However, no reports of skewed sampling were reported by 
any health staff. Smith et al. (2003), in the ASHR, found that volunteer bias was minimal 
as self-reports of sexual behaviour can be argued to be of sufficient reliability and validity. 
 
3.13 Data entry, coding and cleaning 
 
Data entry was undertaken as surveys were received at the University of Queensland 
School of Medicine and was completed by the end of July 2010. An Excel spreadsheet 
(and corresponding coding booklet) was developed and research assistants helped to 
enter the data. Upon completion of data entry, each variable was checked by the 
researcher for consistency of coding and anomalies were corrected. Following this, checks 
on the consistency of results across variables was undertaken. For example, if a 
respondent indicated “male” at the beginning of the survey, checks were undertaken to see 
if they completed the section on pap smears. Discrepancies were checked with original 
surveys and anomalies were corrected. 
 
Subsequent to these checking procedures, a random audit of coding against the original 
surveys was completed. Starting at the 10th survey recorded in the Excel spreadsheet, 
every subsequent 10th survey was included in the audit. Seventy surveys were picked at 
random (9.5%) and all 96 variables were checked against the original data. In total, 96 x 70 
= 6720 codes were checked. An error rate of 0.36% (n=24) was detected.  
 
3.14 Data Analysis 
 
3.14.1 Descriptive Statistics 
 
The characteristics of the sample were described using tables (including summary 
statistics) in order to assess their comparability to the larger ADF population and the 
general Australian population. 
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3.14.2 Prevalence of C. trachomatis  
 
C. trachomatis prevalence rates between populations were compared using two-by-two 
tables and the chi-squared statistic, initially in SPSS Version 16.0 and then manually in 
Excel (with a null hypothesis of no difference in prevalences). Differences in the 
prevalences between subgroups were examined using multiple logistic regression with 
infection as the main outcome and demographics and risk-taking as the explanatory 
variables. Where evidence supporting the null hypothesis was not able to be gathered due 
to limited data because of the lower than expected prevalence, odds ratios were employed 
to illustrate how strongly one variable was associated with C. trachomatis compared to 
other variables. As well as the main outcome focused on subgroups of deployment and 
individuals who had taken doxycycline in the previous 12 months, other subgroup analyses 
included safe sex practices, alcohol consumption, sex while overseas, and sex work.  
 
3.14.3 Sexual Behaviour and Risk 
 
Levels of engagement in unsafe sexual practices between subpopulations were compared 
using two-by-two tables and the chi-squared statistic. Unsafe sex was categorised as 
engagement in unprotected vaginal or anal intercourse (insertive or receptive) with a 
partner who was not the individual’s regular monogamous partner. Descriptive variables to 
determine subpopulations included:  
- age 
- gender 
- relationship status 
- change in relationship status within the last 12 months 
- length of time in the ADF 
- history of deployment within the last 12 months 
- number of times deployed in total 
- alcohol dependence and hazardous drinking (AUDIT) 
- intoxication levels during sexual activity 
- number of sexual contacts (within 12 months) 
- casual or regular partners 
- relationship status of sexual contacts 
- frequency of condom use 
- type of sexual activity 
MAIN TEXT 
Page 70 of 256 
- gender of last sexual contact 
- presentation of symptoms of any STI in previous 12 months 
- sexual experiences whilst on overseas deployment both with deployed 
personnel and with outside personnel 
- sexual experiences overseas whilst on deployment with the ADF or whilst on 
other trips (eg holiday) 
- where sexual experiences occurred (geographically) 
- paying for sex work and / or payment as a sex worker. 
 
This analysis aimed to identify optimal target groups for potential secondary and primary 
prevention interventions in the ADF. Subpopulations that showed statistically higher rates 
of unsafe sex or high odds ratios compared to the remaining sample were included as part 
of the optimal target groups. These subpopulations were compared to published data from 
the ASHR. 
 
3.15 Education Interventions 
 
From the evidence provided by the data analysis, a follow-up literature review was 
undertaken in order to determine potential education interventions for the ADF. This 
comprised two components:  
- Review of evidence-based healthcare and evidence-based policy and its impact on 
the use of evidence from this project to recommend health directives for the ADF 
- Review of education interventions in sexual health among defence forces.  
Information was also sourced directly from the ADF and a review of the Surgeon General 
ADF Health Directives was undertaken.  
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3.16 Steering Committee 
 
A steering committee comprising the supervisors of the PhD candidate and key CMVH 
personnel oversaw the progress, decisions and outcomes of the project. The steering 
committee (with affiliations noted at the commencement of the study) included: 
 A/Prof Scott Kitchener, CMVH 
 CAPT Sonya Bennett, CMVH 
 Dr Joe Debattista, Queensland Health 
 Prof Basil Donovan, the Kirby Institute  
 Prof Ken Donald, University of Queensland School of Medicine 
 Lieutenant Colonel (Dr) Peter Nasveld, CMVH 
 Mr Steve Lambert, PhD Candidate. 
 
3.17 Funding 
 
Funds were secured from the Chlamydia Targeted Grants Program from the 
Commonwealth Department of Health and Ageing ($141,000) for the first part of this study. 
This included the development of the aims and objectives of the study, the development of 
the data collection tools, and the data collection itself. A report was submitted to the 
Commonwealth Department of Health and Ageing in June 2009 detailing the expenditure 
of these funds and the outcomes of the support. In-kind support was sourced from the 
CMVH and from the HIV & HCV Education Projects of the University of Queensland, 
School of Medicine. 
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Chapter 4: Results 
 
This chapter presents the results of the research conducted in this study, and is divided 
into six sections. The first section provides a description of the findings from the urine 
screen and all the questions in the survey (Section 4.1). The second section provides an 
analysis of C. trachomatis prevalence and of self-reported STIs (Section 4.2) including a 
summary table (Table 4.2.0). Where the sample size demonstrates enough power to make 
a determination of statistical significance, the full analysis is included in this chapter, 
including any analysis that illustrates no statistically significant difference between the 
subpopulations being studied. This is because, for the purposes of this study, the results 
that demonstrated no statistically significant difference (e.g. C. trachomatis prevalence 
among different ages) are as important as the results that demonstrated a difference. In 
addition, the inclusion of all the results can help to minimise the problem of publisher bias 
(de Vries 2014). Where the sample size of a subpopulation was not large enough to make 
a determination of significance, this is noted in the discussion. The full analysis appears as 
Appendix 13.  
 
The third section analyses safe sex practices among the subpopulations of the ADF 
(Section 4.3). A summary table also appears at the beginning of this section (Table 4.3.0). 
The fourth section analyses access to health services (Section 4.4) and provides 
examination of utilisation of ADF health services and of civilian health services.    
 
The final two sections compare the findings and analysis presented in the previous 
sections to the broader ADF population (Section 4.5) and to the Australian population 
(Section 4.6). Again, findings that demonstrate no statistical difference provide important 
data for the ADF and are therefore included in this section. Results that demonstrate no 
difference, in C. trachomatis prevalence, self-report of STIs and/or safe sex behaviour, 
between subpopulations of the ADF and between the ADF and the Australian population 
also provide insights that may assist the reinforcement of existing education and 
prevention measures within the ADF.  
 
Seven hundred and thirty-three participants provided data for this study. Data was 
collected from April 2008 to December 2009 (21 months). Surveys were completed by 733 
participants (100%) and a urine sample was provided by 719 participants (98.09%). 
22.45% of the participants were female (n=161) and 67.63% were aged 25 or younger 
(n=487). 190 participants were enrolled in this study while on deployment (25.92%).    
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Of the 733 participants, 352 had been on a deployment within the last 12 months. This 
included 319 who provided this information in the survey and an additional 33 who were on 
deployment at the time of their recruitment but did not indicate this in their survey. The 
smaller than desired sample had some impact on the findings of the study as there was 
not enough statistical power to make a determination of findings in some instances, 
especially where subsamples were analysed (e.g. the subset of participants who engaged 
in sex overseas).  
 
4.1 Description of Findings 
 
4.1.1 Prevalence of C. Trachomatis 
 
C. trachomatis prevalence was determined by urine PCR. A urine sample was provided by 
719 participants (98.09%). The 14 participants who elected not to provide a urine sample 
were an even mix of gender (6 male and 8 female), a mix of ages and from six different 
sites (including two deployments). An indeterminate result was found for three urine 
samples. These were each from the same land-based site where the maximum time 
between collection of the urine sample and testing was less than one week. The three 
participants who returned an indeterminate urine sample were male. Table 4.1.1 presents 
the results on the prevalence of C. trachomatis. 
 
Table 4.1.1: C. Trachomatis prevalence in the ADF 
 No. % 
Positive 14 1.95% 
Negative 702 97.64% 
Indeterminate result 3 0.41 % 
Total 719 100% 
 
4.1.2 Age and Gender 
 
Most of the participants were male (556; 77.55%) and 22.45% were female (161). Sixteen 
participants failed to indicate their gender on the survey. These 16 were from seven 
different sites and none of their urine samples were reactive for C. trachomatis.   Ninety-
eight percent (n=720) of participants answered the question on their age. Of those who 
indicated their age, a small percentage (12.50%) were aged 30 or above with the majority 
(67.63%) indicating they were 25 or younger. Where relevant, those aged 30 and above 
were excluded from some analysis. Those aged under 18 were ineligible to participate. 
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Table 4.1.2 summarises the ages of the participants at the time of their participation in the 
survey.  
Table 4.1.2: Age of participants at time of participation in the survey 
Age No. 
% of those who answered 
question 
18-20 149 20.69% 
21-22 131 18.19% 
23-25 207 28.75% 
26-29 143 19.86% 
30+ 90 12.50% 
Missing data 13 - 
Total 733 100% 
 
4.1.3 Relationships and dependants 
 
The majority of participants in the study were single at the time of the survey (67.09%). 
Participants were also asked to specify the length of time of their current relationship 
status (eg if single, how long; if married, how long). The majority (76.98%) had maintained 
their current status for more than the previous 12 months. Tables 4.1.3 and 4.1.4 
summarise the participants’ relationship status and relationship duration.  
 
Table 4.1.3: Relationship status 
Status No. % 
Married 87 12.08% 
De Facto 150 20.83% 
Divorced 8 1.11% 
Separated 4 0.56% 
Single 471 65.42% 
Missing data 13 - 
Total 733 100% 
 
Table 4.1.4: Duration of current relationship 
Relationship Duration No. % 
Less than 12 months 145 23.02% 
More than 12 months 485 76.98% 
Missing data 103 - 
Total 733 100% 
 
Participants were asked to report the number of children: 85.93% had no dependent 
children (n=580), a further 6.67% had one child (n=45) and the remaining 7.4% had two or 
more children (n=50). The largest number of dependants was five. Fifty-eight participants 
did not complete this question.  
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4.1.4 Employment Information 
 
Employment information was requested in this study primarily to assist with a 
determination of the representativeness of the sample to the ADF population (see Section 
4.5) and analysis of subpopulations by location or service was not undertaken. This was a 
requirement of the design of this study by the ADF. As shown in Table 4.1.5, even though 
land-based sites were only located in five of the seven states and territories of Australia, 
the participants originated from all locations.  
 
Table 4.1.5: Locality of usual place of work of participant 
State No. % 
Western Australia 147 21.03 
Northern Territory 218 31.19 
Queensland 89 12.72 
New South Wales 157 22.46 
Victoria 81 11.59 
South Australia 2 0.29 
Tasmania 3 0.43 
Australian Capital Territory 2 0.29 
Missing data 34 - 
Total 733 100% 
 
The majority of participants were members of the permanent force (n=689, 97.87%), with 
only 15 indicating they were in the reserves. Of these, all 15 were from the army reserve. 
Twenty-nine participants did not complete this section of the survey. The ADF is divided 
into both officer (commissioned) and non-officer (non-commissioned and enlisted) ranks 
and junior and senior members. Sufficient information about employment classification to 
determine the ranks of officer/non-officer and junior/senior was provided by 714 
participants (Table 4.1.6). Nineteen participants did not complete this section. Most of the 
participants had been in the ADF for 5 or fewer years (72.45%; n=518), while just over 5% 
had been in the ADF for more than 13 years (5.60%; n=40) (Table 4.1.7).  
 
Table 4.1.6: Rank in the ADF at the time of participation in the survey 
Rank Junior Senior 
Officer 66 9.25% 5 0.70% 
Non-officer 603 84.45% 40 5.60% 
 
MAIN TEXT 
Page 76 of 256 
Table 4.1.7: Length of time in the ADF 
Years of Service (up to) No. % 
0 97 13.57% 
1 109 15.24% 
2 90 12.59% 
3 75 10.49% 
4 85 11.89% 
5 62 8.67% 
6 39 5.45% 
7 43 6.01% 
8 20 2.80% 
9 17 2.38% 
10 14 1.96% 
11 13 1.82% 
12 11 1.53% 
13 or more 40 5.60% 
Missing data 18 - 
Total 733 100% 
 
4.1.5 Deployment 
 
The sample recruited into this study was comprehensively deployed. Deployment 
information was collected through two mechanisms. Firstly, specific questions were asked 
about the history of deployment; secondly, four of the fourteen sites included in this study 
were actual deployments. One hundred and ninety (25.92%) participated while on an 
actual deployment. Three hundred and nine participants (42.15%) indicated they had been 
deployed at some stage during the previous 12 months. The majority of these were for 
only one deployment within that 12 month period (n=148). Table 4.1.8 summarises the 
participants’ number of deployments within the last 12 months.  
 
Table 4.1.8: Number of deployments within the last 12 months 
Number of 
deployments 
No. % of those who indicated any deployment 
1 148 47.89% 
2 70 22.65% 
3 34 11.00% 
4 16 5.18% 
5 40 12.94% 
11 1 0.34% 
No deployment 391 - 
Missing data 33 - 
Total 733 100% 
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Two hundred and sixty eight of those who indicated they had been deployed in the last 12 
months (86.73%) provided the length of time since last deployment.  Those who indicated 
one month or less (n=165) included those currently on deployment at the time they 
participated in the study.   A small number (n=5) indicated a length of time longer than 12 
months since their last deployment in this question even though they previously answered 
they had been deployed within the previous 12 months. Table 4.1.9 shows the breakdown 
of the results on the length of time since the participants’ last deployment. 
 
Table 4.1.9:  Time since last deployment 
Months since last 
deployment 
No. % of those who indicated any 
deployment 
≤1 165 61.57% 
2 14 5.21% 
3 15 5.60% 
4 12 4.48% 
5 4 1.49% 
6 5 1.87% 
7 6 2.24% 
8 5 1.87% 
9 10 3.73% 
10 8 2.99% 
11 2 0.75% 
12 17 6.33% 
<12 5 1.87% 
Missing data 41 - 
Total 309 100% 
 
Information on the length of time spent on deployment within the last 12 months was able 
to be calculated for two hundred and ninety-one of those who indicated they had been 
deployed at least once in the last 12 months (94.17%).  This was calculated by adding the 
length of all deployments listed within the 12 month period (Table 4.1.10).     
 
Table 4.1.10:  Length of time in deployment within the last 12 months 
Weeks of deployment 
with the last 12 months 
No. 
% of those who indicated weeks of 
deployment 
< 1 week 39 13.40% 
1 – 2 weeks 40 13.75% 
2 – 4 weeks 60 20.62% 
4 – 10 weeks 95 32.65% 
10 – 20 weeks 43 14.77% 
> 20 weeks 14 4.81% 
Missing data 18 - 
Total 309 100% 
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Information on the location of a participant’s most recent deployment was available for 
97.08% (n=300) of those who had indicated any deployment in the last 12 months. The 
majority of these were deployed within the Asian region. By combining the information 
available for the last five deployments, 659 individual episodes of deployment were able to 
be described. Information was available for 642 (97.42%) of these. Again, the most 
common area of deployment was the Asian region. The African continent was the only part 
of the world not visited on deployment within the last 12 months by the participants in this 
study. Table 4.1.11 summarises the results on the participants’ regions of deployment. 
 
Table 4.1.11:  Regions of deployment 
Region  Most recent deployment Combination of up to last 5 deployments 
No. % No. % 
Americas 31 10.33% 77 11.99% 
Europe 5 1.67% 77 11.99% 
Middle East 23 7.67% 37 5.76% 
Asia 201 67.00% 360 56.07% 
Pacific 40 13.33% 91 14.17% 
Missing data 9 - 17 - 
Total 309 100% 659 100% 
 
4.1.5.1 Doxycycline use  
 
Doxycycline is used by the ADF for malaria prophylaxis. Among the participants in this 
study, 13.77% had used doxycycline within the last 12 months (Table 4.1.12).   
 
Table 4.1.12: Frequency of prescription and use of doxycycline in previous 12 months 
 Prescribed Used 
No. % No. % 
Yes 105 17.05% 84 13.77% 
No 511 82.95% 526 86.23% 
Missing data 117 - 123 - 
Total 733 100% 733 100% 
 
4.1.6 Alcohol Consumption 
 
The participants in the study drank regularly. Few (2.51%) never drank, while more than 
half (58.47%) indicated they drank more than six standard drinks on at least one occasion 
at least monthly. Tables 4.1.13 and 4.1.14 present the results on the number of occasions 
the participants drink alcohol and the quantity of alcohol consumed in a typical day when 
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drinking. Table 4.1.16 shows the results on the frequency of six or more standard alcoholic 
drinks being consumed on one occasion.   
 
Table 4.1.13: Number of occasions on which an individual drinks alcohol 
How often No. % 
Never 18 2.51% 
Monthly or less 126 17.55% 
Two to four times a month 318 44.29% 
Two to three times a week 217 30.22% 
Four or more times a week 39 5.43% 
Missing data 15 - 
Total 733 100% 
 
Table 4.1.14: Quantity of alcohol consumed in a typical day when drinking 
How many standard 
drinks 
No. % 
One or two 118 16.91% 
Three or four 249 35.67% 
Five or six 194 27.79% 
Seven to nine 84 12.04% 
Ten or more 53 7.59% 
Missing data 35 - 
Total 733 100% 
 
Table 4.1.15: Frequency of six or more standard drinks being consumed on one  occasion 
How often No. % 
Never 51 7.25% 
Less than monthly 241 34.28% 
Monthly 280 39.83% 
Weekly 131 18.64% 
Missing data 30 - 
Total 733 100% 
 
Seven hundred and four participants answered the question: “Thinking about the last time 
you participated in sexual activity with another person, had you had anything to drink?” 
(Table 4.1.16). Of these, 282 indicated they had drunk something during their last sexual 
encounter (40.06%) and of these, more than half (63.22%) indicated more than five drinks. 
This included responses from an additional 17 participants who completed only the second 
part of the question about quantity.  
 
MAIN TEXT 
Page 80 of 256 
Table 4.1.16: Quantity of alcohol consumed during last sexual encounter. 
Number of drinks No. % 
One or two 55 18.39% 
Three or four 55 18.39% 
Five or six 77 25.75% 
Seven to nine 53 17.73% 
Ten or more 59 19.74% 
Missing data 0 - 
Total 299 100% 
 
4.1.7 Sexual Partners 
 
44.02% of participants indicated they had one or no partners in the previous 12 months. 
The highest indicated by any individual was 30 different partners. In the 18–29 age range, 
45.80% (67/146) of female participants and 39.50% (188/476) of male participants 
indicated they had one or no partners over the previous 12 months (Table 4.1.17). 
 
Table 4.1.17: Number of different sexual partners in the last 12 months 
Number of sexual 
partners 
No. % 
0 23 3.23% 
1 290 40.79% 
2 97 13.64% 
3 72 10.13% 
4 62 8.72% 
5 30 4.22% 
6 36 5.06% 
7 24 3.38% 
8 14 1.98% 
9 4 0.56% 
10 21 2.95% 
11 3 0.43% 
12 6 0.84% 
13 5 0.70% 
14 3 0.42% 
15 10 1.41% 
More than 15 11 1.54% 
Missing data 22 - 
Total 733 100% 
 
4.1.7.1 Regular sexual partners 
 
Over 60% indicated they had a regular sexual partner (n=445); however, 36.62% of these 
indicated they had been in this relationship for less than one year. When asked if they had 
had sex with anyone else over the last 12 month period, 19.37% of those who had been in 
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a relationship for more than 12 months indicated that they had. Tables 4.1.18 and 4.1.19 
present the results on the length of time involved in the current regular relationship and the 
frequency of sex in that relationship. Table 4.1.20 presents the results on the number of 
people the participant had sex with other than their regular partner in the last 12 months. 
 
Table 4.1.18: Length of time involved in current regular relationship 
 No. % 
Less than one year 156 36.62% 
One to five years 195 45.77% 
More than five years 75 17.61% 
Missing data 19 - 
Total 445 100% 
 
Table 4.1.19: Frequency of sex in current regular relationship 
 No. % 
Daily 130 29.35% 
Weekly 227 51.24% 
Monthly 58 13.09% 
Every few months 23 5.19% 
Not in the last 12 months 5 1.13% 
Missing data 2 - 
Total 445 100% 
 
Table 4.1.20: Number of people the participant had sex with other than their regular partner in the 
last 12 months 
Number 
of  other 
partners 
All participants who indicated a 
current regular partner 
Participants who indicated a current 
regular partner who had been their partner 
for more than 12 months. 
No. % No. % 
0 265 60.64 204 80.63% 
1 42 9.61 21 8.30% 
2 30 6.86 11 4.34% 
3 36 8.24 6 2.36% 
4 9 2.07 3 1.19% 
5 15 3.43 1 0.40% 
6 13 2.97 3 1.19% 
7 8 1.83 0 - 
8 5 1.14 3 1.19% 
9 5 1.14 0 - 
10 or 
more 
9 2.07 1 0.40% 
Missing 
data 
8 - 5 - 
Total 445 100% 258 100% 
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This table illustrates, as example, that of the 30 people who were in a regular relationship 
and who had two partners over the previous 12 months, that 11 of these 30 had been in 
that regular relationship for more than 12 months.  This shows that these individuals were 
having sex with their regular partner and another individual at the same time.  The next 
table examines condom use for this subset of individuals. 
 
Condom use among those participants who indicated a regular partner was low. Of note, 
the low rate of condom use was also evident among those who had had another partner 
within the last 12 months and especially those who indicated they had been in the regular 
relationship for more than 12 months and had had sex with someone else in that 12 month 
period. Table 4.1.21 shows the breakdown of the results on the participants’ use of 
condoms with a regular partner.  
 
Table 4.1.21: Condom use with a regular partner 
 
Condom use 
All participants who 
indicated a current 
regular partner 
Participants who 
indicated a current 
regular partner and who 
indicated sex with 
someone else in the last 
12 months 
Participants who had 
been in a regular 
relationship for more 
than 12 months and 
had sex with someone 
else in that time 
No. % No. % No. % 
Always 68 15.21% 23 15.13% 6 12.50% 
Often 57 12.75% 25 16.45% 8 16.67% 
Occasionally 97 21.70% 41 26.97% 16 33.33% 
Never 225 50.34% 63 41.45% 18 37.50% 
Total 447 100% 152 100% 48 100% 
 
4.1.7.2 Casual sexual partners 
 
Approximately 57% of all participants indicated they had had a casual sexual encounter in 
the last 12 months (n=419). This included 188 who also indicated they were in a regular 
relationship at the time of the survey. These participants may also be having sex with 
casual partners or may have previously had sex with casual partners prior to their current 
relationship. Condom use among those participants who indicated sex with casual 
partners was significantly higher than those who indicated sex with regular partners (x2 
82.12, p<0.0001, OR 39.94, 95% CI 24.25–65.70) but remained low overall. Table 4.1.22 
shows the results on condom use with casual partners in the last 12 months. Tables 4.1.23 
and 4.1.24 present the results on the frequency of casual sexual encounters and the 
relationship status of the last sexual encounter.  
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Table 4.1.22: Condom use with casual partners in the last 12 months 
 
 No. % 
Always 172 40.76% 
Often 97 22.98% 
Occasionally 93 22.04% 
Never 34 8.06% 
I don’t have vaginal or 
anal sex with my casual 
encounters 
23 6.16% 
Missing data - - 
Total 419 100% 
 
Table 4.1.23: Frequency of casual sexual encounters  
 
 No. % 
Daily 10 2.42% 
Weekly 46 11.11% 
Monthly 116 28.02% 
Every few months 145 35.02% 
Yearly 42 10.14% 
Not in the last 12 months 55 13.29% 
Missing data 5 - 
Total 419 100% 
 
Table 4.1.24: Relationship status of last casual sexual encounters 
 No. % 
Married 10 2.42% 
De Facto relationship 17 4.10% 
Widowed 1 0.24% 
Divorced 11 2.65% 
Separated  4 0.97% 
Single (never married) 275 66.43% 
Don’t know 96 23.19% 
Missing data 5 - 
Total 419 100% 
 
4.1.7.3 Sex while overseas 
 
The participants were asked about their sexual encounters while overseas, both while on 
deployment and while overseas for other reasons (holiday, business) in the previous 12 
months (Table 4.1.25). One hundred and two participants indicated they had engaged in at 
least one sexual practice while on deployment in the last 12 months from a total of 319 
who indicated deployment at some stage in the previous 12 months (31.35%). One 
hundred and sixty-six participants indicated they had been overseas for a reason other 
than deployment in the last 12 months and 101 of those indicated they had engaged in 
sexual practices while overseas (60.83%). Twenty-two participants indicated they had sex 
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both while overseas on deployment and while overseas for other reasons, indicating that 
181 individuals of the full sample had engaged in at least one sexual act while overseas in 
the previous 12 months (26.934%). Missing data was noted for 61 participants.  
 
Table 4.1.25: Number of sexual partners while overseas over a 12 month period 
 
Deployment 
overseas 
Other reason 
overseas 
Combined 
 No. % No. % No % 
No sex overseas 217 68.03% 65 39.16% 273 61.07% 
One person 53 16.61% 73 43.98% 100 22.37% 
Two people 22 6.90% 11 6.63% 30 7.38% 
Three people 13 4.08% 6 3.61% 16 3.58% 
Four people 11 3.45% 8 4.82% 16 3.58% 
Five - ten people 3 0.98% 3 1.81% 12 2.68% 
Total 319 100% 166 100% 447 100% 
 
Table 4.1.26 presents the results on the partner status of sexual encounters while 
overseas. The participants were not deployed with partners, therefore the question of 
whether or not they had sex with their partner while on deployment was omitted. 
Percentages are presented as a total of the number of sexual encounters. As each 
participant may have indicated sex with more than one type of partner, totals are omitted. 
Participants were most likely to have engaged in sex with a stranger or a sex worker while 
on deployment and with their own regular partner while overseas for another reason. 
 
Table 4.1.26: Partner status of sexual encounters while overseas 
 Deployment overseas Other reason overseas 
 No. % No. % 
A regular partner - - 60 45.45% 
A stranger (but not a sex 
worker) 
50 35.46% 34 25.76% 
A sex worker 44 31.21% 12 9.01% 
A member of the ADF 28 19.89% 7 5.30% 
A member of another 
Defence Force 
7 4.96% 3 2.27% 
A person known other than 
listed 
12 8.51% 16 12.12% 
 
4.1.7.4 Sex work 
 
The participants were asked whether they had paid for sex and whether they had been 
paid for sex. Surveys that indicated a 'yes' response to the latter were checked for 
reliability of responses and each dataset indicated all questions were answered 
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appropriately throughout. Of note, none of those who indicated that they had been paid for 
sex in the last 12 months (n=7) indicated that their last sexual partner was of the same 
gender. Table 4.1.27 presents the results on the participants’ payment for sex in the last 
12 months.   
 
Table 4.1.27: Paid for sex and/or paid as a sex worker in the last 12 months 
 
 
Paid for sex in previous 12 months 
Paid as a sex worker in previous 12 
months 
Male Female Male Female 
No. % No. % No. % No. % 
Yes 75 13.71% 0 - 6 1.32% 1 0.63% 
No 472 86.29% 160 100% 537 98.68% 159 99.57% 
Missing data 9 - 1 - 13 - 1 - 
Total 556 100% 161 100% 556 100% 161 100% 
 
4.1.8 Activity at Last Sexual Contact 
 
Eight participants indicated they had not had sex at all and were discounted from this 
section. Twelve additional individuals did not complete this section. For 3.15% of males 
and 2.60% of females, the gender of their last sexual contact was the same as their own.  
 
Table 4.1.28: Gender of last sexual contact 
 
Male Female 
No. % No. % 
Male 17 3.18% 150 97.40 
Female 517 96.64% 4 2.60% 
Don’t know 1 0.19% 0 - 
Missing data 17 - 3 - 
Total 552 100% 157 100% 
 
The participants were asked to provide information about the activity they participated in at 
the time of their last sexual contact, and 697 participants (95.09%) provided this 
information. More than one response could be provided. There were 710 episodes of 
vaginal sex recorded (indicating that some participants had vaginal sex at the time of their 
last sexual encounter that was both safe and unsafe) and condoms/dams were used 
43.9% of the time. There were 68 episodes of anal sex recorded and condoms/dams were 
used 55.88% of the time. There were 592 episodes of oral sex recorded and condoms 
were used 16.22% of the time. Table 4.1.29 presents the breakdown of the results on the 
participants’ activities at last sexual contact.  
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Table 4.1.29: Activities at last sexual contact 
 
Condom / 
dam use 
Type of activity Number % of total sample 
Yes 
Oral 
Inserting 58 8.32% 
Receiving 38 5.45% 
Vaginal 312 44.76% 
Anal 
Inserting 32 4.59% 
Receiving 6 0.86% 
No 
Oral 
Inserting 273 39.17% 
Receiving 223 31.99% 
Vaginal 398 57.10% 
Anal 
Inserting 22 3.16% 
Receiving 8 1.15% 
 
4.1.9 Signs and Symptoms of STIs  
 
The participants were asked if they had experienced any symptoms characteristic of STIs 
within the last 12 months. While individual reporting rates were low, 15.11% of male 
respondents (n=84) and 22.36% of female respondents (n=36) indicated at least one sign 
or symptom. Very few participants indicated they had been diagnosed with any STI or (for 
females) had an abnormal pap smear. Of note, 35.20% of the sample (n=258) indicated 
they had not been tested for any STIs in the last 12 months. Only 20 participants (2.7%) 
did not answer this question, which implies that 62.07% of participants (n=455) had been 
tested for at least one STI over the previous 12 months. It is acknowledged this may have 
been for a specific STI or for cervical screening and may not have been a comprehensive 
STI check. Tables 4.1.30 and 4.1.31 present the results on the signs or symptoms of STIs 
and the diagnosis of STIs in the last 12 months. 
 
Table 4.1.30: Signs or symptoms of STIs in previous 12 months 
 
Gender Sign or symptom No. % 
Females  
(total number = 161) 
Discomfort when urinating 16 9.94% 
Unusual vaginal discharge 16 9.94% 
Genital itch 18 11.18% 
Painful ulcers in genital area 2 1.24% 
Painless ulcers in genital area 1 0.62% 
Males 
(total number = 556) 
Unusual discharge from the penis 16 2.88% 
Pain while urinating 40 7.19% 
Pain or irritation in the urethra 17 3.06% 
Pain in the scrotum 17 3.06% 
Genital itch 43 7.73% 
Painful ulcers in genital areas 0 0.00% 
Painless ulcers in genital area 2 0.36% 
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Table 4.1.31: Diagnosis of an STI in previous 12 months 
 No. % 
Chlamydia 20 2.73% 
Genital Herpes 3 0.41% 
Genital Warts 7 0.95% 
Gonorrhoea 2 0.27% 
Pubic Lice or Crabs 1 0.14% 
Syphilis 0 0.00% 
Abnormal Pap Smear 17 2.32% 
Do not know as have not been tested 258 35.20% 
 
4.1.10 Health Service Attendance  
 
The participants were asked if they attended a health service in the last 12 months seeking 
the testing and treatment of an STI and the type of health service they had attended. In 
total, 137 participants indicated they needed to access a health service for this reason 
(19.21%). Of these 137, 85.40% accessed an ADF health service (n=117). Thirteen 
participants accessed both an ADF health service and a civilian health service, while 20 
accessed only a civilian service. Twenty participants did not provide complete data on this 
topic.    
 
4.2 Prevalence of C. trachomatis and STIs in the ADF Sample  
 
The participants were asked for a urine sample to test for C. trachomatis. Because the 
identified C. trachomatis prevalence in this study (1.95%) was lower than the expected 
ADF prevalence (7%), further analysis was undertaken by combining the group who tested 
positive to C. trachomatis at the time of the study and the group who indicated they had 
been diagnosed with an STI within the 12 months prior to their participation in the study. 
When these two factors were combined, 5.86% of the cohort (n=43) reported at least one 
STI within the previous 12 months. This combined group is referred to as the ‘STIs in last 
12 months’ cohort in the analysis below.  
 
One of the 14 individuals (7.14%) who tested positive for C. trachomatis at the time of the 
study also indicated a history of STI diagnosis in the last 12 months.  Twenty-six of the 
individuals included in the ‘STIs in the last 12 months’ cohort (60%) also indicated at least 
one symptom in the last 12 months.  
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For analysis of the C. trachomatis positivity and the frequency of STIs within the previous 
12 months, the standard x2 statistic was used. Where sample sizes were small, the 
Fisher’s Exact Test was also calculated. Where quoted, statistical significance was at the 
conventional p<0.05 level (two-tailed) and statistical power was at the 80% level. Where 
there was not enough power to determine a result, this is identified in the relevant section. 
Where there was enough power to make a determination of significance, this is not 
explicitly stated for each individual analysis.   
 
The odds ratios were used to summarise the association of being diagnosed with C. 
trachomatis or the presence of STIs in the previous 12 months with each risk factor. 
Results were expressed with 95% confidence intervals. Confidence intervals were 
calculated using the more specific Jeffrey’s Interval as some proportions were close to 
zero.  
 
Table 4.2.0 presents a summary of the findings reported in this section. Detailed analyses 
of all findings where the sample was large enough to generate power to determine a 
finding are included in this chapter irrespective of whether the finding demonstrates a 
statistically significant difference. For the purpose of drawing conclusions of use to the 
ADF, findings that demonstrate no difference are of equal importance as findings that 
generate a difference. Where sample size did not allow a determination due to the lack of 
power, findings are noted in the summary table and discussed in this section, and the 
detailed analysis is presented in Appendix 13. In the summary table, these latter results 
are highlighted in yellow. For convenience, findings that demonstrate statistically 
significant differences are highlighted in green. This includes: 1) the percentage 
highlighted where 95% confidence intervals do not cross the two subsets or where the 
prevalence of one subset is zero; 2) the p-value highlighted where significant at the 95% 
confidence interval; and 3) the odds ratio highlighted where the odds ratio at the 95% 
confidence interval does not cross one and/or the odds ratio is greater than 2. 
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Table 4.2.0:   Summary of C. trachomatis positivity and diagnosis of STIs in previous 12 for all 
sample subsets 
 
 C. trachomatis STIs in previous 12 months 
Positive Negative % p-value OR Yes No % p-value OR 
Gender  
Female 3 150 1.96% 
p=0.976 1.02 
11 150 6.83% 
p=0.612 1.27 
Male 11 539 2.00% 32 524 5.76% 
Age 
≤ 25 12 468 2.50% 
p=0.157 2.83 
31 456 6.36% 
p=0.520 1.25 
> 25 2 221 0.89% 12 221 5.15% 
Rank 
Officer 1 70 1.41% 
p=0.703 1.48 
3 68 4.23% 
p=0.532 1.46 
Non-Officer 13 613 2.08% 39 604 6.07% 
Seniority 
Senior 2 42 4.55% 
p=0.215 2.54 
3 42 6.67% 
p=0.818 1.15 
Junior 12 641 1.84% 39 630 5.83% 
Number of sexual partners in previous 12 months 
0-1 2 300 0.66%
 
p=0.026 4.71 
7 306 2.24% 
p=0.0002 4.35 
2 or more 12 382 3.05% 36 362 9.80% 
Relationship status 
Single 12 463 2.53% 
p=0.143 2.92 
35 449 7.23% 
p=0.041 2.22 
Not single 2 226 0.89% 8 228 3.39% 
Deployed anytime in the previous 12 months 
Deployed 5 295 1.67% 
p=0.535 0.706 
18 291 5.82% 
p=0.949 0.98 
Not deployed 9 375 2.34% 23 364 5.94% 
On deployment at the time of the study 
Deployed at 
time of study 
2 182 1.09% 
p=0.554 2.24 
9 181 4.74% 
p=0.623 1.35 Previous 
deployment 
3 113 2.65% 9 113 7.56% 
Not deployed 9 375 2.34% 23 364 5.94% 
Ever deployed 
Yes 11 422 2.54% 
p=0.327 1.89 
28 416 6.31% 
p=0.149 1.82 
No 3 217 1.38% 8 216 3.57% 
Casual partners in previous 12 months 
Yes 11 402 2.66% 
p=0.212 3.93 
35 384 9.11% 
p=0.007 5.79 
No 1 123 0.81% 2 127 1.57% 
Sex with casual partner according to relationship status 
Single 5 210 2.33% 
p=0.543 1.97 
18 197 8.37% 
p=0.822 1.33 
In relationship 
less than 12 mth 2 104 1.89% 8 101 7.34% 
In relationship 
more than 12 
mths 
3 64 2.56% 7 63 10.00% 
Frequency of sex 
At least weekly 8 316 2.47% 
p=0.542 1.38 
23 369 5.87% 
p=0.636 0.86 Less than weekly 6 
 
328 1.80% 19 262 6.76% 
Gender of last sexual contact 
Same 0 17 0.00% 
p=0.543 2.70 
1 20 4.76 
p=0.775 1.34 
Opposite 14 643 2.13% 42 625 6.30% 
Condom use with regular partner 
Always 2 164 3.03% 
p=0.554 1.61 
3 65 4.41% 
p=0.645 1.34 
Not always 7 361 1.90% 22 357 5.80% 
Condom use with casual partners 
Always 4 167 2.34% 
p=0.820 0.86 
6 166 4.92% 
p=0.067 3.32 
Not always 6 216 2.71% 24 200 10.71% 
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Table 4.2.0:   Summary of C. trachomatis positivity and diagnosis of STIs in previous 12 for all 
sample subsets (Continued) 
 
 C. trachomatis STIs in previous 12 months 
Positive Negative % p-value OR Yes No % p-value OR 
Condom use at time of last sexual encounter 
Always 5 245 2.00% 
p=1.00 0.99 
13 242 5.10% 
p=0.402 1.34 
Not always 8 388 2.02% 27 376 6.70% 
Condom use with casual partners and total number of partners in last 12 months 
0-1 
partners 
always 0 24 0.00% 
p=0.872 - 
0 24 0.00% 
p=0.009 3.92 
Not 
always 1 36 2.70% 1 38 2.56% 
2 or 
more 
always 4 141 2.76% 6 140 4.11% 
Not 
always 6 201 2.90% 25 184 11.96% 
Safe Sex  
Yes 8 454 1.73% 
p=0.401 1.57 
18 458 3.78% 
p=0.0003 3.05 
No 6 216 2.70% 24 200 10.71% 
Alcohol use 
Not harmful 7 352 1.95% 
p=0.868 0.93 
21 352 5.63% 
p=0.624 1.17 Potentially 
harmful 7 328 2.09% 22 316 6.51% 
 
Alcohol use during last sexual encounter 
Yes 8 274 1.96% 
p=0.874 1.10 
24 264 5.69% 
p=0.702 1.13 
No 5 400 1.79% 18 398 6.38% 
Sex while overseas (all occasions overseas) 
Yes 3 129 2.27% 
p=0.266 2.67 
12 161 6.94% 
p=0.380 1.46 
No 2 231 0.89% 11 215 4.88% 
Sex while overseas (deployment only) 
Yes 3 96 3.03% 
p=0.207 3.03 
7 87 7.45% 
p=0.446 1.47 
No 2 194 1.02% 10 173 5.18% 
Sex while overseas (travel other than work) 
Yes 0 - - 
- - 
6 95 5.61% 
p=0.422 1.99 
No 0 - - 2 63 2.99% 
Sex while overseas (those who had sex on deployment and on other travel) 
Yes sex at 
both times 
- - - 
- - 
5 54 8.47% 
p=0.520 2.04 
No - - - 1 22 5.35% 
Sex work (Paid for sex in last 12 months) 
Yes 0 75 0.00% 
p=0.188 1.71 
3 72 4.00% 
p=0.486 1.53 
No 14 605 2.26% 38 597 5.98% 
 
Sex worker (been paid for sex in last 12 months) 
Yes 0 7 0.00% 
- - 
2 5 28.57% 
p=0.011 6.59 
No 14 669 2.05% 40 659 5.72% 
Doxycycline use 
Yes 0 83 0.00% 
p=0.176 1.82 
10 74 11.90% 
p=0.054 2.06 
No 11 503 2.14% 33 502 6.17% 
 Yellow highlight indicates a sample size that did not allow a determination of significance due to lack of power 
 Green highlight indicates confidence interval of percentage did not cross zero; p-value of significance; and / or 
odds ratio higher than 2.0 
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4.2.1 Gender and Age 
 
There was no difference between males and females in C. trachomatis positivity (x2 
0.0009, p=0.9761, OR 1.02, 95% CI 0.28–3.70) or in the diagnosis of STIs within the 
previous 12 months (x2 0.257, p=0.612, OR 1.27, 95% CI 0.63–2.59). Table 4.2.1 presents 
the results on C. trachomatis positivity and STI diagnosis in the last 12 months by gender. 
 
Table 4.2.1: C. trachomatis positivity and STI diagnosis by gender 
Gender C. trachomatis STIs in last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95%CI n % 95%CI 
Female 3 1.96% (0.56-5.14) 150 153 11 6.83% (3.68-11.51) 150  161 
Male 11 2.00% (1.07-3.43) 539 550 32 5.76% (4.04-7.92) 524 556 
Total 14  689 703 43   674 717 
 
Age was also not a significant variable for either C. trachomatis positivity (x2 2.005, 
p=0.1568, OR 2.83, 95% CI 0.62–12.76) or the diagnosis of STIs within the previous 12 
months (x2 0.414, p=0.520, OR 1.25, 95% CI 0.63–2.48). Of note, those who were younger 
were almost three times more likely to test positive for C. trachomatis than those who were 
older. Table 4.2.2 presents the results on C. trachomatis positivity and STI diagnosis in the 
last 12 months by age. 
 
Table 4.2.2: C. trachomatis positivity and STI diagnosis by age 
Age C. trachomatis STIs in last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95%CI n % 95%CI 
≤25  12 2.50% (1.37-4.20) 468 480 31 6.36% (4.45-8.80) 456 487 
26 and older 2 0.89% (0.19-2.85) 221 223 12 5.15% (2.85-8.56) 221 233 
Total 14  689 703 43   677 720 
 
 
4.2.2 Rank 
 
No difference between officers and non-officers in C. trachomatis positivity or STI 
diagnosis in the previous 12 months was able to be determined due to the small sample 
size of officers. Detailed analysis can be found in Appendix 13.   
 
A comparison between senior and junior members of the ADF was able to be made for C. 
trachomatis prevalence (Table 4.2.3); however, there was insufficient power to make a 
determination of significance for STI diagnosis in the previous 12 months. This analysis is 
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presented in detail in Appendix 11. Seniority was not a significant variable for C. 
trachomatis positivity (x2 1.54, p=0.215, OR 2.54, 95% CI 0.55–11.74).   
 
 
Table 4.2.3: C. trachomatis positivity and ADF seniority 
Seniority C. trachomatis 
Positive 
Negative Total 
n % 95%CI 
Senior 2 4.55% (0.96-13.79) 42 44 
Junior 12 1.84% (1.01-3.09) 641 653 
Total 14  683 697 
 
4.2.3 Number of Sexual Partners 
 
The number of sexual partners was a significant variable for both C. trachomatis positivity 
(x2 4.927, p=0.0264, OR 4.71, 95% CI 1.04–21.21) and STI diagnosis within the previous 
12 months (x2 14.295, p=0.0002, OR 4.35, 95% CI 1.90–9.90). Those who had two or 
more partners over the previous 12 months were almost five times more likely to be 
diagnosed with C. trachomatis at the time of the study and four times more likely to have 
reported an STI diagnosis within the previous 12 months. Table 4.2.4 presents the results 
on C. trachomatis positivity, STI diagnosis and the number of sexual partners. 
 
Table 4.2.4: C. trachomatis positivity, STIs and number of sexual partners 
Number of 
sexual 
partners 
C. trachomatis STIs in last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95%CI n % 95%CI 
0-1 2 0.66% (0.14-2.11) 300 302 7 2.24% (1.01-4.34) 306 313 
2 or more 12 3.05% (1.68-5.10) 382 394 36 9.80% (6.52-12.16) 362 398 
Total 14  682 696 43   668 711 
 
4.2.4 Relationship Status 
 
Participants who listed their relationship as single, divorced, separated or widowed were 
identified as single. Those identified as ‘not single’ were those who listed their relationship 
as married or de facto. While there was no significant difference in C. trachomatis positivity 
(x2 2.146, p=0.143, OR 2.92, 95% CI 0.63–13.20) between those who were single and 
those who were not, there was a statistical difference in STI diagnosis in the previous 12 
months (x2 4.17, p=0.0411, OR 2.22, 95% CI 1.01–4.87) between these two groups. 
Participants who were single were twice as likely to have been diagnosed with an STI 
within the previous 12 months and twice as likely to have tested positive for C. 
trachomatis. Table 4.2.5 presents the results on C. trachomatis positivity, STI diagnosis 
and relationship status. 
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Table 4.2.5: C. trachomatis positivity, STIs and relationship status 
Relationship 
status 
C. trachomatis STIs in last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95%CI n % 95%CI 
Single 12 2.53% (1.39-4.24) 463 475 35 7.23% (5.19-9.82) 449 484 
Not single 2 0.89% (0.18-2.78) 226 228 8 3.39% (1.61-6.27) 228 236 
Total 14  689 703 43   677 720 
 
4.2.5 Deployment 
 
The effect of deployment was examined through several mechanisms. Firstly, a 
comparison was made between those who had been deployed in the last 12 months and 
those who had not. This included individuals who were on deployment at the time they 
completed the survey (n=184). As shown in the results presented in Table 4.2.6, there was 
no significant difference in C. trachomatis positivity (x2 0.385, p=0.535, OR 0.70, 95% CI 
0.23–2.13) or in STI diagnosis in the previous 12 months (x2 0.004, p=0.949, OR 0.98, 
95% CI 0.52–1.85) between those who had been deployed at least once in the previous 12 
months and those who had not.   
 
Table 4.2.6: C. trachomatis positivity, STIs and deployment in the previous 12 months. 
Deployed 
anytime in the 
previous 12 
months 
C. trachomatis STIs in last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95%CI n % 95%CI 
Deployed 5 1.67% (0.64-3.61) 295 300 18 5.82% (3.62-8.86) 291 309 
Not deployed 9 2.34% (1.17-4.23) 375 384 23 5.94% (3.91-8.63) 364 387 
Total 14  670 684 41  655 696 
 
This finding was contrary to the hypothesis proposed in this study and to the literature on 
overseas defence forces that suggested a higher C. trachomatis prevalence among 
deployed populations compared to non-deployed populations. Further examination was 
undertaken to compare those who had ever been deployed and those who hadn’t (Table 
4.2.7). Again, there was no significant difference in C. trachomatis positivity (x2 0.962, 
p=0.327, OR 1.89, 95% CI 0.52–6.83) or in STI diagnosis in the previous 12 months (x2 
2.078, p=0.149, OR 1.82, 95% CI 0.81–4.06) between those who had ever been deployed 
and those who had not.   
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Table 4.2.7: C. trachomatis positivity, STIs and ever been deployed 
Ever deployed C. trachomatis STIs in last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95%CI n % 95%CI 
No 3 1.36% (0.39-3.59) 217 220 8 3.57% (0.17-6.63) 216 224 
Yes 11 2.54% (1.36-4.35) 422 433 28 6.31% (4.32-8.86) 416 444 
Total 14  639 653 36  632 668 
 
Further examination was undertaken to compare those on deployment at the time of the 
study and the remainder of the sample; however, the sample size of those deployed at the 
time of the study with C. trachomatis positive results or an STI diagnosis in the previous 12 
months was not large enough to determine any level of significance. This analysis appears 
in Appendix 11.  
 
This data suggests that deployment may not be a variable of significance in increased C. 
trachomatis infection or in STI diagnosis within the previous 12 months as hypothesised or 
as indicated by the literature. The odds ratios point toward a trend indicating that it may 
actually offer a protective influence. Those who had not been deployed at some stage in 
their ADF career were almost twice more likely to have been diagnosed with an STI in the 
12 months prior to their participation in the study, and those who were not deployed at the 
time of the study were more than twice more likely to have tested positive for C. 
trachomatis.  
 
4.2.6 Doxycycline Use 
 
The participants were asked if they had been prescribed doxycycline for malaria 
prophylaxis and if they had actually taken the doxycycline. Of the 105 who indicated they 
had been prescribed doxycycline, 34 (32.38%) indicated they had taken it less than they 
were prescribed and three (2.86%) indicated they had taken more than they were 
prescribed. Table 4.2.8 presents the results on C. trachomatis positivity, STI diagnosis and 
doxycycline use. The analysis below is based on the 84 who indicated they had taken 
doxycycline at some stage in the previous 12 months.     
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Table 4.2.8: C. trachomatis positivity, STIs and doxycycline use. 
Used 
Doxycycline in 
last 12 months 
C. trachomatis STIs in last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95%CI n % 95%CI 
Yes 0 0.00% (~0.00-3.61) 83 83 10 11.90% (6.29-11.90) 74 84 
No 11 2.14% (1.14-3.67) 503 514 33 6.17% (4.36-8.45) 502 535 
Total 11  586 597 43  576 619 
 
Because no participant who had used doxycycline in the previous 12 months tested 
positive for C. trachomatis, no further analysis was undertaken. While there was no 
significant difference in STI diagnosis in the previous 12 months (x2 3.70, p=0.054, OR 
2.06, 95% CI 0.97–4.35), those who had used doxycycline within the last 12 months were 
almost twice more likely to have had an STI diagnosis in the previous 12 months. 
 
4.2.7 Casual Partners 
 
While there was no significant difference in C. trachomatis positivity (x2 1.51, p=0.212, OR 
3.93, 95% CI 0.44–26.54) between those who had engaged in sex with casual partners 
over the previous 12 months and those who hadn’t, there was a statistically significant 
difference in STI diagnosis in the previous 12 months (x2 7.25, p=0.0071, OR 5.79, 95% CI 
1.37–24.40) between those two groups. Table 4.2.9 presents the results. 
 
Table 4.2.9: C. trachomatis positivity, STIs and sex with casual partners 
Casual partner 
in last 12 
months 
C. trachomatis STIs in last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95%CI n % 95%CI 
Yes 11 2.66% (1.42-4.56) 402 413 35 9.11% (1.42-4.56) 384 419 
No 1 0.81% (~0.00-3.71) 123 124 2 1.57% (0.32-4.88) 127 129 
Total 12  525 537 37  511 548 
 
Those who had sex with casual partners within the 12 months prior to participation in the 
study were almost six times more likely to have been diagnosed with an STI in the same 
time period and were almost four times more likely to have tested positive for C. 
trachomatis. The subset of participants who had engaged in sex with a casual partner in 
the previous 12 months was further examined based on relationship status at the time of 
participation in the study; however, the sample sizes were not large enough to generate 
power to make a determination of significance. These analyses appear in Appendix 11.  
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4.2.8 Frequency of Sex 
 
As shown in the summary of results in Table 4.2.10, there was no significant difference in 
C. trachomatis positivity (x2 0.002, p=0.961, OR 0.974, 95% CI 0.33–2.84) or in STI 
diagnosis in the previous 12 months (x2 0.224, p=0.636, OR 0.86, 95% CI 0.46–1.61) 
among those who indicated they had sex at least weekly or less than weekly.  
 
Table 4.2.10: C. trachomatis positivity, STIs and frequency of sex 
Frequency of 
sex 
C. trachomatis STIs in last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95%CI n % 95%CI 
At least weekly 8 2.11% (1.00-3.94) 316 324 23 5.87% (3.86-8.52) 369 392 
less than 
weekly 
6 2.17% (0.90-4.38) 328 334 19 6.76% (4.26-10.15) 262 281 
Total 14  644 658 42  631 673 
 
4.2.9 Gender of Last Sexual Contact 
 
The sample sizes of those who indicated that the gender of their last sexual contact was 
the same as their own gender were not large enough to generate power to make a 
determination of significance. These analyses appear in Appendix 11.  
 
4.2.10 Condom Use 
 
Condom use was investigated during three separate sets of questions: use with a regular 
partner; use with a casual partner; and use at the time of last sexual contact. For the first 
two questions, the participants were asked to indicate ‘always’, ‘often’, ‘sometimes’, or 
‘never’; the latter three were combined for this analysis. For the question on sexual activity 
during last sexual contact, those who indicated they participated in vaginal and/or anal 
intercourse were used as the sample due to the sample size for different activities. 
‘Always’ is noted as having used condoms for all occasions of vaginal and anal sex. Table 
4.2.11 presents the results on C. trachomatis positivity, STI diagnosis in the last 12 months 
and condom use. 
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Table 4.2.11: C. trachomatis positivity, STIs and condom use 
Use condoms all the 
time during any vaginal 
and/or anal sex 
C. trachomatis STIs in the last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95%CI n % 95%CI 
With 
regular 
partner 
Always 2 3.03% (0.63-9.37) 64 66 3 4.41% (1.26-11.31) 65 68 
Not always 7 1.90% (0.85-3.70) 361 368 22 5.80% (3.78-8.50) 357 379 
Total 9  425 434 25  422 447 
   
 
  
     
With 
Casual 
partners 
Always 4 2.34% (0.79-5.47) 167 171 6 4.92% (1.47-7.05) 166 172 
Not always 6 2.71% (1.14-5.49) 216 222 24 10.71% (7.17-15.27) 200 224 
Total 10  383 393 30  366 396 
   
 
  
     
At the 
time of 
last 
sexual 
contact 
Yes 5 2.00% (0.77-4.33) 245 250 13 5.10% (2.89-8.32) 242 255 
No 8 2.02% (0.97-3.80) 388 393 27 6.70% (4.56-9.45) 376 403 
Total 13  633 643 40  618 658 
 
 
Among the participants who indicated they had a regular partner, there was no significant 
difference in C. trachomatis positivity (x2 0.351, p=0.554, OR 1.61, 95% CI 0.33–7.93) or in 
STI diagnosis in the previous 12 months (x2 0.212, p=0.645, OR 1.34, 95% CI 0.39–4.59) 
between those who indicated they always used condoms for vaginal and anal sex and 
those who indicated that they didn’t.   
 
Among the participants who indicated they had sex with casual partners within the 
previous 12 months, there was also no significant difference in C. trachomatis positivity (x2 
0.052, p=0.820, OR 0.86, 95% CI 0.24–3.11) or STI diagnosis in the previous 12 months 
(x2 3.35, p=0.067, OR 3.32, 95% CI 1.33–8.31) between those who indicated they always 
used condoms for vaginal and anal sex and those who indicated that they didn’t. However, 
the participants who did not always use a condom for vaginal and anal sex with their 
casual partners were more than three times more likely to have been diagnosed with an 
STI in the 12 months prior to participation in the study than the participants who indicated 
they always used condoms for these activities with casual partners.   
 
Additionally, when examining practices at the time of last sexual contact, there was also no 
significant difference in C. trachomatis positivity (x2 0.0003, p=0.986, OR 0.99, 95% CI 
0.32–3.06) or in STI diagnosis in the previous 12 months (x2 0.702, p=0.402, OR 1.34, 
95% CI 0.68–2.64) between those who indicated they used condoms for vaginal and anal 
sex at that last encounter and those who indicated that they didn’t.   
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In the ADF sample, condom use was not a significant marker of either C. trachomatis 
positivity or of diagnosis with and STI within the previous 12 months. Further analysis was 
undertaken examining those who indicated the number of partners they had in the last 12 
months and condom use with their casual partners (Table 4.2.12).   
 
Table 4.2.12: C. trachomatis positivity, STIs, condom use and No. of partners in previous 12 months 
C. trachomatis 
Number of partners in 
the previous 12 mths 
Use condoms during 
vaginal and/or anal sex 
Positive  
Negative Total 
n % 95%CI 
0-1 
Always 0 0.00%  24 24 
Not always 1 2.78% (0.29-11.94) 36 37 
2 or more 
Always 4 2.76% (0.94-6.42)  141 145 
Not always 6 2.90% (1.22-5.88) 201 207 
 Total 11  402 413 
 
STIs in the previous 12 months 
  Yes 
No Total 
n % 95%CI 
0-1 
Always 0 0.00% - 24 24 
Not always 1 2.56% (0.28-11.36) 38 39 
2 or more 
Always 6 4.11% (1.73-8.27) 140 146 
Not always 25 11.96% (8.09-16.88) 184 209 
 Total 32 386 418 
 
 
This sub-analysis confirmed that the variable of significance was primarily the number of 
partners within the previous 12 months rather than the level of condom use. The sample 
sizes of participants who had one or no partners in the previous 12 months were too small 
to statistically analyse; however, analysis of those who had two or more partners indicated 
that the level of condom use was not a significant variable for C. trachomatis (x2 0.706, 
p=0.872) even though it was a significant variable for STI diagnosis in the previous 12 
months (x2 11.50, p=0.009, OR 3.92 95% CI 1.66–9.29). Those who had two or more 
partners within the previous 12 months and who did not always use condoms for vaginal 
and/or anal sex were almost four times more likely to have been diagnosed with an STI in 
the previous 12 months than those who had two or more partners and always used 
condoms over the same time period.  
 
4.2.11 Safe Sex 
 
The definition of safe sex that is utilised in this study’s analysis is discussed in the next 
section (Section 4.3) which analyses the relationship between the practice of safe sex and 
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other variables. This section only examines the relationship between the practice of safe 
sex and C. trachomatis positivity and STI diagnosis in the previous 12 months.  
 
The practice of safe sex was not a significant variable for C. trachomatis positivity (x2 
0.705, p=0.401, OR 1.57, 95% CI 0.54–4.60); however, it was statistically significant for 
STI diagnosis in the previous 12 months (x2 0.12.98, p=0.0003, OR 3.05, 95% CI 0.1.62–
5.75). Of note, those who were younger were almost three times more likely to test 
positive for C. trachomatis than those who were older. Those who didn’t practise safe sex 
were three times more likely to have been diagnosed with an STI in the previous 12 
months compared to those who did practise safe sex in that time period. Table 4.2.13 
presents the results on C. trachomatis positivity, STI diagnosis and safe sex practices. 
 
Table 4.2.13: C. trachomatis positivity, STIs and safe sex practices 
Practised  safe 
sex 
C. trachomatis STIs in last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95%CI n % 95%CI 
Yes 8 1.73% (0.82-3.24) 454 462 18 3.78% (2.34-5.78) 458 476 
No 6 2.70% (1.14-5.49) 216 222 24 10.71% (7.17-15.27) 200 224 
Total 14  670 684 42  658 700 
 
It is noted that for the C. trachomatis analysis, there was not quite enough statistical power 
(at 80%) to make a determination of significance. The sample required was 466 and 221, 
whereas the actual sample was 462 and 222. As the sample was close to the size needed, 
it is included in the analysis.  
 
4.2.12 Alcohol Use  
 
Three standardised questions were taken from the AUDIT (Department of Veterans’ Affairs 
[DVA] 2013) asking: 1) how often a respondent had a drink containing alcohol; 2) how 
many standard drinks containing alcohol did the respondent have on a typical day; and 3) 
how often did the respondent have six or more drinks in one day. Responses to the 
questions were combined, using the AUDIT interpretation guidelines (DVA 2013), in order 
to provide a “consumption score” and to determine whether or not the consumption rate 
may indicate a risk of alcohol-related harm. Table 4.2.14 presents the AUDIT consumption 
scores.  
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Table 4.2.14: AUDIT consumption scores 
Alcohol use Number % 
Not 
harmful 
No alcohol consumption 16 2.30% 
Some alcohol consumption (AUDIT score 1 – 5) 357 50.21% 
Potentially 
harmful 
Lower band (Audit score 6 -7) 223 31.35% 
Higher band (AUDIT score 8 – 12) 115 16.17% 
Total respondents 711 100% 
 
The consumption of alcohol (and related potential for alcohol-related harm) was compared 
to C. trachomatis positivity and STI diagnosis in the previous 12 months by examining the 
difference between alcohol use that is considered not harmful and alcohol use that is 
considered potentially harmful according to the AUDIT criteria (Table 4.2.15).  
 
Table 4.2.15: C. trachomatis positivity, STIs and alcohol consumption 
Alcohol use C. trachomatis STIs in last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95%CI n % 95%CI 
Not harmful 7 1.95% (0.88-3.79) 352 359 21 5.63% (3.63-8.32) 352 373 
Potentially 
harmful 
7 2.09% (0.94-4.06) 328 335 22 6.51% (4.24-9.52) 316 338 
Total 14  680 694 43  668 711 
 
Alcohol consumption was not a significant variable for C. trachomatis positivity (x2 0.017, 
p=0.868, OR 0.93, 95% CI 0.32–2.69) nor for STI diagnosis in the previous 12 months (x2 
0.241, p=0.624, OR 1.17, 95% CI 0.63–2.16). As some Australian studies used an AUDIT 
cut-off score of 8 in their analyses, this was also applied in the present study. There was 
no difference in C. trachomatis positivity between these samples. Use of alcohol during the 
last sexual encounter was also analysed, as shown in Table 4.2.16.   
 
Table 4.2.16: C. trachomatis positivity, STIs and alcohol use at the time of last sexual encounter 
Use of alcohol 
during last 
sexual 
encounter 
C. trachomatis STIs in last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95%CI n % 95%CI 
No 5 1.79% 0.69-3.88 274 279 24 5.69% (3.77-8.21) 264 288 
Yes 8 1.96% 0.93-3.67 400 408 18 6.38% (3.97-8.21) 398 416 
Total 13  674 687 42  662 704 
 
Alcohol consumption at the time of last sexual encounter was also not a significant 
variable for C. trachomatis positivity (x2 0.025, p=0.874, OR 1.10, 95% CI 0.35–3.39) nor 
for STI diagnosis in the previous 12 months (x2 0.146, p=0.702, OR 1.13, 95% CI 0.60–
2.12).    
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4.2.13 Sex While Overseas 
 
The participants were asked about sex while overseas in two circumstances: while on 
deployment, and while overseas for reasons that were not work-related. Table 4.2.18 
provides an analysis of the two groups combined. It is noted that more participants 
answered the question about sex while on deployment than indicated they had been 
deployed within the last 12 months in an earlier question (n=129). As these individuals had 
not previously discussed deployment in the survey, they are not included in this analysis. 
There were 22 participants in both groups and these were removed from one group to 
avoid double counting. The combined (and non-duplicated) sample of participants who had 
indicated they had been overseas and whether or not they engaged in sex is analysed 
below. 
 
Table 4.2.17: C. trachomatis positivity, STIs and sex while overseas (all purposes) 
Sex while 
overseas (all) 
C. trachomatis STIs in last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95%CI n % 95%CI 
Sex 3 2.27% 0.60-5.90 129 132 12 6.94% 3.85-11.45 161 173 
No sex 2 0.89% 0.20-2.70 231 233 11 4.88% 2.61-8.26 215 226 
Total 5  360 365 23  376 399 
 
Engaging in sex while overseas (deployment and other reasons) was not a significant 
variable for C. trachomatis positivity (x2 1.24, p=0.266, OR 2.67, 95% CI 0.44–16.28) nor 
for STI diagnosis in the previous 12 months (x2 0.772, p=0.380, OR 1.46, 95% CI 0.66–
3.39). Of note, all five positive C. trachomatis results were found in the subgroup of those 
who were on deployment rather than in the subgroup of those who were overseas for other 
reasons. The deployment subgroup was further analysed, with the results shown in Table 
4.2.18 and discussed in more detail below. 
 
Table 4.2.18: C. trachomatis positivity, STIs and sex while on deployment 
Sex while on 
deployment 
C. trachomatis STIs in last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95%CI n % 95%CI 
Yes 3 3.03% 0.86-7.80 96 99 7 7.45% 3.39-14.06 87 94 
No 2 1.02% 0.21-3.23 194 196 10 5.18% 2.84-9.48 173 183 
Total 5  290 295 17  260 277 
 
Engaging in sex while deployed was not a significant variable for STI diagnosis in the 
previous 12 months (x2 0.582, p=0.446, OR 1.47, 95% CI 0.54–4.00). Even though there 
was not enough statistical power to determine a significant difference in C. trachomatis 
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positivity among those who had sex while on deployment and those who did not, the data 
is included here in order to compare it to the data on STI diagnosis in the previous 12 
months.  
 
The analysis of STI diagnosis in the previous 12 months among those who had sex while 
overseas for a reason other than deployment is presented in Appendix 13 as the sample 
sizes were too small to generate enough power to make a determination of significance. 
This was also the case when examining the subpopulation of participants who had sex 
both on deployment and while overseas for other reasons (n=82). 
 
4.2.14 Sex Work 
 
The sample sizes of those participants who indicated they had sex with a sex worker 
(M=75; F=0) and/or were paid for sex (M=6; F=1) within the 12 months prior to 
participation in the study were not large enough to generate power to make a 
determination of significance. These analyses appear in Appendix 13. Of note, no 
participant who indicated they had paid for sex, or had been paid for sex, tested positive 
for C. trachomatis.  
 
Separately, the participants were asked if they had sex with sex workers while overseas 
(either while on deployment or on other trips) and 49 indicated they had. Of these, 43 had 
sex only while on deployment, six had sex only while on an overseas trip other than 
deployment, and six had sex while overseas for both purposes. The correlation between 
the answers to these questions was very high (94%), indicating the reliability of the 
answers provided by the participants in the survey. Only three of the 49 participants who 
indicated they had sex with a sex worker overseas within the last 12 months failed to note 
that they had sex with a sex worker (anywhere) in the earlier question. Therefore, 61.33% 
(n=46) of those who indicated that they paid for sex in the last 12 months had also noted 
they paid for sex while overseas. This does not mean they paid for sex solely while 
overseas. Fifty-one respondents indicated the country in which they procured sex while 
overseas. These locations are listed in Table 4.2.19. 
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Table 4.2.19: Country location of procuring sex while overseas 
Region Country 
Sex while on 
deployment 
Sex while on 
other travel 
Pacific Guam 2 - 
Vanuatu 1 - 
Palau 2 - 
PNG 1 - 
Samoa 1 - 
Tonga 1 - 
New Zealand 2 - 
Asia 
 
 
 
 
 
Singapore 17 2 
Thailand 2 - 
Philippines - 1 
China - 2 
Malaysia - 1 
Indonesia (Bali) - 2 
North 
America 
Canada 1 - 
USA 5 1 
Bahamas 2 - 
Europe UK 3 - 
Spain 1 - 
France 1 - 
 
A very small number of participants also indicated they had been paid for sex in the last 12 
months. Each of these surveys was examined for inconsistent responses between 
questions and none was found.  
 
4.3 Safe Sex Practice among Subpopulations in the ADF  
 
Since the 1980s, safe sex has been defined in the context of HIV transmission (Kippax et 
al. 1992; DilOrio et al. 1992) and more broadly as the prevention of the acquisition of STIs 
(DilOrio et al. 1992; Warner et al. 2006). Prior to this, the definition was used in the context 
of the avoidance of pregnancy (DilOrio et al. 1992). Regarding HIV acquisition, safe sex 
has been defined as consistent condom use (Connell & Kippax 1990). This definition has 
been translated into the prevention of other STIs, especially gonorrhoea and chlamydia. 
Inconsistent condom use is associated with STI acquisition (Warner et al. 2006; Chen & 
Donovan 2004; Gaydos et al. 1998). 
 
The opposite of safe sex, namely, high-risk behaviour, has also been defined by some 
researchers. Nikula et al. (2009) in their study of 10,446 Finnish conscripts analysed the 
variable of high-risk behaviour and defined it as the behaviour of “sexually active 
respondents who reported not using a condom at last intercourse and three or more 
partners over the last year”. Goyal et al. (2012) defined high-risk behaviour as using 
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condoms inconsistently, having multiple partners, having a new partner or having sex 
while under the influence of alcohol or drugs.  
 
The definition used in this study builds on the literature and includes the four 
characteristics of safe sex defined by Moskowitz et al. (2006): condom use, abstinence, 
monogamy, and safe partners. The definition of safe sex practice in the analysis below 
therefore includes: 
1. Those who indicated they have never had any sexual contact with another 
person (n=7) 
2. Those who indicated they had had sex with only one person over the 12 month 
period, irrespective of condom use 
3. Those who indicated they had had sex with more than one person, however 
they always used a condom for vaginal and anal sex with casual encounters 
(and may or may not have used a condom with their regular partner) 
4. Those who indicated they were not in a relationship and who indicated they 
always used a condom for vaginal and anal sex with casual partners 
5. Those who indicated they did not have vaginal and/or anal sex with casual 
partners. 
It is acknowledged that the second and third points assume the regular partner is also 
practising safe sex.   
 
The definition of unsafe sex practice in this study includes: 
1. Those who indicated they had had sex with more than one person and indicated 
they did not always use a condom for vaginal and anal sex with casual encounters  
2. Those who indicated they were not in a relationship and who indicated they did not 
always use a condom for vaginal and anal sex with casual partners. 
Seven hundred participants provided all the information required to ascertain their safe sex 
practices according to the above definition. Of these, 476 (67.71%) had practised safe sex 
during the previous 12 months. As noted above in Section 4.2.11, there was no significant 
difference in C. trachomatis positivity (p=0.401) between those who practised safe sex and 
those who didn’t; however, there was a significant difference in STI diagnosis in the 
previous 12 months (p=0.0003) between those who practised safe sex and those who did 
not. 
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This section examines the characteristics of those who practised safe sex, in anticipation 
of a discussion about recommended targets for sexual health education within the ADF. 
Table 4.3.0 provides a summary of the analysis in this section. The findings highlighted in 
green represent areas of importance (as in Table 4.2.0 summarising the analysis in the 
previous section). 
 
Table 4.3.0:  Summary of unsafe sex practices within the ADF 
 
 Unsafe Sex Practice 
Unsafe sex Safe sex % of unsafe sex p-value OR 
Gender  
Female 51 104 32.90% 
p=0.076 1.02 
Male 172 370 31.73% 
Age 
≥ 25 162 311 34.25% 
p=0.109 1.33 
< 25 64 163 28.19% 
Rank 
Officer 22 47 31.88% 
p=0.994 1.00 
Non-Officer 199 426 31.84% 
Seniority 
Senior 6 39 13.33% 
p=0.006 3.22 
Junior 215 434 33.13% 
Length of time in ADF 
Less than one year 40 67 37.33% 
p=0.0054 
3.48 
(7 years or less to more 
than 7 years) 
>1 and ≤ 2 34 52 39.53% 
>2 and ≤ 3 30 44 40.54% 
>3 and ≤ 4 26 58 30.95% 
>4 and ≤ 5 21 39 35.00% 
>5 and ≤ 6 13 24 35.14% 
>6 and ≤ 7 15 28 34.88% 
>7 and ≤ 8 2 17 10.53% 
>8 and ≤ 9 3 14 17.65% 
More than 9 years 11 66 16.67% 
Deployed anytime in the previous 12 months 
Deployed 82 222 26.80% 
p=0.018 2.05 
Not deployed 134 244 35.45% 
On deployment at the time of the study 
Deployed at time of study 44 134 24.44% 
p=0.037 1.58 Previous deployment 38 88 30.16% 
Not deployed 134 244 35.45% 
Ever deployed 
No 78 307 35.45% 
p=0.089 1.35 
Yes 125 142 28.94% 
Change in relationship status 
Single 
Changed 
status 8 29 21.62% 
p=0.086 2.17 Same 
status 22 173 11.28% 
In a relationship 
Changed 
status 39 66 37.14% 
p=0.475 0.84 Same 
status 114 163 41.15% 
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Table 4.3.0:  Summary of unsafe sex practices within the ADF (Continued) 
 
 Unsafe Sex Practice 
Unsafe sex Safe sex % of unsafe sex p-value OR 
Alcohol use 
Not harmful 82 281 22.59% 
p<0.0001 2.52 
Potentially harmful 139 189 42.38% 
Alcohol use during last sexual encounter 
Yes 127 148 46.18% 
p<0.0001 2.92 
No 93 316 22.74% 
Number of sexual contacts in previous 12 months (total) 
one 23 257 8.21% 
p<0.0001 11.76 
2 or more 
 
 
200 190 51.28% 
Number of sexual contacts by individual number 
2 37 59 38.54% 
p=0.00019 
7.71 
(2 partners compared 
to 11 or more) 
3 34 36 48.57% 
4 27 35 43.55% 
5 14 15 48.27% 
6 22 14 61.11% 
7 13 10 56.52% 
8 10 4 71.43% 
9 0 4 0% 
10 14 7 66.67% 
11 or more 29 6 82.88% 
Frequency of sex 
At least weekly 123 156 44.09% 
p<0.0001 2.23 
Less than weekly 200 283 26.11% 
Gender of last sexual contact 
Same 7 14 33.33% 
p=1.00 1.02 
Opposite 215 435 33.08% 
Sex work (Paid for sex in last 12 months) 
Yes 36 38 48.65% 
p=0.0038 2.03 
No 203 434 31.87% 
Sex worker (been paid for sex in last 12 months) 
Yes 3 4 42.86% 
p=0.543 1.59 
No 218 462 32.66% 
 Yellow highlight indicates a sample size that did not allow a determination of significance due to lack of power 
 Green highlight indicates confidence interval of percentage did not cross zero; p-value of significance; and / or 
odds ratio higher than 2.0 
 
 
4.3.1 Gender and Age 
 
There was no difference in safe sex practice between males and females (x2 0.076, 
p=0.788, OR 1.05, 95% CI 0.72–1.54) (Table 4.3.1) or between participants aged 25 years 
and younger and participants aged 26 and older (x2 2.573, p=0.109, OR 1.33, 95% CI 
0.94–1.88). While there was no statistically significant difference between the two age 
groups and not enough statistical power to make that determination, the odds ratio only 
just crossed ‘1’ and warranted further exploration. An analysis of each tier of age range is 
presented in Table 4.3.2.  
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Table 4.3.1: Safe sex practice, age and gender 
 Not practising safe sex Practicing 
safe sex 
Total 
n % 95%CI 
Gender Female 51 32.90% (25.88-40.56) 104 155 
Male 172 31.73% (27.92-35.74) 370 542 
Total 223  474 697 
 
Age 25 and younger 162 34.25% (30.08-38.61) 311 473 
26 and older 64 28.19% (22.64-34.30) 163 227 
Total 226  474 700 
 
Table 4.3.2: Safe sex practice and age range 
Gender Not practising safe sex Practicing 
safe sex 
Total condoms 
often 
condoms 
sometimes 
condoms 
never 
18-20 21 18 8 98 145 
21-22 21 20 7 78 126 
23-25 28 28 11 135 202 
26 and above 27 27 8 163 225 
Total 97 93 34 474 698 
 
The x2 statistic was 5.186 (p=0.818).  However, on the basis of these small numbers, no 
difference could be demonstrated, 
 
 
4.3.2 Rank and Duration of Service 
 
No difference in safe sex practice between officers and non-officers or between senior or 
junior members of the ADF was able to be determined due to the small sample size of 
officers and senior members of the ADF. The detailed analysis can be found in Appendix 
13.   
 
Safe sex practices were able to be determined for 604 participants who indicated their 
length of service in the ADF (Table 4.3.3). Participants in initial basic training (11 weeks) 
were excluded from this analysis. Length of time (≤7 years compared to >7 years) was a 
significant variable for safe sex practice (x2 23.38, p=0.0054, OR 3.48, 95% CI 0.1.99–
6.09) over the 12 months prior to participation in the survey.     
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Table 4.3.3: Safe sex practice and length of time in the ADF 
Length of time in ADF at time of 
participation in the study 
Not practicing safe sex Practicing 
safe sex 
Total 
n % 95%CI 
Less than 1 year 40 37.33% (28.65-46.79) 67 107 
>1 and ≤ 2 34 39.53% (29.69-50.07) 52 86 
>2 and ≤ 3 30 40.54% (29.89-51.91) 44 74 
>3 and ≤ 4 26 30.95% (21.84-41.35) 58 84 
>4 and ≤ 5 21 35.00% (23.86-47.55) 39 60 
>5 and ≤ 6 13 35.14% (21.33-51.17) 24 37 
>6 and ≤ 7 15 34.88% (21.99-49.74) 28 43 
>7 and ≤ 8 2 10.53% (2.25-29.69) 17 19 
>8 and ≤ 9 3 17.65% (5.23-40.01) 14 17 
More than 9 years 11 16.67% (7.83-23.36) 66 77 
Total 195  409 604 
 
4.3.3 Deployment 
 
A comparison was made between the practice of safe sex among those who had been 
deployed in the last 12 months and those who had not (Table 4.3.4). This included 
individuals who were on deployment at the time they completed the survey (n=180).  
 
Table 4.3.4: Safe sex practices and deployment in previous 12 months 
Deployed anytime in the 
previous 12 months 
Not practising safe sex Practising 
safe sex 
Total 
n % 95%CI 
Deployed 82 26.80% (22.07-31.96) 222 304 
Not deployed 134 35.45% (30.75-40.37) 244 378 
Total 216  466 682 
 
Being deployed at any time over the previous 12 months was a significant variable for safe 
sex practice (x2 5.59, p=0.018, OR 2.05, 95% CI 1.48–2.83). Deployment was further 
examined by analysing the subpopulation of those who were deployed at the time of the 
study (Table 4.3.5).  
 
Table 4.3.5: Safe sex practices and deployment at time of participation in the study 
On deployment at time 
of study 
Not practising safe sex Practising 
safe sex 
Total 
n % 95%CI 
Deployed at time of 
study 
44 24.44% (18.61-31.10) 134 178 
Previous deployment 
in last 12 months 
38 30.16% (22.66-38.55) 88 126 
Not deployed in last 
12 months 
134 35.45% (30.75-40.37) 244 378 
Total 216  466 682 
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Being deployed at the time of the study was also a significant variable for safe sex practice 
(x2 6.602, p=0.037, OR 1.58, 95% CI 1.07–2.32). Differentiating between those who 
completed the survey while on deployment compared to those who had not been deployed 
or those who had previously been deployed in the last 12 months illustrated that those on 
deployment practised safe sex more often. Those not currently on deployment were more 
than 1½ times more likely to have participated in unsafe sex within the previous 12 months 
than the remainder of the sample. Comparison between the practice of safe sex by those 
who had ever been deployed during their time in the ADF and those who had never been 
deployed was also undertaken (Table 4.3.6).   
 
Table 4.3.6: Safe sex practice and ever been deployed 
Ever deployed Not practising safe sex Practising 
safe sex 
Total 
n % 95%CI 
No 78 35.45% (29.36-41.93) 142 220 
Yes 125 28.94% (24.81-33.34) 307 432 
Total 203  449 652 
 
Although having ever been deployed was not a statistically significant variable for the 
practice of safe sex (x2 2.889, p=0.089, OR 1.35, 95% CI 0.95–1.91), there was a trend 
indicating that those who had been deployed were more likely to practise safe sex.  
 
4.3.4 Change in Relationship Status 
 
The practice of safe sex in relation to a change in relationship status (from being single to 
being in a regular relationship, or from being in a regular relationship to being single) was 
examined; however, no difference between these subpopulations was able to be 
determined due to the small sample sizes. Detailed analysis can be found in Appendix 13. 
It is noted that single participants who had changed their relationship status within the 
previous 12 months (that is, had become single after finishing a relationship) were more 
than twice more likely to be engaged in unsafe sexual practices than those who had been 
single for more than 12 months.   
 
4.3.5 Alcohol Use 
 
As noted previously, three standardised questions were taken from the AUDIT (DVA 2013) 
and using AUDIT interpretation guidelines, the answers were used to provide a 
consumption score and to determine if the consumption rate may indicate a risk of alcohol-
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related harm. The consumption use (and related potential for alcohol-related harm) was 
compared to safe sex practice by examining the difference between alcohol use that is 
considered not harmful and alcohol use that is considered potentially harmful (Table 
4.3.7). 
 
Table 4.3.7: Safe sex practices and alcohol consumption 
Alcohol Use Not practising safe sex Practising 
safe sex 
Total 
n % 95%CI 
Not harmful 82 22.59% (18.52-27.10) 281 363 
Potentially harmful 139 42.38% (37.12-47.77) 189 328 
Total 221  470 691 
 
Alcohol use to levels that may be potentially harmful was a statistically significant variable 
for safe sex practice (x2 31.62, p<0.0001, OR 2.52, 95% CI 1.81–3.50). Alcohol use at the 
time of last sexual encounter was also significant (Table 4.3.8).  
 
Table 4.3.8: Safe sex practice and alcohol use at the time of last sexual encounter 
Use of alcohol during last 
sexual encounter 
Not practising safe sex Practising 
safe sex 
Total 
n % 95%CI 
Yes 127 46.18% (40.36-52.09) 148 275 
No 93 22.74% (18.88-26.98) 316 409 
Total 220  464 684 
 
There was a significant correlation between safe sex practice and those who consumed 
alcohol on the occasion of their last sexual encounter (x2 41.42, p<0.0001, OR 2.92, 95% 
CI 2.09–4.02). Those who consumed alcohol at the time of their last sexual encounter 
were almost three times more likely to participate in unsafe sex over the previous 12 
month period (not particularly at the time of the last sexual encounter) than those who 
didn’t.   
 
4.3.6 Sexual Practices  
 
As the definition of safe sex utilised in this study includes those individuals who reported 
having sex with only one person in the previous 12 months (irrespective of condom use), 
this definition confounds any analysis by number of sexual contacts. Given this, those who 
had two or more partners were almost 12 times more likely to have practised unsafe sex at 
some stage over the previous 12 months than those who had only one partner (x2 136.14, 
p<0.0001, OR 11.76, 95% CI 7.35–18.83). To further explore this, those who only had one 
sexual partner over the 12 month period were removed from the cohort and a comparison 
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was made between those with fewer partners and those with a greater number of partners 
in the timeframe (Table 4.3.9).   
 
Table 4.3.9:  Safe sex practice and number of sexual contacts in previous 12 months by  individual 
number of contacts 
Number of 
contacts 
Not practising safe sex Odds Ratio Practising 
safe sex 
Total 
n % 95%CI 
2 partners is 
referent group 
2 37 38.54% (29.26-48.50) - 59 96 
3 34 48.57% (37.12-60.14) 1.51 
(0.81-2.81) 
36 70 
4 27 43.55% (31.73-55.95) 1.23 
(0.64-2.35) 
35 62 
5 14 48.27% (30.98-65.90) 1.49 
(0.65-3.44) 
15 29 
6 22 61.11% (44.84-75.68) 2.51 
(1.14-5.50) 
14 36 
7 13 56.52% (36.50-75.01) 1.23 
(0.49-3.08) 
10 23 
8 10 71.43% (45.47-89.50) 3.99 
(1.16-13.64) 
4 14 
9 0 0% - - 4 4 
10 14 66.67% (45.40-83.68) 3.19 
(1.18-8.64) 
7 21 
11 or more 29 82.88% (68.03-92.51)) 7.71 
(2.92-20.34) 
6 35 
Total 200   190 390 
 
There was a correlation between an increasing number of sexual partners within the 
previous 12 months and an increasing incidence of unsafe sex practice (2 partners vs >10 
partners x2 32.118, p=0.00019, OR 7.71, 95% CI 2.92–20.34). In short, the more sexual 
partners an individual reported, the more likely they were to have indicated that they did 
not practise safe sex on all occasions over the same time period.  
 
The 35 individuals who indicated they had had sex with 11 or more partners within the 
previous 12 months presented an interesting subpopulation and were further analysed. 
Eleven of these individuals indicated they had never (31%) or only occasionally used 
condoms with their partners. Thirty-four were male and one was female. They were evenly 
spread across the age range with only seven being between 18 and 20 years of age. Most 
were single (one was in a relationship) and most had been single for more than 12 months 
(n=30). All 35 provided a urine sample to be screened for C. trachomatis and none were 
positive. All 35 drank alcohol, with 43% (n=15) drinking more than weekly. Over 60% 
(n=22) consumed alcohol on the occasion of their last sexual contact. The gender of their 
last sexual partner was opposite to their own gender for all 100%. Only 30% (n=11) had 
ever been deployed and all of these individuals had been deployed within the last 12 
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months. Of those who had been deployed, 81% (n=9) had engaged in at least one sexual 
activity while on deployment. Twenty of the 35 had been overseas (other than on 
deployment) within the previous 12 months and eight of these (40%) had engaged in at 
least one sexual encounter while overseas. Among the 35 who had had sex with more 
than 11 or more partners, 26% (n=9) had engaged the services of a sex worker and one 
individual indicated they had been paid for sex within the last 12 months.   
 
To provide extra information about the sexual practices of the whole sample, the frequency 
of sex was also analysed. As shown in Table 4.3.10, there was a significant correlation 
between unsafe sex practice and the increasing frequency of sex (weekly vs < weekly x2 
23.35, p<0.0001, OR 2.23, 95% CI 1.61–3.10). Those who had sex more often were less 
likely to report that they had practised safe sex on all occasions over the previous 12 
month period.  
 
Table 4.3.10: Safe sex practice and frequency of sexual encounters 
Number of contacts Not practising safe sex Practising 
safe sex 
Total 
n % 95%CI 
At least weekly 123 44.09% (38.35-49.95) 156 279 
Less than weekly 200 26.11% (21.90-30.68) 283 383 
Total 223  439 662 
 
The gender of the participants’ last sexual contact and the use of sex workers was also 
examined; however, no difference between these subpopulations was able to be 
determined due to the small sample sizes. The detailed analysis can be found in Appendix 
13.    
 
4.4 Health Service Attendance 
 
Nineteen percent of participants (n=135) indicated they had accessed a health service for 
testing or treatment of an STI within the previous 12 months. The age- and gender-
adjusted rate for the ADF was 18.12%. Attendance by gender, age, rank and seniority is 
summarised in Table 4.4.1 and analysed in more detail on the next page.  
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Table 4.4.1: Attendance at health services by age, gender, rank and seniority 
 Yes No % 95% CI p-value OR 95% CI 
Gender Female 42 117 26.42% 20.03-33.65 
p=0.005 1.81 1.19-2.76 
Male 91 460 16.52% 13.59-19.79 
Age ≥ 25 93 391 19.21% 15.89-22.90 
p=0.781 1.06 0.71-1.59 
< 25 42 187 18.34% 13.74-23.73 
Rank Officer 16 55 22.53% 14.03-33.22 
p=0.417 1.28 0.71-2.31 
Non-Officer 118 518 18.55% 15.68-21.71 
Seniority Senior 5 39 11.36% 4.47-23.13 
p=0.185 1.88 0.73-4.88 
Junior 129 534 19.46% 16.58-22.60 
 
Differences in age and rank were not statistically significant indicators of attendance (or 
non-attendance) at a health service for STI testing or treatment. Gender was a statistically 
significant indicator, with females almost twice as likely to have attended as males. The x2 
statistic was 7.943 (p=0.0048). However, even though those who were senior members of 
the ADF were almost twice as likely to have attended a health service there was not 
enough statistical power to make this determination. A sample of 189 senior personnel 
was required.  
 
The vast majority had attended an ADF health service (n=117). The participants were 
three times more likely to have attended an ADF health service for testing and treatment of 
an STI than they were to attend a civilian health service (16.4% vs 5.61%) (Table 4.4.2).  
 
Table 4.4.2: Attendance at health services for testing and/or treatment of STIs 
 Attendance at ADF health service 
Total 
Yes No 
Attendance at civilian 
health service 
Yes 22 3.09% 18 2.52% 40 
No 95 13.32% 578 81.07% 673 
total 117  596  713 
 
The participants were significantly more likely to have attended an ADF health service for 
STI testing or treatment than a civilian health service (x2 46.01, p<0.0001). Attendance at 
an ADF health service compared to attendance at a civilian health service by age, gender, 
rank and seniority was also examined (Table 4.4.3). 
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Table 4.4.3: Attendance at ADF or civilian health services for STI testing and/or by gender, age, 
rank and seniority 
  n %  n % 
Male 
(n=91 
ADF service only 65 71.43% 
All ADF service  attendance 80 87.91% 
Both services 15 16.48% 
All civilian service attendance 26 28.57% 
Civilian service only 11 12.09% 
Female 
(n=42) 
ADF service only 28 66.66% 
All ADF service  attendance 35 83.33% 
Both services  7 16.67% 
All civilian service attendance 14 33.33% 
Civilian service only 7 16.67% 
       
Age 25 
or less 
(n=93) 
ADF service only 66 70.97% 
All ADF service  attendance 79 84.95% 
Both services  13 13.98% 
All civilian service attendance 27 29.03% 
Civilian service only 14 15.05% 
Age 26 
or more 
(n=42) 
ADF service only 29 69.04% 
All ADF service attendance 34 80.95% 
Both services  5 11.90% 
All civilian service attendance 13 30.95% 
Civilian service only 8 19.05% 
       
Officer 
(n=16) 
ADF service only 12 75.00% 
All ADF service  attendance 14 87.50% 
Both services  2 12.50% 
All civilian service attendance 4 25.00% 
Civilian service only 2 12.50% 
Other 
rank 
(n=118) 
ADF service only 83 70.34% 
All ADF service attendance 102 86.44% 
Both services  19 16.10% 
All civilian service attendance 35 29.66% 
Civilian service only 16 13.56% 
       
Senior 
(n=5) 
ADF service only 4 80.00% 
All ADF service  attendance 5 100.00% 
Both services  1 20.00% 
All civilian service attendance 1 20.00% 
Civilian service only 0 0.00% 
Junior 
(n=129) 
ADF service only 91 70.54% 
All ADF service attendance 111 86.05% 
Both services  20 15.50% 
All civilian service attendance 38 29.46% 
Civilian service only 18 13.96% 
 
While there appeared to be no difference in gender, age, rank or seniority in the 
comparison of attendance at ADF or civilian health services, the sample sizes were too 
small to generate enough statistical power to make any determination.    
 
4.4.1 History of STIs and Health Service Attendance 
 
As expected, there was a significant relationship between attendance at a health service 
for STI testing or treatment and an STI diagnosis in the previous 12 months (x2 63.58, 
p<0.0001 OR 9.82 95% CI 5.07–19.01) (Table 4.4.4).   
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Table 4.4.4:  STIs in the last 12 months and access to health services for sexual health 
History of STIs 
Accessed health service 
Did not access health service Total 
n % 95%CI 
Yes 28 65.12% (50.26-78.01) 15 43 
No 107 15.97% (13.35-18.89) 563 670 
Total 135  578 713 
 
The strong correlation extended to the participants’ self-identification of STI symptoms 
(Table 4.4.5). Males were more likely to have attended a health service if they had also 
self-identified symptoms of STIs in the previous 12 months (31.71% vs 16.67%).  
 
Table 4.4.5:  Access to health services for sexual health by self-identification of STI symptoms 
 
Symptoms of STIs in last 12 months  
Accessed health service Did not access 
health service 
Total 
n % 95%CI 
Females Yes 4 16.67% (5.90-34.91) 20 24 
No 36 26.09% (19.31-33.86) 102 138 
Total 40  122 162 
Males Yes 26 31.71% (22.40-42.28) 56 82 
No 70 14.61% (11.67-17.99) 409 479 
Total 96  465 561 
 
Male self-identification of STI symptoms was significantly correlated with attendance at a 
health service for testing or treatment of STIs (x2 14.42, p=0.0001 OR 2.71 95% CI 1.60–
4.61). There was insufficient statistical power to make any determination of significance for 
females.  
 
4.4.2 Safe Sex Practice and Health Service Attendance 
 
Attending a health service for a sexual health matter was significantly related to the 
practice of unsafe sex (x2 27.57, p<0.0001 OR 2.75 95% CI 1.87–4.04) and the significant 
correlation remains when examining attendance at solely ADF health services (x2 19.574 
p<0.0001 OR 2.47 95% CI 1.64–3.71). Participants who accessed an ADF health service 
for a sexual health matter were almost 2½ times more likely to be practising unsafe sex 
than those who didn’t access the health service for these reasons. This correlation is 
axiomatic as this study also shows that unsafe sex practice is linked to self-reported STIs, 
which in turn correlates with attendance at sexual health services. This correlation 
represents an opportunity to target safe sex education.   
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Table 4.4.6:  Safe sex practice and health service attendance for sexual health 
Accessed a health service in 
previous 12 months for STI 
Not practising safe sex Practising 
safe sex 
Total 
n % 95%CI 
All health services Yes 69 51.49% (43.07-59.85) 65 134 
No 156 27.86% (24.27-31.68) 404 560 
Total 225  469 694 
ADF health services Yes 57 49.56% (41.38-59.47) 58 115 
No 165 28.50% (24.93-32.27) 414 579 
Total 222  472 694 
 
4.4.3 Comparison to Other Populations 
 
The ACCEPt trial provided data on the attendance at health services by young people 
(Yeung et al. 2014). ACCEPt was funded by the Department of Health and Ageing to 
investigate whether annual chlamydia testing for 16–29 year olds in general practice could 
reduce chlamydia prevalence. The trial involved 34 GP clinics and Aboriginal Medical 
Services in 54 towns in Australia. A total of 4284 young people participated in the trial and 
were recruited at the time of attendance (for any reason) at the GP clinic or Aboriginal 
Medical Service. Twenty percent of females and approximately 7% of males attended the 
service for a sexual health-related reason. Compared to the ADF sample (F=26.42%, 
M=16.52%), the ACCEPt trial demonstrated a lower attendance rate for a sexual health-
related reason. It is noted that the ACCEPt data may over-represent the attendance rates 
as the study population was a cohort of those seeking health care (even though 89% of 
the participants in the trial indicated they had attended a GP clinic in the previous 12 
months which may indicate a representative sample of the age group).  
 
The Australian Collaboration for Chlamydia Enhanced Sentinel Surveillance (ACCESS) 
study reported that the rate of 16–29 year olds attending a GP clinic who were tested for 
C. trachomatis was 8.9% (Kong et al. 2011). It is noted that this did not include all sexual 
health matters but only the narrower topic of C. trachomatis.  
 
The closest published research to this topic outside Australia was set in the UK (Johnson 
et al. 1996) where 18,876 randomly selected residents were surveyed to gauge whether or 
not sexual health services were reaching their target populations. In that study, 8.3% of 
men and 5.6% of women had attended a sexual health clinic in their lifetime. The sample 
was not stratified by age and therefore cannot be compared to the ADF population. In 
addition, the time period of the UK sample covered the whole life whereas the time period 
for the ADF sample was the previous 12 months.   
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4.5 Comparability with ADF Population 
 
The data enabling a comparison with the ADF population was sourced from the 
Department of Defence Census 2007 Public Report, published in February 2009. This 
information was chosen for the comparison as it is the closest in time to the present study. 
The census report divides the defence community into permanent and reserve members. 
As only 15 of the 723 respondents (2.13%) in the present study indicated they were 
reserve members, this comparison was undertaken only with the permanent ADF 
members.  
 
Compared to the permanent ADF population, the survey sample over-represented females 
and younger individuals. The over-representation of younger individuals affects other 
areas, such as marital status, dependants, and length of service. According to the census 
report, 87% of the permanent members were male—compared to 77.21% of the sample in 
this study. There was deliberate oversampling of females in this study, with a target of 
25%.   
 
This study targeted individuals aged from 18 to 29. There was deliberate oversampling of 
younger members. The age ranges in the ADF census report were slightly different to the 
age ranges in this study. For comparison purposes, each age range was divided into 
average responses per year. Table 4.5.1 presents the age range comparison of the study 
population and the ADF population.  
 
Table 4.5.1:  Age range comparison of study sample and ADF population 
Study 
Comparable 
age range 
Permanent ADF 
n 
Av per 
year 
Age by 
year 
Adjusted  
n % % n 
144 
48 18 
96 15.53% Under 20 11.77% 3065 
48 19 
48 20 
311 50.32% 20-24 49.01% 12773 
129 
64 21 
65 22 
203 
67 23 
67 24 
68 25 
210 34.15% 25-29 39.23% 10219 
142 
35 26 
36 27 
35 28 
36 29 
618  618 100%  100% 26058 
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The effect of targeting younger people in the sample is illustrated by comparing 
subpopulations of the study sample and of the ADF. Regarding relationship status, 55% of 
the permanent ADF were married or in an interdependent relationship while 33.19% of the 
sample in this study were married or in an interdependent relationship. Regarding the 
number of children, 48% of the permanent ADF indicated they had dependants while 15% 
(n=92) of the survey sample indicated they had dependants. The median length of service 
in the permanent ADF was 6.8 years, while the median length of service of this study’s 
respondents was 4.88 years. 
 
To compare the ADF permanent population to the Australian population, the study sample 
was weighted for age and gender. This calculation is shown in detail in Appendix 10.  
 
For example, using the design weighting formula (Appendix 10), the weighted proportion of 
respondents who were married or were in an interdependent relationship rose to 35.03% 
(from 33.19%). However, this remains well below the proportion of the total ADF 
population (55%) as this was for the entire ADF while 35.03% was for those in the ADF 
aged 18–29 years.  
 
4.6 ADF Compared to Australian Populations 
 
The ADF population was compared to the Australian population utilising the weighted data 
described above. Where design weighting was employed in the analysis reported in the 
following sections, it is noted explicitly and the detailed calculations appear in Appendix 
10. A second comparison technique between the ADF and Australian populations was also 
utilised in some of the analysis: the Australian population data was used to generate an 
expected prevalence or proportion and this was compared to the observed prevalence or 
proportion in the ADF. 
 
4.6.1 Prevalence of C. trachomatis 
 
The age- and gender-adjusted C. trachomatis prevalence in the ADF population aged 18–
29 was 1.87%. For females it was 1.13% and for males it was 2.13%. These low 
prevalences compare favourably to the Australian population.  
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Comparable studies in time and age include a study by Martin et al. (2009) where 277 16–
24 year old males and females returned a positivity rate of 3.1% in New South Wales and 
a study by Davies et al. (2011) of 432 international backpackers in Sydney that returned a 
positivity rate of 3.1% for males and 3.9% for females. Earlier, a study in Victoria by 
Hocking et al. (2004) found a C. trachomatis prevalence rate among sexually active 
women aged 18–24 of 3.7%. A systematic review and meta-analysis by Lewis et al. (2012) 
found pooled prevalence rates among women under 25 of 5.0% and among men under 30 
of 3.9%. The latest published data in Australia from Yeung et al. (2014) reported a C. 
trachomatis prevalence rate among 4284 16–29 year old GP clinic attendees of 4.6% 
(F=4.4%, M= 5.2%). 
 
4.6.2 Sexual Practices 
 
The ADF population extrapolated from the present study’s sample was compared to the 
ASHR data (Visser et al. 2003) for specific subpopulations with additional more recent 
data from the ACCEPt trial (Yeung et al. 2014). The ADF data was adjusted for age and 
gender and was compared to the population-adjusted data within the age range of the 
ASHR. 
 
4.6.2.1 Frequency of sex 
 
The ASHR data reports the frequency of sex with a regular heterosexual partner by the 
number of sexual encounters per week. The study found that younger people were more 
likely to report more frequent sex than older people and that men were more likely to 
report more frequent sex than women (p<0.001).   
 
The survey in the present study asked how often the respondent had sex with their regular 
partner (daily, weekly, monthly, every few months, yearly) and from this an average per 
week for the sample was calculated. Again, to avoid bias and for better comparability, the 
following were removed from the ADF weighted sample: 
- Those who indicated they had not had any sexual experiences (n=7) 
- Those who indicated the gender of their last sexual contact was the same gender 
as themselves (n=21) 
- Those who were aged more than 30 (n=84) 
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- Those who indicated they had a regular partner but had not engaged in any sexual 
practice over the last 12 months (n=4). 
Again, the ADF weighted sample may be slightly under-reported because both males and 
females were more likely to have reported a higher frequency of sexual encounters if they 
were younger and the ASHR sample included those aged 16–29. 
 
There was no significant difference in the average number of times that a male respondent 
in the ASHR sample (16–29 years) indicated they had sex (2.70 times per week) with their 
regular heterosexual partner compared to a male respondent in the ADF population (2.80 
times per week) (t=1.0111, p=0.312). There was a significant difference between females 
in the ASHR sample (2.2 times per week) and females in the ADF population (2.91 times 
per week) (t=4.448, p<0.0001). Females in the ADF population were far more likely to 
report a higher frequency of sex with their regular heterosexual partners than females in 
the Australian population as reported in the ASHR.   
 
4.6.2.2 Number of sexual partners in addition to regular sexual partner 
 
The ACCEPt trial gathered data on the number of partners in the previous 12 months 
(Yeung et al. 2014), reporting that 40.06% of males and 28.53% of females had more than 
one sexual partner within the previous 12 months (16–29 year olds). Compared to the ADF 
population (18–29 year olds), where 60.50% of males (288/476) and 54.11% of females 
(79/146) reported more than one sexual partner in the previous 12 months, the ACCEPt 
sample is lower. It is acknowledged that the age ranges are different and this may account 
for some of the difference.  
 
Both the present study and the ASHR asked specific questions about the number of 
sexual partners. This included respondents who had been in a regular relationship for 
more than 12 months. Again, to avoid bias and for better comparability, the following were 
removed from the ADF weighted sample: 
- Those who indicated they had not had any sexual experiences (n=7) 
- Those who indicated the gender of their last sexual contact was the same gender 
as themselves (n=21) 
- Those who were aged more than 30 (n=84). 
In this instance, the number of sexual partners in the ADF weighted sample may have 
been over-reported because both males and females in the ASHR were more likely to 
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report additional sexual partners beyond their regular relationship if they were older. Table 
4.6.1 summarises the comparison between the ADF and Australian populations (aged 18–
29) reporting more than one sexual partner in the last year while having been in a 
relationship with a regular partner for more than one year. 
 
Table 4.6.1: Comparison between ADF and Australian populations (aged 18-29) in reporting more 
than one sexual partner in the last year while having been in a relationship with a regular partner 
for more than one year 
 
 ADF ASHR (Rissel et al. 2003) 
Age 
range 
n Total % 
Adjusted 
% 
Age 
range 
Adjusted 
n 
Total Adjusted % 
Female 
18-29 
4 49 8.16% 7.57% 
16-29 
140 2231 6.28% 
Male 18 157 11.46% 10.69% 280 2169 12.91% 
 
The sample size for females was too small to generate enough statistical power. For 
males, there was statistical power and there was not a significant difference (p=0.609). 
Additionally, the expected finding in the ADF population using the Australian population as 
the reference was compared to the actual finding (Table 4.6.2).  
 
Table 4.6.2: Observed versus expected reporting in the ADF population of more than one sexual 
partner in the  last year while having been in a relationship with a regular partner for more 
 than one year 
 
More than one partner in last 12 
months 
More than one One 
partner 
Total 
n % 95%CI 
Males 
Expected 21 12.91% (8.62-19.12) 138 159 
Observed 18 11.32% (7.10-16.93) 141 159 
Females 
Expected 3 6.28% (1.75-15.54) 46 49 
Observed 4 8.16% (2.82-18.25) 45 49 
 
While it appeared there was no difference in these proportions (x2 0.263, p=0.608), there 
was not enough statistical power to make this determination for either males or females.  
 
The ACCEPt trial found that, among their 4284 (16–29 year old) respondents, 5.04% of 
males and 4.42% of females were involved in two or more overlapping partnerships at the 
time of participation in the study.  
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4.6.2.3 Condom use 
 
Examination of condom use with casual partners (for heterosexual activity) was 
undertaken. To avoid bias and for better comparability, the following were removed from 
the ADF weighted sample: 
- Those who indicated they had not had any sexual experiences (n=7) 
- Those who indicated no vaginal or anal sex with casual partners (n=25) 
- Those who indicated the gender of their last sexual contact was the same gender 
as themselves (n=21) 
- Those who were aged more than 30 (n=84). 
 
The age range in the ASHR sample was 16–29 years and the age range in the ADF 
weighted sample was 18–29 years. In the ASHR sample, for females there was no 
significant difference in the association between always using condoms and age 
(p=0.679); for males, those who were younger (16–19 years) were more likely to have 
always used condoms (p=0.026) than the rest of the sample (20–59 years). In addition, the 
ASHR sample was asked about condom use within the previous six months and the ADF 
sample was asked about condom use over the previous 12 months.  
 
Considering the ADF sample did not include those younger than 18 and the ADF sample 
was asked about practices over a longer time period, the ADF data on condom use may 
be slightly under-reported because those who were younger tended to use condoms more 
often. Table 4.6.3 presents the comparison between ADF and Australian populations aged 
18–29 in regard to condom use with casual partners. 
 
Table 4.6.3: Comparison between ADF and Australian populations aged 18-29 in condom use 
casual partners 
 
 ADF ASHR 
Age 
range 
 Total % 
Adjusted 
% 
Age 
range 
Adjusted 
n 
Total 
Adjusted 
% 
Female 
18-29 
21 67 31.30% 31.05% 
16-29 
42 108 38.89% 
Male 126 283 44.52% 43.63% 99 199 49.75% 
 
This analysis assumed the two samples were independent; however, the ASHR sample 
may have included members of the ADF. ADF membership was not reported. There was 
no significant difference between the proportion of females in the ADF sample who always 
used condoms during casual encounters and the proportion of females in the ASHR 
MAIN TEXT 
Page 123 of 256 
sample who always used condoms during casual encounters (p=0.312). Similarly, there 
was no difference in the proportions of males in this regard (p=0.258).  
 
Additionally, the expected finding in the ADF using the Australian population as the 
reference was compared to the actual finding (Table 4.6.4). There was no significant 
difference between the expected and observed levels of condom use for males (x2 1.59, 
p=0.207); however, for females there was not enough statistical power to make this 
determination. 
 
Table 4.6.4: Observed versus expected condom use with casual partners in the ADF 
 
Condom use with casual 
partners 
Use condoms 
Do not use condoms Total 
n % 95%CI 
Males 
Expected 141 49.75% (44.02-55.63) 142 283 
Observed 126 44.52% (38.81-50.34) 157 283 
Females 
Expected 26 38.89% (27.81050.75) 41 67 
Observed 21 31.30% (21.20-43.06) 46 67 
 
Condom use at the time of last sexual encounter (for vaginal intercourse only) was also 
examined (Table 4.6.5). Again, to avoid bias and for better comparability, the following 
were removed from the ADF weighted sample: 
- Those who indicated they had not had any sexual experiences (n=7) 
- Those who indicated the gender of their last sexual contact was the same gender 
as themselves (n=21) 
- Those who were aged more than 30 (n=84). 
Again, condom use in the ADF sample may have been slightly under-reported because the 
ASHR sample included those aged 16–29, and both males and females were more likely 
to report condom use at the time of last vaginal intercourse if they were younger.  
 
Table 4.6.5: Comparison between ADF and Australian populations aged 18-29 in condom use at 
most recent event of vaginal intercourse 
 
 ADF ASHR 
Age 
range 
n Total % 
Adjusted 
% 
Age 
range 
Adjusted 
n 
Total 
Adjusted 
% 
Female 
18-29 
49 130 37.69% 36.77% 
16-29 
896 1505 37.32% 
Male 227 429 52.29% 52.20% 1338 1177 53.20% 
 
There was no significant difference between the proportion of females in the ADF sample 
who used condoms during their most recent vaginal intercourse and the proportion of 
females in the ASHR sample who used condoms during their most recent vaginal 
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intercourse (p=0.933). Similarly, there was no difference in proportions of males in this 
regard (p=0.912).  
 
Additionally, the expected finding in the ADF population using the Australian population as 
the reference was compared to the actual finding (Table 4.6.6). There was no significant 
difference between the expected and observed levels of condom use for males or females 
(x2 0.005, p=0.944). 
 
Table 4.6.6:  Observed versus expected condom use at most recent event of vaginal intercourse in 
the ADF 
 
Condom use at most recent 
vaginal intercourse 
Use condoms 
Do not use condoms Total 
n % 95%CI 
Males 
Expected 228 53.20% (48.42-57.43) 202 430 
Observed 227 52.29% (48.18-57.60) 202 429 
Females 
Expected 48.6 37.32% (29.70-46.18) 81 130 
Observed 49 37.69% (29.71-46.22) 81 130 
 
4.6.2.4 Gender of last sexual partner 
 
While the ASHR asked specific questions about sexual identity and sexual practices with 
those of the same gender, the present study only asked the gender of the last sexual 
partner. Table 4.6.7 presents the comparison of the data from the ASHR and the ACCEPt 
trial to the age- and gender-adjusted data on the ADF. 
 
Table 4.6.7: Comparison between ADF and Australian populations in sexual contact with the same 
gender 
 
 Age Male Female 
ADF Unadjusted last sexual contact 18-29 3.23% 2.10% 
Adjusted last sexual contact 18-29 3.20% 2.32% 
ASHR 
(Grulich et 
al. 2003) 
Any same sex experience 16-29 5.45% 11.40% 
Any same sex experience 16-59 5.90% 8.60% 
In last 12 months 16-59 1.90% 1.49% 
ACCEPt 
(Yeung et 
al. 2014) 
Any same sex experience 16-29 3.8% 9.3% 
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4.6.3 Sex Work 
 
No women in the present study reported having paid for sex in the previous 12 months and 
very few women (0.1%) in the ASHR (Rissel et al. 2003) reported having ever paid for sex. 
Both studies reported payment for sex by men. There is likely to have been over-reporting 
in the ADF sample due to the age range (older men are more likely to pay for sex). Table 
4.6.8 presents the comparison between the ADF and Australian male population on paying 
for sex in the previous 12 months. 
 
Table 4.6.8:  Comparison between ADF and Australian male population paying for sex  in 
previous 12 months 
 
 ADF ASHR 
Age 
range 
n Total % 
Adjusted 
% 
Age 
range 
Adjusted 
n 
Total 
Adjusted 
% 
Male 18-29 66 471 14.01% 13.96% 16-29 80 3100 2.58% 
 
There was a significant difference between males in the ADF and males in the Australian 
population, in regard to paying for sex in the previous 12 months (x2 168.8, p<0.0001 OR 
7.35, 95% CI 5.21–10.37). Males in the ADF aged between 18 and 29 were five times 
more likely to engage the services of a sex worker than males (aged 16–29) in the general 
Australian population. A note of caution in interpretation is needed due to the difference in 
age ranges of the samples, as it may be concluded that those who are younger are less 
likely to engage the services of a sex worker. If it is assumed that in the ASHR 16–29 age 
range, the sample distribution is evenly distributed across age groups, there would be 
2657 in the 18–29 age range. If it is also assumed that those under 18 did not engage the 
services of a sex worker, the adjusted percentage would be 3.01%. This remains very 
different to the ADF sample. This issue is further examined by comparing the expected 
proportion based on the ASHR to the observed proportion (Table 4.6.9). This alternate 
analysis supports that there was a significant difference between males in the ADF and 
males in the Australian population (x2 45.54, p<0.0001).   
 
Table 4.6.9: Observed versus expected payment for sex among males in the ADF 
 
Payment for sex Yes 
no Total 
n % 95%CI 
Expected 10 2.58% (1.28-4.34) 395 405 
Observed 66 16.30% (12.95-20.13) 339 405 
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In the Australian population, 0.5% of women had been paid for sex. This is comparable to 
the present study where 0.84% (age adjusted) of women in the ADF aged 18–29 years 
had indicated they had been paid for sex. The ASHR data covers all age groups while the 
ADF data covers only 18–29 years. As individuals are likely to have been paid for sex in 
younger years, women’s payment for sex in the ADF data was likely to be over-reported. 
Under 1% of males in the Australian population had been paid for sex (16–59 years of 
age) compared to 1.39% (age adjusted) for the ADF among 18–29 year olds. Again, men’s 
payment for sex in the ADF data was likely to be over-reported. The sample sizes in both 
studies are too small to allow further analysis.  
 
4.6.4 Sex While Overseas  
 
There is very limited comparable Australian data on rates of sexual activity while overseas. 
A study about hepatitis B (Streeton et al. 2006) indicated that 5% of respondents to a 
telephone survey (n=503) indicated they had had sex with a new partner while overseas. 
Only 23% of respondents were in the age range correlating with the present study, 
resulting in a non-comparable dataset.  
 
Studies of sexual behaviour among travellers set in other countries have concentrated on 
sex with new sexual partners. Approximately 63% of those in the ADF who had travelled 
overseas for reasons other than deployment reported having sex while overseas. This 
included sex with regular partners. When sex with regular partners was removed, 37.5% 
(n=72) of the participants reported sex with someone other than their regular partner while 
overseas. This is comparable with studies set in other countries of similar age groups, as 
summarised in Table 4.6.10. 
 
Table 4.6.10:   Summary of studies of sexual behaviour among travellers 
Country Group Year 
Sample 
size 
Age 
% engaged 
in sex Reference 
Finland Travellers 1983 2665 - 39% Peltola 
Switzerland Tourists to 
developing 
countries 
1993 10524 - 30% Eichmann 
Sweden Females in 
Sweden 
1996 996 
25 
(mean) 
27.7% Arvidson 
USA Undergraduate 
spring break 
vacationers 
2002 534 18-25 30% Apostolopoulos 
UK Young people 
holidaying in Ibiza 
2004 1559 16-35 47.5% Bellis 
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A probability survey in the UK examining trips undertaken between 1999 and 2001 
(n=12110) concluded that 23% of males and 17% of females aged 16–24 had sex with a 
new partner while on their overseas trip.   
 
4.6.5 Alcohol Use 
 
Data for the comparison on alcohol use was sourced from the Australian Institute of Health 
and Welfare (AIHW) ‘Report on Drinking Patterns in Australia 2001–2007’, published in 
December 2010. The 2007 data was used in the analysis. The AIHW report utilises age 
groupings that include the 20–29 age range. This group is compared to the ADF cohort 
aged 21–29. The alcohol use in the ADF cohort may therefore be under-reported in the 
analysis. In the AIHW data, the lower age grouping is 14–19 years and this age group is 
not comparable to any ADF data.  
 
This data was not weighted for age and gender in the ADF as the genders were analysed 
separately in the AIHW report and only one age range was analysed.  
 
In general, even with consideration of possible under-reporting, members of the ADF drank 
alcohol less often (examining rates of drinking less than weekly), were less likely to drink 
with the potential of short-term harm, and were less likely to drink with the potential for long-
term harm. However, fewer individuals in the ADF were likely to be totally abstinent in 
alcohol consumption. Table 4.6.11 presents the comparison in abstinence from alcohol 
between the ADF and Australian population aged 20–29 years. 
 
Table 4.6.11: Comparison in abstinence from alcohol between ADF and Australian population aged 
20-29 years 
 
 ADF AIHW report 
n Total % % 
Male 5 376 1.33% 11.1% 
Female 5 105 4.76% 14.8% 
 
Both males and females aged 20–29 in the ADF were significantly more likely to consume 
alcohol than males and females in the general Australian population (for both male and 
females p<0.0001). The tables in the AIHW report included abstinence in the percentages. 
For comparison, the same percentages were calculated from the ADF data (Table 4.6.12).   
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Table 4.6.12: Comparison in frequency of alcohol consumption between ADF and Australian 
population aged 20-29 years 
 
 ADF AIHW report 
n Total % % 
Male Abstinence 5 376 1.33% 11.1% 
Daily 20 376 5.32% 2.80% 
Weekly 131 376 34.84% 55.7% 
Less than weekly 220 376 58.51% 30.30% 
Female Abstinence 5 105 4.76% 14.80% 
Daily 3 105 2.86% 1.70% 
Weekly 19 105 18.10% 39.60% 
Less than weekly 78 105 74.28% 44.00% 
 
Patterns for males and females in the ADF 20–29 years of age cohort were similar. More 
individuals were likely to drink daily; however, the majority in the ADF drink less often than 
the general population.     
 
The consumption of alcohol to levels that may cause short-term harm and long-term harm 
were also compared between the two populations. The AIHW used the NHMRC Australian 
Alcohol Guidelines (2001) to determine the risk of harm in the short term. In the guidelines, 
high risk in the short for males is 11 or more drinks on any day. High risk in the short term 
for women is seven or more drinks on any day. The comparison data on the ADF from the 
present study arises from the question “How many standard drinks containing alcohol do 
you have on a typical day when you are drinking?” This did not ask if an individual had 
ever had that number of drinks but asked if they usually had that number of drinks. This 
slight difference in the question may have resulted in further under-reporting of the 
consumption of alcohol to levels that may cause short-term harm and long-term harm in 
the ADF cohort.  
 
The AIHW also used the NHMRC guidelines to determine risk of harm in the long term. In 
the guidelines, high risk in the long term for males is seven or more drinks per day on an 
average day. High risk in the long term for women is five or more drinks per day. The 
present study asked ADF members how often they consumed six or more drinks on one 
occasion. If they answered ‘daily’ (for both males and females) they were included in the 
analysis. Table 4.6.13 presents the comparison of alcohol-related high risk of short-term 
harm between the ADF and Australian population aged 20–29 years.    
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Table 4.6.13: Comparison of alcohol related high risk of short term harm between ADF and 
Australian population aged 20-29 years 
 
 ADF AIHW report 
n Total % % 
Short term harm Male 31 368 8.42% 29.30% 
Female 10 100 10.00% 22.10% 
Long term harm Male 0 364 0.00% 6.20% 
Female 0 100 0.00% 5.40% 
 
No members of the ADF who participated in this study, aged 20–29 years, indicated they 
consumed alcohol to levels that the NHMRC considered high risk for long-term harm; 
consequently, no further analysis of alcohol consumption to levels of long-term harm was 
undertaken. Alcohol consumption to levels of short-term harm was further examined by 
comparing the expected proportion based on the AIHW report to the observed proportion 
(Table 4.6.14). 
 
Table 4.6.14: Observed versus expected alcohol related risk of short term harm in the ADF 
 
Alcohol related risk of short 
term harm 
Yes 
No Total 
n % 95%CI 
Males 
Expected 108 29.30% (24.87-34.15) 260 368 
Observed 31 8.42% (5.91-11.59) 337 368 
Females 
Expected 22 22.10% (14.75-30.84) 78 100 
Observed 10 10.00% (5.26-17.01) 90 100 
 
There was a significant difference between the expected and observed levels of alcohol 
consumption to levels that may cause short-term harm for males (x2 52.59, p<0.0001); 
however, for females there was not enough statistical power to make this determination (x2 
5.36, p<0.0206). Males aged 20–29 in the ADF were significantly less likely to consume 
alcohol resulting in short-term harm than males in the general Australian population and 
there was a similar trend for females.  
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Chapter 5: Discussion 
 
The findings from this study provide a profile of ADF sexual health and sexual behaviour 
that has not previously been demonstrated. The profile of this study cohort is comparable 
to the Australian population and displays, in some instances, greater levels of safe sexual 
practice and lower levels of sexual risk behaviour. Additionally, this ADF sample was found 
to have a lower prevalence of C. trachomatis than other comparable military populations 
and a healthier sexual health profile.   
 
Three hypotheses were posited at the beginning of this study and, importantly, each of 
these is rejected based on the evidence presented. Firstly, the hypothesis that the 
prevalence of C. trachomatis infection is higher in ADF members compared with the (age- 
and sex-matched) Australian population is rejected. Secondly, the hypothesis that the 
prevalence of C. trachomatis infection is higher in ADF members returning from overseas 
deployment than those not deployed overseas is rejected. Thirdly, the hypothesis that 
sexual risk behaviour is higher in those ADF members with genitourinary C. trachomatis 
infection than those without can only be accepted if the definition of risk behaviour is solely 
the number of sexual partners an individual has had in a 12 month period. By rejecting 
these hypotheses, this study demonstrates that the ADF is similar in sexual health and 
sexual risk profile to the general Australian population, and that certain characteristics of 
employment in the ADF—contrary to expectations—offer protective factors to sexual 
health. This supports the conclusion in the discussion that contemporary defence forces 
are different from their predecessors in STI prevention, management and health 
promotion.     
 
The discussion in this chapter focuses on risk behaviour and risk determinants in the ADF. 
Strategies for effective prevention, education and screening measures are suggested. 
 
5.1 Comparison with Other Military Populations  
 
To compare the findings from this study with other military populations, an examination of 
the characteristics of those military populations is required. Australia has a military 
population that is broadly representative of Australia’s civilian population (Department of 
Defence 2009) excepting for age and gender which are able to be adjusted in most 
studies. In some countries, the subpopulations of defence personnel may not actually be 
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representative of the broader civilian population. For example, among those countries 
where studies in C. trachomatis prevalence have been conducted in the military itself, such 
as, Israel (Israel Defense Forces 2013), Norway (Ministry of Defence 2001) and the US 
(Office for Personnel and Readiness 2004), the defence populations are broadly 
representative of the country’s civilian population excepting in age and gender.  
 
5.1.1 C. trachomatis Prevalence 
 
The prevalence of C. trachomatis of 1.87% (1.13% for females and 2.13% for males) in the 
ADF compares favourably with published prevalence rates among other military 
populations around the world. Studies about recruits and studies that focused on particular 
subpopulations (e.g. attendance at a health clinic) reported higher C. trachomatis 
prevalence rates, which may have resulted from sample bias. Of the 10 studies examined 
in this research that reported a sample population of serving personnel and included a 
random component in the recruitment, the sample of 4,792 participants with 139 positive 
results revealed a pooled prevalence rate of 2.9% overall (1.6% for females and 4.2% for 
males).   
 
The expectation of higher rates of C. trachomatis infection in military populations 
compared to civilian populations has come into question in recent years, and the findings 
from this study may be more reflective of the true picture. Low et al. (2003) first raised this 
issue in The Lancet. Jordan et al. (2011) examined it in relation to US military populations 
and concluded that the types of studies previously undertaken may have been limiting. He 
suggested that standardised studies across services and the inclusion of deployed 
populations in the study samples were warranted. 
 
5.1.1.1 Sample bias through use of recruits 
 
A large amount of the data presented in the literature relates to recruits tested at entry 
point and this may be more a reflection of prevalence among those populations who 
choose to join a defence force rather than defence populations themselves. The data itself 
is also variable. For female recruits, the cited rates of C. trachomatis infection vary from 
8.51% (Gaydos et al. 2003) to 13% (Shafer et al. 2008). For male recruits, it varies 
between 1.2% (Baud et al. 2008) and 9.8% (McKay et al. 2003). Much of the data about 
recruits originates from the US. For females, Gaydos et al. (1998) reported an overall 
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prevalence of 9.2% in a study of 13,204 female US Army recruits tested within three days 
of starting basic training. The highest prevalence, 12.2%, was among 17 year-old recruits 
(17–39 age range) (Gaydos et al. 1998). While that study didn’t attempt to make a 
comparison with civilian populations, the researchers noted that their age- and race-
adjusted figures were higher than reported from family planning clinics and lower than 
reported from adolescent health clinics. In a more comprehensive follow-up study, Gaydos 
et al. (2003) reported prevalence rates between 8.51% and 9.92% among four different 
cohorts of new recruits across a four year period. Further, in a study examining 
preferences for urine screening or self-administered vaginal swab, Hsieh et al. (2003) 
found a C. trachomatis prevalence rate of 11.8% among 1,403 female army recruits.  
 
For males in the US, Sutton et al. (2001) found a prevalence rate of 2.48% among 
asymptomatic males in a study of 1,443 cadets enrolled in the Reserved Officer Training 
Corp, and Cecil et al. (2001) reported a C. trachomatis prevalence rate of 5.3% in male 
army recruits. Compared to these US recruits, studies have reported the overall C. 
trachomatis prevalence rate in the US as 6.5% among 1,933 Grades 7 to 12 students 
(Cohen et al. 1998) and 4.19% (Miller et al. 2004) among 14,322 young adults aged 18 to 
26 years. Additionally, it was estimated that the C. trachomatis prevalence rate among 15–
24 year-old Americans in 2000 was 2.54%; this was based on an estimate by Weinstock et 
al. (2004) of 1 million C. trachomatis positive notifications in this age group and was 
correlated to the US Census data of 2000 (US Census Bureau 2000) indicating there were 
39,357,000 individuals in this age group in 2000. At first glance, it would be concluded that 
C. trachomatis prevalence among recruits is higher than among civilians.  
 
There are also studies reporting C. trachomatis prevalence among military recruits from 
countries other than the US. Stary et al. (1996) reported at C. trachomatis prevalence of 
4.1% among 705 Austrian male military recruits. McKay et al. (2001) reported a C. 
trachomatis prevalence of 9.8% among 798 male military recruits in Scotland, and Brule et 
al. (2002) reported a prevalence of 4.6% among 388 male Danish military recruits. 
Fioravante et al. (2005) reported a C. trachomatis prevalence of 5.0% among 523 Brazilian 
sexually experienced male military recruits. The most recent is a study by Baud et al. 
(2008) which found a C. trachomatis prevalence of 1.2% among 517 Swiss recruits.   
 
However, C. trachomatis prevalence rates among those tested at entry into a defence 
force are not necessarily indicative of the C. trachomatis prevalence rates of the defence 
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force itself. Low et al. (2003) argued this case in a letter to The Lancet stating: “Survey 
results based on military recruits are…subject to selection biases that could overestimate 
chlamydia prevalence”. Pollack et al. (2009) provided evidence to support this in their 
study on attrition rates from recruit training. They found that, of the 17.1% of recruits who 
left the military in their first year of training, the predictors for attrition were unsafe sex and 
race/ethnicity among other factors. In short, recruits are more likely to have higher rates of 
C. trachomatis infection.  
 
5.1.1.2 Sample bias through non-representativeness 
 
In US studies a further complexity arises. Given that the 2002 report on US military 
population representativeness (Office for Personnel and Readiness 2004) broadly 
indicated that for race the military is representative of the civilian population, the 
subsample of the entire military that is recruited into sexual health studies is over-
represented by African Americans (Hsieh et al. 2003; Sutton et al. 2003; Gaydos et al. 
1998; Schafer et al. 2002). This is important because African Americans represent 12.3% 
of the population (USA Census 2000) but represent almost 48% of C. trachomatis 
notifications (CDC 2007) and Hispanic Americans represent 12.5% of the population but 
account for 19% of all reported C. trachomatis cases. An over-representation in the 
sample of African Americans and/or Hispanic Americans could lead to a higher reported C. 
trachomatis prevalence rate.   
 
For example, in the study by Schafer et al. (2008) which reported a C. trachomatis 
acquisition rate of 13.0% among young women in their first year of military service, the 
racial distribution (Caucasian 51.5%, Latina 23.2% and African American 18.1%) was 
disproportionate compared to the broader military and civilian populations. Similar 
disproportions exist in other studies. In Sutton et al. (year), the division by race was 
Caucasian 70.4%, Hispanic 7.4% and African American 13.9%; in Gaydos et al. (1998) the 
division by race was Caucasian 51.0%, African American 35.9% and other 13.1%; and in 
Sena et al. (2000), the division by race was Caucasian 62.4%, Hispanic 5.5% and African 
American 23.8%.   
 
It is noted that Sena et al. (2000) did standardise the sample population by race for 
comparison with the civilian population and noted that “the crude rates of gonorrhea and 
C. trachomatis were partially explained by the demographic characteristics of the (sample) 
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population”; however, other studies did not standardise the sample population. In the study 
by Gaydos et al. (2003), African Americans (n=8099) comprised 35.2% of the total study 
sample (n=23010) and had a C. trachomatis prevalence of 16%. This equated to 59% of 
the C. trachomatis notifications overall, much more than the CDC-reported rate of 48%. 
One piece in the puzzle about the perceived higher prevalence of C. trachomatis in 
defence populations may be the disproportionate representativeness of some 
demographic characteristics that are drawn from the broadly representative defence 
populations.   
 
5.1.1.3 Sample bias through recruitment methodology 
 
Recruitment methodology may also have impacted on prevalence comparisons. In the 
study by Sena et al. (2003), the sample (42,160 clinic visitors) was gathered from the 
database of those who had appointments at the Epidemiology and Disease Control Clinic 
and a C. trachomatis incidence rate was extrapolated for the entire facility. This was 
compared to the civilian population in the same geographic area. The data was 
standardised for age, sex and race with the civilian population. While the article noted that 
the study may have underestimated the actual C. trachomatis incidence rate (because it 
was unlikely that not all STIs were reported to that clinic) and it was noted that the 
comparable rates in civilian populations were also likely to be underestimated because of 
variable testing practices, the article did not highlight the possible magnitude of these 
underestimations. Two comments in this article hint that the underestimation may have 
been greater for the civilian population than for the defence population. Firstly, the defence 
personnel were required to seek care if there was a health problem, whereas this was not 
the case with civilian populations; and secondly, the defence personnel received free care 
whereas many civilians would have needed to pay for their care.    
 
Other studies also reported confounding due to the sampling methodology. A study by 
Greene and Stafford (2007) recruited 138 male soldiers between the ages of 18 and 25 
who reported for sick parade at a troop medical clinic between November 2004 and March 
2005. The C. trachomatis prevalence was 8.0%; however, it was noted that 26% of these 
men reported to the sick parade because of an “STD concern”. In addition, there was no 
standardisation for race. A study in Israel of women in the military (Bamberger et al. 2003) 
also drew the sample population from those actively seeking health care, including 
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treatment of genitourinary symptoms. That study, of 708 women in 2002, reported a C. 
trachomatis prevalence of 3.25%. 
 
5.1.1.4 Military and civilian populations 
 
A small number of studies actually reported lower C. trachomatis prevalence in defence 
populations compared to other populations. One study of male Brazilian conscripts 
(Fioravante et al. 2005) reported a C. trachomatis prevalence of 5.0% compared to studies 
in civilian populations indicating female rates between 8.5% and 19.6%. A study by Castro 
(2000) reported a C. trachomatis prevalence rate of 23.3% among asymptomatic males in 
Brazil. It is acknowledged that the same limitations applied to the study as described 
above. In support, some studies reported generally lower C. trachomatis prevalence rates 
(than those described previously) in military populations without comparison to other 
populations. A study conducted in Slovenia tested military recruits between 1999 and 2001 
and found a C. trachomatis prevalence of 2.6% among 1,272 asymptomatic males (Skaza 
et al. 2003). The study indicated there was no data on C. trachomatis prevalence in the 
country at the time. The study in Israel reported a prevalence of 3.25% (Bamberger et al. 
2003). A study in New Zealand by Cole et al. (2000) reported a C. trachomatis prevalence 
of 4.0% among 200 male military personnel, and a small study by Peacock et al. (2006) 
reported a C. trachomatis prevalence of 2% among 103 male and female army personnel 
in Australia. It is acknowledged that each of these studies presents the same limitations in 
recruitment and methodology as those studies that have reported higher C. trachomatis 
prevalence and, as such, the reliability of these results is also open to discussion.  
 
Even when the complexity described above is taken into account, the C. trachomatis 
prevalence in the ADF compares very favourably with infection rates in other military 
populations using similar sampling methods. The present study revealed an assumption 
among ADF personnel that there was a high incidence of C. trachomatis infection in the 
ADF and that ADF health services “saw a lot of chlamydia”. This assumption was 
reinforced by one multi-service base that received new recruits from all services labelling 
itself “chlamydia county” due to the perception of high levels of sexual activity. The results 
in this study show that the reality may not match these assumptions. C. trachomatis 
prevalence in the ADF is low by any comparable measure. 
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5.1.2 History of STIs  
 
The participants were asked if they had experienced any symptoms characteristic of STIs 
within the last 12 months. Over 15% of the male respondents and over 22% of female 
respondents indicated at least one sign or symptom of an STI within the previous 12 
months, and only 4.5% of respondents indicated any diagnosis of any STI within the 
previous 12 months. These results are comparable to other military populations. 
 
A number of studies in military populations asked respondents about symptoms for STIs at 
the time of participation in the study (Sutton et al. 2003; Bamberger et al. 2003) and found 
the presence of symptoms to be low; however, no studies in military populations have 
asked about the experience of symptoms over the previous 12 month period. Studies have 
asked about the diagnosis of STIs over the previous 12 months. Stahlman (2014) reported 
in her PhD thesis on gender influences in STI risks in the US military that 4.2% of men and 
6.9% of women had been diagnosed with an STI in the previous 12 months (of a sample of 
10,250 active duty personnel). Cecil et al. (2001) reported that 4.7% of male recruits 
(n=2245) in the US indicated a prior diagnosis of an STI within the previous 12 months. 
Fioravante et al. (2005) reported that 4.4% of Brazilian male conscripts indicated a prior 
diagnosis of an STI (time period unknown). Greene et al. (2007) reported that 12.3% of 
males attending a health clinic at a recruit training base indicated a prior diagnosis of an 
STI within the previous 12 months. Sutton et al. (2003) noted that 4.9% of college cadets 
(n=1443) had been diagnosed with an STI within the previous 12 months. 
 
5.1.3 Sexual Practices 
 
Almost all the respondents in the present study had had sex in the last 12 months (96.7%) 
and this figure is comparable to all military populations (Anastario 2010; Korzeniowski et 
al. 2003; Shafer 2002; Bing 2008; Crutcher & Papdimos 1992; McCeary 1980; Eitzen 
1997). 
 
Fifty-six percent of the respondents in this study indicated they had had more than one 
sexual partner within the previous 12 months. Stahlman (2014) found that 60% of army 
recruits in the US reported more than one partner in the previous 12 months. In a study 
involving 17,264 US military personnel, Palmer (2003) found that 27% had had more than 
one sexual partner in the previous 12 months. It is noted that this was for the entire age 
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range, whereas the present study targeted 18–29 year olds. Gaydos et al. (2003) reported 
that, of 23,010 female 17–39 year olds, 25.7% had had more than one partner in the last 
12 months and 29.1% had had a new partner in that time. Cecil et al. (2001) reported that, 
of 2,245 male 17–35 year olds, 32.9% had had more than one partner in the last three 
months and 34.1% had had a new partner in that time. Bamberger et al. (2003) in their 
study of Israeli female soldiers found that 38% had had more than one partner in the 
previous three months, and Fioravante et al. (2005) in their study of Brazilian conscripts 
found that 25.4% had had more than one partner in the previous two months.  
 
The most common description of condom use in military sexual health and risk behaviour 
studies centres on the last sexual encounter. In the ADF sample in the present study, 
38.8% of respondents indicated they had used a condom during their last sexual 
encounter that involved vaginal or anal sex. In research on the Slovak army, Bianchi and 
Popper (2000) found that 38% of soldiers used a condom during their last sexual 
encounter (17–24 age range). Greene et al. (2007) found that 36.4% of active duty 
soldiers attending a health facility used a condom during their last sexual encounter (18–
25 age range). Stahlman (2014) found that 36% of sexually active unmarried women in the 
US military reported condom use at last intercourse. Nikula et al. (2009) in their study of 
10,446 Finnish military conscript recruits (over an eight year period) found that 48% used a 
condom at the time of last sexual encounter.   
 
Even though the use of condoms in the last sexual encounter is a common question in 
military sexual health and risk behaviour studies, Hallum-Montes et al. (2012) argued that 
it may be a misleading question. In a study of 334 members of the Belize military (both 
genders) and 653 members of the Dominican Republic military (both genders), they 
compared responses to a question about self-reported condom use during last sexual 
contact to the consistency of condom use during the previous 30 days. For the Belize 
cohort, they reported that of the 20.9% who reported condom use at the time of last sexual 
encounter, 40.5% had used condoms inconsistently over the previous 30 days. Similarly 
for the Dominican Republic cohort, of the 25.3% who reported condom use at the time of 
last sexual encounter, 43.8% had used condoms inconsistently over the previous 30 days. 
When the sample analysis is applied to the ADF sample, a similar result is found. Just over 
50% of those in the ADF sample who reported condom use (for vaginal and/or anal 
intercourse) on the occasion of last sexual encounter also reported inconsistent condom 
use over the previous 12 month period. Relying on findings solely relating to condom use 
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at the time of most recent sexual encounter may limit the effectiveness of education and 
prevention initiatives.  
 
The percentage of those who always used condoms is another marker of condom use 
found in military populations and may offer a refined target population for education and 
prevention initiatives. In the ADF sample in the present study, condom use with regular 
partners was low—15.21%—while condom use with casual partners was higher—40.76%. 
When examining consistent condom use with casual partners Oguzoncul et al. (2011) in 
their small study of 191 Turkish soldiers found a condom usage rate of 30.4%; Fioravante 
et al. (2005) reported a rate of 36.7%; Sutton et al. (2003) reported a rate of 33.6%; and 
Skaza et al. (2003) reported a rate of 24%. Gaydos et al. (2003) and Cecil et al. (2001) 
provided information on rates for all partners combined (being 16.4% and 19.7%, 
respectively). Palmer (2003) in the study involving 17,264 US military personnel found that 
32% of males and 31% of females used condoms all the time with casual partners. It is 
noted that this was for the entire age range, whereas the present study targeted 18–29 
year olds.  
 
Of the males in the ADF sample in the present study, 13.71% had paid for sex in the 
previous 12 months. In a sample of 498 military personnel, Anastario et al. (2010) reported 
37% of soldiers stationed at the border crossing between the Dominican Republic and 
Haiti had a history of having sex with sex workers and that 19% had undertaken this 
activity in the previous 12 months. In a study of STIs in the Afghan army, Todd et al. 
(2012) found that 21.3% of male respondents (n=4750) reported paying for sex with 
women in the previous 12 months. Kitsiripornchai et al. (1998) reported rates of sex with 
sex workers of up to 42% in the Royal Thai Army.  
 
There is little data among defence populations about sex with the same gender. When 
examining the occasion of last sexual contact, the age-adjusted rate in the ADF sample in 
the present study was 3.20% for males and 2.32% for females. Todd et al. (2012) asked 
this question in their study of 4750 male Afghan army recruits and reported a rate of 
sexual encounters with the same gender of 4.6%.  
 
Overall the results of the present study indicate that the sexual behaviours exhibited by 
personnel within the ADF are comparable to behaviours found in other military populations 
across the world.  
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5.1.4 Alcohol Consumption 
 
Even though many studies about sexual health in defence forces list alcohol consumption 
as a risk factor (e.g. Bing 2008; Cook et al. 2006; Anastario 2013; Stahlman 2014; Eitzen 
1997; MacQueen 1995), there is limited data on actual consumption rates. In the ADF 
sample in the present study, 35.65% consumed alcohol more than once a week. Bianchi 
and Popper’s (2000) study of the Slovak army found that 32% of the participants (n=432) 
consumed alcohol more than once a week, and Palmer’s (2003) survey of US military 
personnel found that only 10% consumed alcohol more than once a week. It is noted that 
those studies involved all ages and cannot be compared to the present study which 
targeted 18–29 year olds.  
 
In the ADF sample in the present study, 8.42% of males and 10.00% of females consumed 
alcohol to a level that could result in short-term harm (see Chapter 4, Section 4.6.5 for a 
definition of short-term harm). Stahlman (2014) referred to this as “binge drinking” and 
found that binge drinking is a highly prevalent military phenomenon, noting evidence that 
rates of binge drinking increased in the US military from 35% in 1998 to 47% in 2008.  
 
Of the ADF sample, 40.06% (n=282) indicated they had consumed alcohol during their last 
sexual encounter and more than half (63.22%) indicated they consumed more than five 
drinks. Bianchi and Popper (2000) found that 51% of the respondents in the Slovak army 
had consumed alcohol during their last casual sexual encounter. As noted previously, 
there is evidence of an association between alcohol consumption and sexual risk 
behaviour in defence populations. Among US Air Force recruits, a study by Cooper et al. 
(2008) reported an association between binge drinking and the likelihood of not practising 
safe sex, as did Thomas et al. (2001); however, Baud et al. (2008) in a study of Swiss 
recruits found no association. 
 
5.2 Protective Factors for Sexual Health in the ADF  
 
The lower than expected prevalence of C. trachomatis and the higher than expected rates 
of attendance at ADF health services for sexual health concerns indicated that 
employment in the ADF may be a protective factor in sexual health. In addition, the 
consistent effect of any type of deployment on sexual health (as measured by self-reported 
STIs and the practice of safe sex) provided further clues. The results of this study 
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demonstrate that a modern defence force is very different to its predecessors. Three 
distinct protective factors associated with employment in the ADF are indicated, namely, 
the availability of a free and confidential health service, a workplace culture of maintaining 
health, and deployment. Each of these factors is discussed in the following sub-sections.  
 
5.2.1 Free and Confidential Health Services 
 
By examining known barriers to access to health services for sexual health concerns and 
discussing those in the context of the ADF, some conclusions about the nature of the 
health service offered to ADF personnel can be drawn.   
 
Firstly, a barrier to accessing health services is cost. Any cost for a health service limits 
access, and access by a population has a direct effect on that population’s STI rates. This 
latter point is well described by Miller et al. (2004) in their findings on STIs among young 
disadvantaged Indigenous people in Far North Queensland where a C. trachomatis rate of 
30% was found. It is also reinforced by Kang et al. (2014) who reported that cost was a 
barrier to C. trachomatis testing for 36.5% of the participants in their study. Sena et al. 
(2000) examined C. trachomatis and gonorrhoea trends at a US military base and found 
that free health care confounded their results when comparing the general US population. 
Jordan et al. (2011) suggested the same; however, their research involved the 
examination of C trachomatis incidence and the suggestion was that the higher incidence 
reported in military populations may be because health services offered in the US military 
are more accessible and therefore more incident cases are found. In short, attendance 
was better because the service was free. ADF health services are also free for ADF 
personnel and, consequently, cost has been removed as a barrier for ADF members.  
 
Secondly, confidentiality and privacy remain key barriers to accessing sexual health 
services throughout Australia (Kang et al. 2014; Buhrer-Skinner et al. 2013; Ryder & 
McNulty 2009). The revised Defence Instructions (General)—Privacy of health information 
in Defence (issued on 30 July 2008) provides the policy on the use of health information in 
ADF. The instructions note that the Commonwealth Privacy Act (1988) “governs the 
collection, management, use and disclosure of personal information, including health 
information, by government agencies”. The instructions further specify that: 
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Health information is classified as sensitive personal information and must be 
handled with due recognition of its sensitivity at all times. Personal health 
information in Defence is to be used or disclosed strictly on a ‘need to know’ basis.  
The disclosure of confidential information by ADF personnel, including health personnel, 
carries a greater penalty than disclosure of similar information by civilian personnel.  
 
Thirdly, the opportunity to attend a health service during work time removes the barrier of 
inconvenience or lack of free time and adds the element of payment while attending the 
health service. In the ADF, work time is referred to as being “on duty” and ADF personnel 
are able to attend health services while on duty. Participation in the present study is an 
example of this policy, with the information and consent form (Appendix 1) clearly stating 
that the participant was on duty while involved in the study. This included the time 
attending the health service for the AHA (or similar routine screen) and the time spent on 
involvement in the study.  
 
This study demonstrates that ADF personnel generally have confidence in the policies of 
their health services, in that 85% of those who indicated they had attended a health 
service for testing or treatment of STIs had chosen to attend a defence health service. The 
privacy, on duty and zero cost policies may be the key factors that influenced this high rate 
of attendance at ADF health services.  
 
5.2.2 Culture of Maintaining Health  
 
A second protective factor in the ADF is the culture of maintaining health. Rounds (2010) 
discussed the US military’s revised approach to force fitness, indicating that the previous 
focus was primarily on fitness to perform set tasks but that the modern military requires a 
much more complex definition of force fitness. This includes attention to risk behaviours 
(although sexual risk behaviour was not particularly mentioned in Rounds’ report). For 
example, Colthirst et al. (2013) discussed the impact of dental emergencies on operational 
preparedness and combat effectiveness during Operation Iraqi Freedom, and Gunepin et 
al. (2010) discussed the effect of tongue piercing complications on operational readiness.   
 
In modern defence forces, all aspects of a soldier’s health are considered important in the 
maintenance of operational readiness. Sexual health is no exception. Shafer et al. (2002) 
were explicit about the reason for this: “STIs not only place these young men and their 
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partners at risk for negative health outcomes, they also pose a threat to military 
readiness”, and this was supported by Jordan et al. (2011) who indicated that health-
seeking behaviours are proactively taught in the US military. 
 
Similarly, health interventions in the ADF have the aim of maintaining capability and 
readiness. The introduction to Health Directive 242 states: “The promotion of physical 
fitness and early detection of risk factors for disease will assist to conserve manpower and 
increase ADF capability”. Similarly, the Defence Instructions (General)—Privacy of health 
information in Defence state: 
The unique role of the ADF means that an individual’s health information may be 
used for purposes other than clinical management. [Information may be used to] 
monitor or manage the impact of the individual’s health condition and for the 
purposes of managing consequences which could arise if a member is not fit to fulfil 
operational requirements. 
In this context, health interventions, including this study on sexual health, are concerned 
with how to assist to maintain operational readiness and capability. A means to do this is 
to identify the potential adverse risks to readiness and capability that an Officer-in-Charge 
may face as a result of sexual ill-health. Further, the ADF suggests screening, treatment 
and education about C. trachomatis is warranted because of the adverse effect of 
undiagnosed C. trachomatis on defence readiness and capability (Director-General DHS 
2006). 
 
This culture translates into attendance at a health service when an individual senses 
something is awry with their health. This may not be the same in civilian populations. The 
high rate of attendance at health services for sexual health concerns found in this study 
supports this proposition. In addition, this study found that those who self-reported an STI 
within the previous 12 months were almost 10 times more likely to have attended a health 
service than those who did not self-report an STI, and that those who indicated they had a 
symptom of an STI in the previous 12 months were almost three times more likely to 
attend a health service than those who didn’t indicate an STI symptom. This further 
supports that the culture of maintaining health to assist operational readiness and 
capability in the ADF acts as a protective factor for sexual health and against C. 
trachomatis infection.  
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Participants who indicated some level of unsafe sex behaviour were almost three times 
more likely to attend a health service for a sexual health matter. This indicates that not 
only does the ADF population seek health services when they sense something is awry, 
but those who do attend health services are mostly those who would benefit from 
education and intervention. The health service appointment offers an opportunity for safe 
sex education and intervention.  
 
5.2.3 Deployment  
 
As noted previously, sample subpopulations who were on deployment at the time of their 
participation in this study, had been deployed over the previous 12 months or had ever 
been deployed were consistently likely to have lower C. trachomatis positivity than sample 
subpopulations not involved in deployment. This pattern also occurred with self-reported 
STIs. Those who were on deployment, had been deployed in the last 12 months or had 
ever been deployed were less likely to have self-reported an STI. Further, those who were 
deployed at the time of participation in the study (p=0.037) and those who had been 
deployed at some stage over the previous 12 months (p=0.018) were significantly more 
likely to have practised safe sex over the last 12 months.   
 
Deployment appears to be a protective factor against sexual ill-health and for safe sex 
behaviour. This may be as simple as individuals having less sex when deployed than 
when not deployed. Approximately 31% of those who indicated any deployment in the 
previous 12 months also indicated they had had sex while deployed. This compares to 
97% of participants who had had sex at some stage in the previous 12 months while at 
home (n=710).   
 
Doxycycline usage while deployed may also be a contributing factor. No individual who 
indicated they took doxycycline during the previous 12 months tested positive for C. 
trachomatis. Additionally, those who had not taken doxycycline over the previous 12 
months were twice as likely to self-report an STI in the previous 12 months. While the 
dosages for malaria prophylaxis (100 mg per day for the period of potential exposure and 
up to 28 days after) and for STI control (100 mg twice daily for 7 days) vary, the findings in 
this study suggest a protective effect against STIs by the use of doxycycline for malaria 
prophylaxis. It is acknowledged that no examination was made of other antibiotics 
prescribed to military personnel involved in the study. A combination of the lack of sexual 
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opportunity (and/or desire) and the availability of health supports and interventions 
associated with deployment may result in deployment being a protective factor for sexual 
health.  
 
There is some evidence that in the literature that deployed populations may have lower C. 
trachomatis infection rates. Buller et al. (2006) reported a prevalence of 0.52% among 
1,737 annual gynaecological checks of women on deployment in Iraq. Jordan et al. (2011) 
noted that C. trachomatis rates were lower in US Navy and Marine populations compared 
to Army and Air Force populations and that the former two groups were deployed at much 
greater rates than the latter two groups. Wasserman et al. (1997) found that only 0.5% of 
sick call visits (n=6772) during Operation Desert Storm were for STIs, and all of these 
were for chronic conditions. This was confirmed by Hyams et al. (2005) who, when 
examining the health of military personnel deployed to Operations Desert Storm and 
Desert Shield, found that infectious diseases were not a major cause of manpower loss. 
 
Palmer (2003) in a study examining sexual practices amongst soldiers undertaking 
humanitarian relief in Africa noted that no soldiers indicated they had engaged in any 
sexual practices while deployed, and that deployment itself decreased their libido to the 
extent that the soldiers reported that masturbation rates had also decreased.  
 
5.3  Comparability of Sexual Behaviour in the ADF with the Australian 
 Population 
 
The C. trachomatis prevalence rates found in this study are lower than in other Australian 
studies with similar samples in terms of age and gender (Kang et al 2014). The protective 
factors noted above may account for some of this difference. In addition, while a younger 
age would suggest higher C. trachomatis prevalence, the disproportionate gender division 
in the ADF (i.e. 87% male and 13% female) would suggest a lower C. trachomatis 
prevalence than the general civilian population if the figure was not adjusted for gender. 
Studies on the incidence and prevalence of C. trachomatis have commonly cited that the 
duration of infection is longer in women than in men. This conclusion first appeared in 
Groseclose and colleagues (1999) and was supported by Weinstock et al. (2004). In their 
modelling, both these studies assumed the duration of infection in men was 0.40 years 
and the duration in women was 0.96. More recently, Geisler et al. (2008) indicated that the 
spontaneous resolution of C. trachomatis was somewhat more common in men than 
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women (36% vs 16%). It naturally follows that a population primarily comprising men 
would have a lower C. trachomatis prevalence than the civilian population.  
 
This study’s findings on condom use in the ADF are consistent with studies on condom 
use in the general Australian population (de Visser et al 2003). Condom use with casual 
partners among the ADF sample was at the same proportion for the same age range in the 
Australian population for both males and females. In addition, condom use during the most 
recent event of vaginal intercourse was almost identical for the two samples (37% for 
females and 53% for males).  
 
The amount of sex that heterosexual partners engaged in was almost identical between 
the ADF population and the general Australian population for males (ADF 2.8 times per 
week vs ASHR 2.7 times per week) (Grulich et al 2003). Females, however, were different. 
A female in the ADF was more likely to report a higher frequency of sex (ADF 2.9 times 
per week vs ASHR 2.2 times per week). Of note, females in the ADF also reported more 
frequent sex than their male ADF counterparts.  
 
The proportion of individuals who had had sex with more than one person in the last 12 
months while being in a relationship for that full 12 months (with the same person) was 
almost identical. This calculation was complex and both male (ADF 10.69% and ASHR 
12.91%) and female (ADF 7.57% and ASHR 6.28%) proportions for both studies were 
almost the same, indicating both the comparability of the ADF population to the Australian 
population and the generalisability of the ADF findings to the general population.  
 
The proportion of males who had paid for sex in the ADF sample was significantly higher 
than in the Australian sample (13.96% vs 2.58%) (Rissel et al 2003a). This is a key finding 
from this study. ADF personnel are much more likely to engage the services of a sex 
worker than their civilian counterparts. A large proportion of this practice appears to occur 
while overseas. Sixty-six individuals in the ADF sample indicated they had paid for sex 
during the previous 12 months and, of these, 44 indicated that this had occurred while on 
deployment and 12 indicated it had been while overseas for other reasons. It is noted that 
the same individuals may have engaged the services of a sex worker at home, on 
deployment and while overseas for other reasons. This study did not have the capacity to 
differentiate these locations. The findings of this study suggest that a reason for the higher 
incidence of paying for sex among members of the ADF may be because of access to and 
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opportunity for such a practice overseas. As noted previously, a further research project 
may examine the characteristics of ADF personnel who engage in sex while overseas and 
particularly those who engage the services of a sex worker.  
 
This study also demonstrates a difference in drinking patterns between the ADF and the 
general Australian populations. While the ADF personnel were less likely to be fully 
abstinent (p<0.0001), they also drank less often than the general population. For example, 
males in the ADF were more likely to drink “less than weekly” (58.51% vs 30.30%). This 
pattern was even stronger for females (74.28% vs 44.00%). The ADF personnel were also 
less likely to drink alcohol at levels that have the potential to cause short-term and long-
term harm. Of note, no individual in the study described alcohol usage that would match 
the AIHW definition for a high risk of long-term harm. This is compared to 6.20% of males 
in the general population and 5.40% of females. It appears that the ADF study sample 
represents a better example of “drinking in moderation” than the general Australian 
population. 
 
5.4 Implications for Screening  
 
This study provides insights into mechanisms that may be useful for the prevention of C. 
trachomatis specifically and STIs generally in the ADF. Screening may be warranted both 
as a public health measure and as an adjunct to force readiness and capability.  
  
5.4.1 Use of the AHA  
 
At the time of recruitment into this study, the AHA was undertaken annually by all 
personnel; however, this did not necessarily encompass sexual health. Health Directive 
242, titled the ‘Australian Defence Force Health Promotion Program’ (dated 21 February 
2007) detailed the policy and content of both the AHA and the 5-yearly CPHE. The Health 
Directive stated: 
The AHA is designed to provide essential annual preventive health screening. The 
AHA provides a regular opportunity for instruction of the member in health promotion 
and lifestyle counselling. [In addition] the AHA provides an efficient system of 
verification of a member’s individual readiness. (p. 2) 
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It was expected that the AHA would take 20 minutes to complete and it encompassed 
weight, height, BMI, blood pressure, pap smear, mammography, faecal occult blood 
testing, serology, vaccinations, hearing, and lifestyle counselling. In the lifestyle 
counselling component, the Health Directive recommended that the following areas be 
covered: mental health, smoking, alcohol, physical activity, diet, sun protection, and sexual 
behaviour.  
 
The original intention of the present study was to recruit volunteers into the study when 
individuals presented for their AHA. This ensured an unbiased sample. As Health Directive 
242 stated: “the AHA is to be performed every 12 months and …. is valid for 12 months”. 
The time to conduct the screen and survey would be allocated during the AHA 
appointment or immediately after.    
 
Utilisation of the AHA for recruitment into this study remained the best practice. However, 
some defence sites were not undertaking the AHA on a routine basis. Reasons for this 
included: 
1. Staff shortages within health services, resulting in priority being given to more 
urgent matters. 
2. Other health assessments taking precedence over the AHA. This included the pre- 
and post-deployment health assessments and the 5 year CPHE.  
3. Rapid rotation of personnel from one deployment to another. This was especially 
true in the RAN due to the overall shortage of personnel.  
4. Non-availability of personnel at the time of their AHA (usually conducted on or near 
the individual’s birthday) due to the frequency of deployment.  
The AHA system ceased in 2011 (Surgeon General 2011). While it is noted that the AHA 
is no longer undertaken in the same format as at the time of the study recruitment, a 
method to select participants utilising a systematic non-random methodology is 
encouraged. At the beginning of the study, different recruitment methodologies were 
tested. Testing the different methodologies presented a picture of what works, what does 
not work, and what appears to make no difference in recruitment.  
 
What worked: 
 The use of dedicated and involved personnel. The majority of participants recruited 
from each site were from one member of the health team who was committed and 
took responsibility for recruitment. 
MAIN TEXT 
Page 148 of 256 
  Attaching the screen to a standard health check (such as the AHA). 
 The use of the gel for transport and storage. There were no reported misuses of 
this medium. 
 
What did not make a difference: 
 Being in uniform or not in uniform; this did not make a difference for either the initial 
recruitment or for presenting the consent form, survey and urine screening tools. 
 The gender of the person recruiting. 
 
What did not work: 
 Passive recruitment—When the briefing notes about the study (including the survey 
and the urine sample components) were left for passive ‘pick up’, the recruitment 
rate was zero.  
 Using ‘point of contact’ personnel from the health service/base known to the base 
community—‘Point of contact’ refers to the first health service staff member whom 
the participant met at arrival to the reception area. Potential participants were 
reluctant to be involved in the study and particularly to return completed surveys to 
people they knew, even though assurances and practices of confidentiality were 
noted and carried through. Participants thought the health service personnel  ‘might 
take a peek’. 
 
By testing different recruitment processes, this study demonstrated that the original 
methodology of including the request to be involved in the study, survey and screen as 
part of the AHA was the best way to maximise recruitment.  
 
5.4.2 Current Screening Practices 
 
At the time of writing, the CPHE, conducted every five, years is now the primary 
mechanism (Surgeon General ADF Health Directive 242) by which ADF health personnel 
can discuss sexual health with individual members. Sexual behaviour, STIs and 
contraception are included in the health questionnaire that ADF members are asked to 
complete as part of the CPHE. ADF members are asked to provide a urine sample. In 
addition, pre- and post-deployment health screens also incorporate sexual health 
discussions. Opportunistic screening when an individual visits a medical service is also 
actively pursued in the ADF.   
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5.4.3 Potential Screening Practices 
 
The results from this study suggest that the (then) current screening practices of the ADF 
were effective because the prevalence of C. trachomatis in this sample was lower than in 
the Australian population and because those who sought health care for a sexual health 
matter were those who would benefit the most from screening, prevention and education 
messages. However, it is noted that the development of a comprehensive screening 
program for C. trachomatis continues to be debated in Australia (Guy et al. 2011; Yeung et 
al. 2014) and ADF health services may offer unique access to relevant target populations.   
 
5.4.3.1 Opportunistic screening 
 
In the context of this study, opportunistic screening may be defined as the offer of a test for 
C. trachomatis on an occasion when the ADF member presents for another matter. 
Examples may include offering a test during a routine cervical screen or during a post-
deployment health check. Anecdotal evidence gathered during the researcher’s liaison 
with health personnel during the data collection period suggests opportunistic screening 
for C. trachomatis already occurs in the ADF. There is an opportunity to develop this more 
comprehensively in the ADF.  
 
5.4.3.2 Targeted screening 
 
The only identifiable subpopulation that may benefit from targeted screening for C. 
trachomatis in the ADF as suggested by this study would be those who have two or more 
sexual partners over a 12 month period. While this may be a difficult subpopulation to 
identify, a question about the number of sexual partners may be asked during any health 
check and, dependent on the response, a screen for C. trachomatis offered.    
 
Gender is a common delineator for targeted screening in defence populations, with 
females being targeted more commonly than males (NMCPHC 2012; Jordan et al. 2011; 
Buller et al. 2006). The need for a targeted screening program specifically for females in 
the ADF is not supported by the results of this study, even though females may be 
targeted because of greater reproductive health consequences.  
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Age is also discussed in the context of targeted screening in military populations. Schafer 
et al. (2002) suggested that age was the best criterion on which to base a screening 
program for chlamydia infection in women military recruits. Their study, of 13,204 women 
recruits, reported that a screening program for all women aged 25 years or younger would 
have identified 95.3% of infected women. While the present study did not identify specific 
age groups that may benefit from targeted screening in the ADF, it is acknowledged that 
the study was limited to a narrow age range (18–29 years) and this focus may have 
confounded the ability of this study to determine the efficacy of an age-based targeted 
screening program. In a meta-analysis of C. trachomatis infection in Australia, Lewis et al. 
(2011) concluded that those aged under 25 (in all subpopulations) were more likely to be 
diagnosed with C. trachomatis. Age does appear to be an appropriate delineator for 
targeted screening for C. trachomatis in the general population; however, in the ADF, 
because of the younger age profile of its members, age may be secondary to the number 
of sexual partners when determining a targeted approach.  
 
Finally, Yeung et al. (2014) reported from the ACCEPt trial that any screening program 
that targets only those with genital symptoms for STIs would miss 75% of C. trachomatis 
infections. This is reinforced by the findings of the present study, whereby 50% of C. 
trachomatis infections would have been missed if the marker of previous STI symptoms 
within the last 12 months had been used. As such, a targeted screening program that 
relies on the presentation of genital symptoms would not be warranted in the ADF.  
 
5.4.3.3 Routine screening 
 
As noted previously, defence forces across the world have developed comprehensive 
surveillance systems for infectious diseases (including STIs) in recent years (Meynard et 
al. 2008); however, these systems are designed primarily to provide early detection of 
outbreaks in “on duty” areas.  
 
Routine screening for C. trachomatis occurs in the US military. The US military has 
mandatory annual screening of women up to 25 years of age for C. trachomatis (Jordan et 
al. 2011; Buller et al. 2006) based on the development of a model (Howell et al. 2000) that 
screening this population in the US military would be cost-effective. There continue to be 
calls for expanded STI surveillance efforts in military populations (Sanchez et al. 2013). 
While routine screening approaches specifically for C. trachomatis in the ADF would have 
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limited additional benefit for the ADF (because prevention, education, diagnosis and 
treatment for C. trachomatis is currently effective as evidenced by the prevalence reported 
in this study), such approaches may have benefit for the broader Australian population. 
This is because ADF personnel engage in sexual practices with individuals outside the 
ADF. Therefore, as the discussion about a screening protocol in Australia emerges, the 
inclusion of health services in the ADF may be beneficial.  
 
5.5 Implications for Education 
 
5.5.1 ADF Health Personnel  
 
This study did not specifically examine the knowledge of health personnel in sexual health; 
however, observations during the researcher’s attachment to health services and 
recruitment of personnel into the study provided a picture of defence health services. 
Health personnel working in the ADF originate from both defence and civilian 
backgrounds. In addition, similar to the non-defence health services, Defence health 
services are staffed by individuals with the complete cross-section of experience and 
qualification. Experience and skill in sexual health is no exception to these comprehensive 
human resources. Anecdotally, the researcher’s experience in conducting the study 
indicated that some personnel had solid knowledge and skill in sexual health matters while 
others had limited understandings of this field of medicine.  
 
Given this varied background, it is acknowledged that ADF health personnel (civilian and 
military) require education and updates on sexual health issues in the same manner as 
their civilian health counterparts. An example of this was presented by Tong et al. (2013) 
who studied the knowledge of CDC staff on sexual health guidelines and found there was 
a need to educate the military health workforce on updated guidelines.  
 
5.5.2 ADF Personnel   
 
A large number of ADF personnel are young active adults who are involved in sexual 
encounters in a similar manner to their non-ADF counterparts. This study illustrates the 
sexually active nature of this population, with 96.77% respondents indicating they had had 
at least one sexual encounter in the last 12 months and more than 80% of those with 
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regular partners indicating they had had sex at least weekly and 42% of the entire group 
indicating that they had casual sex at least monthly.   
 
While this study did not attempt to address the knowledge of sexual health among the 
study population, contact with ADF personnel in the course of conducting the research 
indicated that the range of levels of knowledge of sexual health issues was very broad. 
This was noted on two separate occasions: firstly, during the focus test discussions; and 
secondly, during the screening recruitment at a large multi-service base. The questions 
asked during the completion of the survey by some individuals indicated a poor 
understanding of sexual health.    
 
It is assumed that the level of knowledge about sexual health among the ADF population is 
similar to comparable populations outside the ADF, such as those of the same age. A 
study into sex and relationships of over 19,000 Australians aged 16 to 59 in 2003 found 
that “knowledge of transmission routes and health consequences of the most common 
STIs was very poor … and the findings suggest that improving public knowledge of STIs is 
an urgent task in reducing the morbidity associated with these common infections” (Grulich 
et al. 2003).  
 
There is an opportunity to address this lack of knowledge through specifically directed 
education in sexual health among ADF personnel. Policy for, and practice in, this type of 
education already exists. ADF Health Directive 240 refers to the prevention of STIs and 
states that “educational material for ADF members is available through the Australian 
Defence Force health promotion guidelines” and that “specific information on STI risk and 
avoidance is provided in pre-deployment health briefs”. Considering the protective effect 
that employment in the ADF appears to have on sexual health, future research into the 
knowledge of sexual health among ADF personnel and a comparison to the Australian 
general population is warranted.  
 
Prevention messages for C. trachomatis may be an effective strategy to build broader 
sexual health messages in the ADF. Large-group educational approaches to controlling 
the spread and further acquisition of C. trachomatis infection have been trialled in the US 
military and found to be effective at reducing sexual risk behaviour (Boyer et al. 2001; 
Arcari et al. 2004). In the study reported by Arcari et al. (2004), 3,911 recruits who 
attended an education intervention demonstrated significantly higher STI knowledge 
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scores and confidence in the correct use of condoms after the education intervention than 
prior to the education intervention.  
 
Targeted safe sex education that may encompass screening messages would be 
additionally effective. This study found that newly-joined ADF members and junior 
members would best benefit from targeted education in safe sex. Of note, these are the 
same subpopulations that are recommended for C. trachomatis screening in the US 
military. The findings on the US military have led to the introduction by the US Navy and 
Marine Corps of routine C. trachomatis screening in their female recruits at entry, and 
screening of females in the Army and Air Force during the first 12 months of their service 
(Brodine & Schafer 2003).  
 
5.5.3 Recruits 
 
Recruits were included in this study. A total of 70 individuals identified as new recruits, 
meaning they had been in the ADF for less than 11 weeks. The C. trachomatis positivity 
rate and self-reported diagnosis of STIs in the previous 12 months were similar to the 
larger sample; however, an associated factor for unsafe sex practice was the length of 
time in which an individual had been in the ADF. The longer an individual had been in the 
ADF, the more likely they were to practise safe sex. This was not associated with age but 
with time in the ADF. As noted previously, a reason why this may not be associated with a 
particular age-based subpopulation is the narrow age range of this study, and the reason 
why safe sex practice may be associated with the length of time in the ADF is the culture 
of the ADF and associated protective factors (e.g. operational preparedness). In short, a 
culture of maintaining health as a component of operational preparedness may translate 
into less risk sexual risk-taking and hence greater levels of safe sex practice.  
 
Because of this relationship between length of time in the ADF and the practice of safe 
sex, targeted education in sexual health during the 12 week initial training period is 
warranted. This is supported by a US study showing that 1 in 5 women acquired a new 
chlamydia infection during their 12 months of military service after recruit training (Gaydos 
et al. 2008). 
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5.6 Methodological Considerations  
 
5.6.1 Approval Processes  
 
Conducting a study in the ADF involved multi-level approval processes, namely:   
1. Ethics approval 
2. ADF approval 
3. Approval from the Chief of the three services (RAN, RAAF, ARA) 
4. Approval from the Director of ADF Health 
5. Approval from the Commanding Officer for each defence facility involved  
6. Approval from the Officer-in-Charge of the health facility for each site and the 
Senior Medical Officer 
7. For deployments, the Captain of the vessel upon which recruitment was to be 
undertaken as well as the Officer-in-Charge of the health facility. 
 
These approval processes were detailed and complex; however, they served a useful 
purpose. Rather than hindering this study, the approval processes within the ADF, both 
ethical and operational, enabled the study to move into areas that had not been thought 
possible. Access to returning deployments by recruiting volunteers while they were still on 
their returning ships (and before they docked in Australian waters) is a good example of 
this advantage. Once approvals were in place, the only barriers to access and activity 
were operational.  
 
5.6.2 Reasons for Non-Participation in the Study  
 
Recruitment practices and non-participation rates were analysed at a large health service 
in a multi-service base early in the study in order to measure the extent to which those 
who chose not to participate in the study may have skewed the sample. The method of 
recruitment at this base was by asking potential participants when they arrived at the 
health service if they would join the study. It was estimated that 50% of those who 
attended the health service were in the appropriate age range. Of these, approximately 
15% joined the study. Potential participants were asked to visit the study personnel in a 
specially designated room after their medical appointment. A convenience sample of those 
who had been approached but who did not visit the study personnel were asked by the 
person at the front of the health service why they chose not to participate. It was estimated 
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this was a further 15% of those who were asked to participate. The checking of the 
reasons for non-participation was quick and ad hoc. The vast majority cited time and the 
need to return to duties. Where individuals cited reasons about the study, the comments 
indicated that the members who chose not to participate fell into two groups: 
1. Those who considered themselves very sexually active and made comments such 
as “You don’t want to know what I have been up to”.  
2. Those who considered themselves to be less sexually active and therefore didn’t 
see the need to be involved (as stated by one individual, “This isn’t for me as I am 
married”). 
From this feedback, it can be concluded that although volunteer bias remained, impact on 
the study dataset itself was minimal because reasons for non-participation potentially 
cancelled each other out. 
 
5.6.3 Staff Shortages  
 
This study highlighted the current staffing environment of many defence health facilities 
and staff shortages in many areas were noted. These shortages impacted on the ability of 
defence health personnel to contribute to this study even when goodwill existed.  
 
This issue was first raised at the face-to-face meeting with the Director of Health Services 
of the RAN in Canberra in October 2007. It was noted at this meeting that the use of local 
health staff would be of concern because many were already overstretched and not 
fulfilling all their own key performance indicators.  
 
This became more evident with subsequent site visits and was present across most sites 
of the ADF. Health staff shortages within the ADF may be indicative of health staff 
shortages across the broader Australian health sector as personnel in defence facilities 
are often drawn from civilian health populations.  
 
5.6.4 Surveillance vs Research  
 
An issue was highlighted concerning the use of anonymous testing for epidemiological 
research. As discussed in Chapter 3 (Section 3.7.2.5), the Principal Epidemiologist and 
Manager of the Surveillance and Research Unit in the Communicable Diseases Branch of 
Queensland Health contacted the Chief Investigator of the project in August 2008. 
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Standard protocol within the Queensland Health disease notification system requires urine 
samples that test reactive for chlamydia by the Queensland Health Pathology Service 
testing laboratory (the agreed site for this project) to be notified automatically to 
Queensland Health through an online system. It is noted that prior agreement with the 
Queensland Health Pathology Service personnel meant that the urine samples would only 
contain one item of identifying information (i.e. the code approved through the ethical 
screening process).  
 
This online system flagged the positive results from this study because they had 
insufficient identifying information. This study was the first to be scrutinised in this way as 
it was the first study to use de-identified data within a Queensland Health laboratory since 
the online data transfer system was commissioned.    
 
This is an important outcome of this study as it highlighted both the research limitations of 
the newly instigated data collection and analysis system and the proficiency of the system 
in targeting results with missing data. From discussions with Queensland Health it 
emerged there were three areas of concern:  
1. The urine samples were non-identifiable and therefore notification of a positive 
result and contact tracing were unable to be undertaken. This was of concern for 
Queensland Health as the Public Health Act (2005) indicates that all positive results 
would be notified and contact tracing undertaken. The resolution of this problem 
was twofold: 
a) When a positive result from this study was entered into the Queensland Health 
online system, an additional sentence noting that the result was part of an 
anonymous study would be included. This would highlight to data analysis 
personnel that this result did not require following-up for more detailed 
information.   
b) When the Public Health Act is next reviewed, the changes proposed for 
consideration by the legislators should include the specification of research as a 
rationale for not fulfilling the requirements of notification and contact tracing.  
2. The study raised the dilemma of positive results originating from other jurisdictions. 
For example, a urine sample that tested positive may have originated from Darwin; 
the result of that urine sample should not be included in Queensland notifications 
but in the Northern Territory notification system. There was agreement on a two-
step process to resolve this dilemma: 
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a) In the short-term, positive results were not included in any state’s ‘tally’. 
b) In the longer-term, discussion between Queensland Health and the researcher 
and supervisors would determine the appropriate course of action.   
3. The study design included the possibility of the dual notification of positive results. 
This is because a participant in the study could request a portion of their urine 
sample to be identified and processed through the local health service. This would 
enable the individual to be notified if the result was positive and to undergo 
treatment if desired. This aspect of the study design opened the possibility that: 
a) The de-identified urine sample was tested at the Queensland Health pathology 
laboratories at Herston in Queensland, and, if positive, notified to Queensland 
Health, which in turn notified the relevant jurisdiction.  
b) The identified urine sample was tested locally, and, if positive, was notified to 
the local jurisdiction. 
Hence, one urine sample may provide two positive results due to the study design. 
Due to the very small number of positive urine samples received through the study, 
there was agreement to continue with the current processes. 
 
The contact with personnel form the Queensland Health Surveillance and Research Unit 
highlighted the mismatch between common study designs and notification requirements.   
 
5.6.5 Use of Gel as a Transport Medium for C. trachomatis Screening  
 
As noted previously, this study utilised the newly-developed transport gel to be able to 
send urine samples through Australia Post. This system worked without any mishaps. The 
use of the gel was also beneficial for screening from sites located a great distance from 
testing facilities. The length of time in which the urine sample remains useable is far 
greater than a straight urine sample. Information supplied by the developers of the gel 
(Bialasiewicz et al. 2009) suggested that the gel would retain most of its sensitivity for an 
extended period; however, this had not previously been tested. The extended time period 
was particularly helpful for the recruitment of research volunteers while aboard ships at 
sea. Without the gel, the participation of the deployed subpopulation in this study would 
not have been possible. Gaydos et al. (2002) discussed the need for a mechanism to 
transport urine specimens over great distances because of military deployment. The 
successful use of the gel in this study may have addressed that challenge.  
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A consequence of this study design was the assessment of the length of time in which the 
gel medium was able to store a viable DNA sample. The longest time from provision of a 
urine sample to testing was eight weeks. This example involved the delivery of a set of 
urine samples from a deployed ship berthed in San Diego. At least one of these urine 
samples tested positive.  
 
A short study to determine the length of time in which a urine sample remains viable was 
developed in collaboration with the testing laboratory at the RBWH and the Sir Albert 
Sakzewski Research Laboratory (from where the gel originated). Thirty-eight known 
positive C. trachomatis urine samples were obtained from the RBWH testing laboratory 
with variable strength. These were decanted into nine tubes of the gel with the first being 
tested at baseline and a further urine sample tested each week. The study was intended to 
run for eight weeks but due to operational constraints it only reached four weeks. The urine 
samples were tested using the COBAS TaqMan C. trachomatis test from Roche. 
 
Of the 38 urine samples, 20 demonstrated a non-reactive result at baseline. One urine 
sample subsequently tested reactive. Of the 18 urine samples that were reactive at 
baseline, eight were still reactive at Week 4. This short evaluation of the gel demonstrated 
that urine samples may still be viable after an extended period of time; however, more 
research (including research on the strength of the urine sample at baseline) is required.  
 
In short, the gel is a convenient and user-friendly method for transporting urine specimens. 
The study participants encountered no difficulty in following the printed instructions and 
utilising this methodology for specimen collection. There may be many other applications of 
this gel for screening and surveillance in remote areas of Australia. 
 
5.6.6 Representativeness of the Sample  
 
5.6.6.1 ADF  
 
The findings of the cohort recruited into this study were able to be weighted for age and 
gender and compared to the full ADF population. Where demographic and behavioural 
characteristics were able to be compared, they were similar. This study sample is 
therefore broadly representative of the whole ADF population. Caution is noted regarding 
the over-representation of one service (ARA, RAN or RAAF) in the full sample; that is, one 
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of the three services had a higher ratio of the sample than that service’s corresponding 
population compared to the full ADF (ARA 55.38%; RAN 22.46%; RAAF 22.16%) 
(Department of Defence 2007).There were more RAN personnel involved in the study than 
representative of the entire ADF. To what degree the RAN was over-represented is not 
able to be reported, as sub-analysis by service was not undertaken at the direction of the 
ADF. In developing the protocol for this study, ADHREC instructed that reporting any data 
that was service-specific or location-specific was not to be undertaken.  
 
5.6.6.2 Australian population 
 
Once adjusted for age and gender, many characteristics of the ADF sample were similar to 
the broader Australian population. C. trachomatis prevalence remained a key difference. 
Sexual behaviour was similar (except for engagement of a sex worker). Considering this, 
some findings from this study that have not previously been researched in the general 
population may be generalisable to the broader Australian population (e.g. sex while 
overseas, other than on deployment, and with whom). These would need to be findings not 
related to the protective factors for sexual health in the ADF.  
 
5.6.7 Bias and Limitations  
 
There may have been some bias in the study resulting from the inclusion of self-identified 
new recruits. The sample contained 70 individuals who identified as recruits in training. 
Contact was made with new recruits within their first 11 weeks of basic training. The exact 
timing of participation in the study within this 11 week period is unknown. This sub-sample 
had the same overall characteristics of the remainder of the sample in C. trachomatis 
positivity (1.33% vs 2.09%), STI diagnosis in the previous 12 months (6.67% vs 5.78%) 
and safe sex practices (27.14% vs 32.48%). For this reason, they were included in the 
overall sample except in analyses that involved length of time in the ADF. 
 
There may also have been some bias as a result of inclusion in the sample of participants 
who were recruited through methods other than the AHA or similar health screen. While 
the exact number is unknown, it is expected to be small because all health service 
personnel were instructed that recruitment was designed to occur at the time of the AHA. It 
is known, through communication with health service staff and notes about recruitment, 
that 404 participants were definitely recruited at the time of their AHA. The majority of the 
MAIN TEXT 
Page 160 of 256 
remainder were most likely recruited through this method; however, it is not explicitly 
known whether or not this was the case. For comparison, this subgroup of 404 was 
compared to the remaining 329. There was no difference in C. trachomatis positivity 
(2.22% vs 1.92%) and the likelihood of bias because of this, although possible, is minimal.  
 
As noted in the previous section, this study did not distinguish between the three services 
of the ADF and a bias may have resulted due to the oversampling of one service. The 
demographics of the services are similar (Department of Defence 2007) and it is assumed 
that participants from each service would have participated in the study in a similar 
manner.    
  
5.6.7.1 Longevity of the effectiveness of the gel  
 
The transport of urine specimens over long distances and over time may have resulted in 
some under-reporting of C. trachomatis prevalence among deployed populations. Positivity 
of urine samples utilising the gel medium is known to be beyond 10 days; however, the 
reduction in sensitivity beyond this time is unknown. A short study examining longevity 
found that, after four weeks, more than 50% of the urine samples remained sensitive (with 
unknown strengths) and one urine sample remained reactive after an eight week journey 
from the deployed site to the testing laboratory.  
 
Of the 719 participants who provided a urine sample, 525 were from land-based sites and 
the urine samples for all of these were tested within 10 days. Of the 184 participants who 
provided a urine sample while on deployment, 75 were tested within 10 days, 91 were 
tested between 10 days and four weeks, and the remaining 18 were tested by eight 
weeks. Two urine samples were reactive to C. trachomatis from the 184 participants on 
deployment. One of these was tested at the eight week mark, and the other was tested 
between 10 days and four weeks.  
 
Even though the length of time in which the gel medium is able to provide a sensitive urine 
sample is unknown, the results of the short study to the four week timeframe and the 
ability of the test to determine C. trachomatis reactivity at the eight week mark for at least 
one urine sample suggest that any under-reporting that may have resulted from the use of 
the gel medium was minimal.  
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5.6.7.2 Non-participation and volunteer bias 
 
Volunteer bias is acknowledged in this study. Non-participation in the study may have 
resulted in some bias. As noted previously, recruitment practices and non-participation 
rates were analysed at a large health service in a multi-service base early in the study in 
order to measure the extent to which those who chose not to participate in the study may 
have skewed the sample. For details of the trial of different recruitment methodologies see 
Appendix 12. Generally, reported reasons for non-participation weighed each other out 
and it is concluded that non-participation did not greatly affect the sample.  
 
In addition, fourteen individuals who participated in the study by completing the survey 
declined to provide a urine sample to screen for C. trachomatis. These participants were 
from different land-based sites and deployed groups. Of note, six of these were from the 
same deployed group where the sampling was undertaken while at sea. On examination of 
individual surveys and comparison to the remaining cohort, there was nothing to indicate 
that the C. trachomatis positivity rate among this subset would be any different to the full 
sample.  
 
5.6.7.3 Reliability of responses  
 
As this study involved sensitive topics among a sensitive population, there was a 
probability that the data collected may be unreliable. The reliability of the survey 
instrument was checked by analysing responses that should have corresponded with other 
responses elsewhere in the document. Questions about condom use provided this 
mechanism. Three different questions were asked about condom use. Participants were 
asked to indicate the level of condom use with their regular partners, the level of condom 
use with their casual encounters, and whether or not they had used condoms for vaginal or 
anal sex during their last sexual contact. The compatibility between the answers was very 
high, with 96.73% of responses being compatible. Of those that were not compatible, nine 
participants (1.28%) indicated they never practised safe sex in the first two questions 
mentioned above, however they also indicated they had used a condom during their last 
sexual contact. Conversely, 15 participants (2.05%) indicated they always practised safe 
sex, but also responded that they did not use a condom during their last contact and that 
this contact involved vaginal and/or anal intercourse.  
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The question on the gender of the participant’s last sexual contact also provided a means 
to check reliability. Where participants indicated that the gender of their last sexual contact 
was the same gender as themselves, the question asking what activities were engaged in 
during this last sexual contact was examined. There was 100% compatibility between the 
two responses. That is, all the participants indicated sexual activity that was consistent 
with the same gender experience noted.  
 
Additionally, seven individuals indicated that they had never had a sexual experience. All 
questions referring to a sexual encounter were checked for each of these seven 
participants. This included relationship status, alcohol during sex, sex while on 
deployment, sex while overseas, sex work, symptoms of STIs, and diagnosis of an STI 
within the last 12 months. Responses to each of these questions for all seven participants 
were consistent with an indication that they had had no sexual encounters.   
 
Finally, seven individuals indicated they had been paid for sex within the 12 months prior 
to the study. To alleviate any perceived irregularity with this response, all responses from 
each survey of these seven individuals were reviewed for inconsistencies (for example, 
were questions about condom use consistent; were questions about last sexual encounter 
consistent). No inconsistent responses were found.   
 
The reliability of responses was found to be very high, with an almost 100% consistency 
across questions. This was reinforced by Smith et al. (2003) who reported that in the 
ASHR study, from which several questions were drawn for this study, self-reported 
information about sexual practices had high validity and reliability.  
 
5.6.7.4 Priority of operational activity 
 
Potential limitations in this study are to be found within the environment in which the study 
was conducted. Approvals were granted for access to health facilities on the condition that 
operational activity was not disrupted and, where operational activity potentially clashed 
with recruitment into the study, recruitment was secondary. This clash rarely occurred.  
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5.6.7.5 Sample size  
 
Original power calculations suggested that a study sample of 468 deployed personnel 
(within the last 12 months) and 468 non-deployed personnel was required. Ultimately, 733 
participants were recruited into the study and, of these, 309 had been deployed within the 
last 12 months (including on deployment at the time of the study). This lower than 
anticipated sample did affect some analysis and is a limitation of this study. Where this 
occurred it has been described in the thesis.  
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Chapter 6: Conclusion  
 
This chapter draws conclusions from the research conducted in the present study, and 
makes recommendations for future directions in policy and practice and recommendations 
for future research. A final summary of the research findings is then presented.   
 
6.1 Future Directions in Policy 
 
The findings of this research suggest opportunities for the enhancement of ADF policy on 
sexual health. The key enhancements would involve: 
- Recognition of the protective factors for sexual health in the ADF 
- Policies on general population screening or targeted screening for C. trachomatis 
- An overall examination of the policy on sexual health education in the ADF in light 
of the findings in this study.  
 
6.2 Future Directions in Practice 
 
There are opportunities for the enhancement in practice as a result of the findings in this 
study. These opportunities include: 
- Utilising attendance at the CPHE to recruit participants into studies on health within 
the ADF 
- Use of the gel-based system to transport urine samples across long distances and 
over time frames that make the use of neat urine untenable.  
 
6.3 Future Research 
 
The outcomes of this study can be extended in future research in three ways: further 
analysis of the data gathered in the study; further research in areas related to the study’s 
findings; and publication of the study’s findings.  
 
The opportunities for further analysis of the data gathered in the study include: 
- Analysis of the characteristics of the participants who engaged in sex while 
overseas, for both deployment and other reasons, in comparison to the participants 
who travelled overseas but did not engage in any sexual practice; such analysis 
would be useful in order to determine any actionable levels of risk.  
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- Examination of the profile of participants who reported being paid for sex in the 12 
months prior to the survey.   
- Further examination and analysis of alcohol rates and the associations between 
alcohol rates and safe sex practice. 
- Analysis of the characteristics of the cohort of newer recruits compared to the rest 
of the sample.  
 
The opportunities for further research in areas related to this study include: 
- Comparison of C. trachomatis incidence in the ADF with the general Australian 
population and other military populations. 
- Comparison between free health services (i.e. ADF health services accessed by 
ADF personnel) and services that charge a fee (clinics accessed by the general 
Australian population) to investigate any impact on access to services for a variety 
of health needs, including sexual health.  
- An investigation of levels of knowledge of safe sex and healthy sexual behaviour 
among ADF personnel; the findings of the present study suggest that any measure 
would be higher than the general Australian population.  
- A qualitative study into the enabling factors in ADF health services and policies that 
have assisted the outcome of low C. trachomatis prevalence in the ADF, and 
examination of the transferability of these factors to the general health environment 
in Australia. 
- An examination of the differences, in STI prevalence and knowledge, among 
recruits in the ADF compared to the serving population in the ADF. 
- An examination of the relationship between STI prevalence and mental health in 
military and other populations. 
- An examination of the gender disparity in the ADF on the implications for design 
and delivery of sexual health education 
- The evaluation of the longevity of the gel medium for PCR testing for C. 
trachomatis. 
 
The findings in this study can be presented for publication with a focus on the following 
topics: 
- C. trachomatis prevalence rates in the ADF along with characteristics of the risk 
factors for C. trachomatis. 
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- Self-reported STI notifications and symptoms in the ADF cohort and the 
characteristics of risk factors for STIs. 
- Comparison of sexual behaviour in the ADF and in the Australian population. 
- Comparison of sexual risk and safe sex in the ADF and in the Australian population.  
- Sex work in the ADF. 
- Sex while overseas, for both deployment and other reasons, among the ADF 
cohort, and comparison with the Australian population.  
- Utilisation of ADF health services for sexual health matters by ADF personnel. 
- Alcohol use in the ADF compared to the Australian population.  
- Alcohol use and the practice of unsafe sex in the ADF cohort. 
- Use of the gel-based medium to transport urine samples over long distances and 
lengthy time periods. 
 
6.4 Conclusions 
 
The findings from this study provide a profile of ADF sexual health and sexual behaviour 
that has not previously been demonstrated. The profile is comparable to the Australian 
population and displays, in some instances, greater levels of safe practice and lower levels 
of risk behaviour.   
 
This study identified an assumption among ADF personnel that there was a high incidence 
of C. trachomatis in the ADF and that ADF health services “saw a lot of chlamydia”. 
However, a low C. trachomatis prevalence compared to the Australian population and to 
other military populations was observed.   
 
C. trachomatis positivity was only associated with the number of sexual partners an 
individual reported in the previous 12 months. Those who had two or more partners were 
almost five times more likely to test positive than those who had one or no partners in the 
same period. No other variable was significant, including the level of safe sex practice. The 
presence of any self-reported STI in the previous 12 months was associated with the 
number of sexual partners and with current relationship status, with the following 
associations found of note: single status (two times more likely to have any self-reported 
STI in the previous 12 months; having had at least one casual partner in the last 12 
months (six times more likely); inconsistent condom use with casual partners (three times 
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more likely); and engaging in unsafe sex at some stage over the previous 12 months 
(three times more likely). 
 
Deployment was found to have a protective influence. Deployment was defined as active 
duty on behalf of the ADF at an overseas location, including at sea in international waters. 
Sample populations who were on deployment, who had been deployed over the previous 
12 months or who had ever been deployed were consistently likely to have lower C. 
trachomatis positivity than sample populations not involved in deployment. Further, those 
who were deployed at the time of participation in the study (p=0.037) and those who had 
been deployed at some stage over the previous 12 months (p=0.018) were significantly 
more likely to have practised safe sex over the last 12 months. This study found that those 
who were deployed were not any less likely to have engaged in sex, but the sex they 
engaged in was safe more often. This may in part be due to the culture of operational 
preparedness (maintaining health) and the members’ access to information and education 
about sexual practice through pre- and post-deployment briefings and health checks.  
 
Access to health services through the ADF and working within a culture of maintaining 
health as an element of operational preparedness were also found to have protective 
influences. Over 18% (age and gender adjusted) of the participants indicated they had 
attended a health service for a sexual health concern in the previous 12 months (n=135). 
The participants were three times more likely to attend an ADF health service for testing 
and treatment of an STI than they were to attend a civilian health service (16.4% vs 
5.61%). Those who engaged in some unsafe sex compared to those who always practised 
safe sex were significantly more likely to attend a health service for a sexual health matter 
(30.67% vs 13.86%). This study illustrates that ADF health services are not only attracting 
personnel for sexual health matters—they are attracting those who most needed to attend 
a sexual health service. The combination of a low prevalence of C. trachomatis and high 
attendance rates at health services for sexual health concerns (compared to Australian 
data from Yeung et al. 2014), especially among those who self-reported STIs, indicates 
that current testing mechanisms for C. trachomatis in particular and STIs generally are 
effective in the ADF. Health service attendance rates may be a contributing factor to the 
lower C. trachomatis prevalence found in this study, and attendance rates may be 
influenced by the culture of maintaining health, the free and easily accessible nature of the 
services, and the added benefit that ADF personnel are able to attend health services 
while on duty.  
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The broad use of doxycycline in the study population affected the findings of this study. 
Among the participants, 14% (n=84) indicated they had taken doxycycline at some stage 
over the previous 12 months. No participant who indicated they had taken doxycycline 
tested positive for C. trachomatis. Additionally, those who had not taken doxycycline over 
the previous 12 months were twice as likely to self-report an STI within the previous 12 
months. The findings from this study suggest a protective effect against STIs through the 
use of doxycycline for malaria prophylaxis while on deployment, further enhancing the 
protective effect of deployment. Any examination of STI prevalence requires investigation 
into participants’ antibiotic usage.   
 
This study found that members of the ADF drank alcohol more often than the general 
Australian population but drank to lesser excess. Very few did not drink at all (2.51%), 
while more than half the sample (58.47%) drank more than six standard drinks on at least 
one occasion at least monthly. While the alcohol consumption rate did not impact on C. 
trachomatis prevalence or on rates of reported STIs, it did impact on safe sex practice. 
Any safe sex education initiative needs to consider the effects of alcohol consumption.  
 
This study highlights that education in C. trachomatis infection is most effectively targeted 
at individuals who regularly have more than one sexual partner. While any individual who 
is single is most likely to fall into this subpopulation and is easily identifiable, this study 
demonstrated that a number of individuals in long-term relationships (19.37%) also had 
multiple partners and this subpopulation is harder to identify.  
 
Education in general STI awareness and prevention is most effectively targeted at those 
who are single, those who regularly have more than one sexual partner, those who have 
sex with casual partners, and those who engage the services of sex workers. Again, 
identifying these subpopulations may be difficult. 
 
Given these insights, general safe sex education (that could include education in C. 
trachomatis infection and broader STI awareness and prevention as noted above) is most 
effectively targeted at those who are new to the ADF, those who are of junior rank (both 
officer and non-officer), those who have recently changed relationship status, those who 
consume alcohol to potentially harmful levels and who drink alcohol during sex, those who 
have sex frequently, those who pay for sex, and those who regularly have more than one 
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sexual partner. The first two of these subpopulations, namely, those who are new to the 
ADF and those of junior rank, are identifiable subpopulations that would be effective 
targets for education and prevention messages.   
 
Education and prevention messages in sexual health that specifically target 
subpopulations based on gender, age or rank are not recommended from the findings of 
this study. 
 
Based on the findings of this study, it is determined that the hypothesis that “the 
prevalence of C. trachomatis infection is higher in ADF members compared with existing 
community data of the (age- and sex-matched) Australian population” must be rejected, 
and the hypothesis that “the prevalence of C. trachomatis infection is higher in ADF 
members returning from overseas deployment than those not deployed overseas” must 
also be rejected. Further, the third hypothesis, “that sexual risk behaviour is higher in those 
ADF members with genitourinary C. trachomatis infection than those without” is also to be 
rejected. By rejecting these hypotheses, this study demonstrates that the sexual health 
and sexual risk profile of the ADF is similar to the profile of the general Australian 
population and that certain characteristics of employment in the ADF, contrary to 
expectations, offer protective factors to sexual health.  
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The study: 
Chlamydia is the most common bacterial Sexually Transmissible Infection in Australia.  The great 
majority of people infected with chlamydia do not realise they have it because it does not produce 
symptoms. If left untreated, it can cause serious reproductive health problems, particularly infertility 
in women.  Treatment is available and is simple to take. 
 
This study involves finding out what the prevalence of chlamydia is in the ADF and will be 
undertaken at three large ADF facilities as well as amongst defence personnel returning from 
overseas deployment.  The screening will be incorporated as part of the Annual Health 
Assessment (AHA) and post overseas deployment health check. 
 
During the AHA, or when returning from overseas deployment, personnel are asked to volunteer 
for involvement in this study. Participation will involve the volunteer providing a urine sample and 
the completion of a sexual behaviour questionnaire that will be administered as part of the 
screening. This survey will help to identify populations within the ADF that may be a greater risk of 
having chlamydia, and will assist the better targeting of future screening and health promotion 
programs. 
 
Your part in the study: 
You are being invited to take part in a study of chlamydia prevalence amongst personnel in the 
ADF.  
 
Participation in the study is entirely voluntary.  There is no obligation to take part in the study and if 
you choose not to take part in the study there will be no detriment to your career or future health 
care. 
 
You may withdraw from involvement in this study at any time with no detriment to your career or 
future health care.  If you volunteer to be involved in this study you will be asked to: 
1. provide a urine specimen that will be used to test for chlamydia infection. 
2. complete a self administered survey that asks for information about sexual behaviours.  
 
We will ask you to complete a survey that will ask you a number of questions about your sexual 
and other relevant behaviour. These questions will be personal but you can complete this written 
survey on your own and then return it in a sealed envelope. Your name will not appear on the 
survey. It will be de-identified.  
 
We will ask you to provide a urine specimen to test for chlamydia. This sample will be split in two. 
Half the urine specimen will be de-identified (that is, it will be anonymously coded), tested at a non-
military laboratory and the result matched with the survey data. We will not be able to trace the 
results of this test or survey back to you.  However, if you wish, the other half of the urine sample 
will remain identified and with your consent we can send this sample to your medical unit’s 
pathology lab to test for chlamydia. You will receive the result of this test so that you may be 
offered treatment by your local medical officer if the test is positive.   
 
The only other identifiable information will be on this consent form and these will be stored 
separately and securely in a locked cabinet in a locked facility to which only the Chief Investigator 
has access. 
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Risks of participating: 
 
Generally, the risks of participating in a study are required to be explained before any consent can 
be obtained from you regarding participation.  The primary risk involved in participating in this study 
is related to the confidentiality of the information provided.  The handling of this information is 
discussed below in the section entitled “Statement of Privacy”.   
 
Please be aware that if you consent to the identified half of your urine sample to be tested for 
chlamydia, and it is positive for chlamydia, you will be encouraged to have a full sexual health 
check, and your doctor will advise you to inform your partner/s as they may need to be offered 
treatment as well. Also be aware that the result will be recorded in your confidential medical file 
maintained at your Unit’s medical facility. 
 
If you do not wish to have an identifiable sample tested, be aware that you will not receive any 
results back. This means that you may have chlamydia and be unaware of it. This can cause 
significant damage to your reproductive ability, and/or affect your partner. If you believe you could 
be at risk, you can have a chlamydia test at any sexual health clinic or GP. 
  
The survey questions asked of you may cause mild distress or embarrassment. Should this 
happen, please notify the Chief Investigator and if necessary we can arrange a counsellor to talk 
with you about issues that have been raised. 
 
Your urine sample will not be tested for any other microbes or substances other than Chlamydia 
trachomatis as described. 
 
On duty: 
 
You will be considered ‘on duty’ during participation in this study. 
 
Statement of Privacy: 
 
Consent forms will be stored securely at the Mayne Medical School, The University of Queensland, 
Brisbane and will be accessible only to the Chief Investigator.   
 
De-identified information from the urine sample and from the sexual behaviour survey will be 
matched for analysis. That is, an individual’s survey will be matched with that individual’s urine test 
result, but it will not be known who that individual is.   
 
By splitting the urine specimen into two samples, anonymity is maintained while opportunity for 
treatment to be offered by your usual medical officer is provided.   
 
Any reports or articles published from this study will only include de-identified data and no personal 
information will be disclosed. 
 
Any personal data collected will be used for the purpose of this study and no other, without your 
expressed permission. 
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Chief investigator: 
 
  Mr Stephen Lambert    
  Lecturer 
  Centre for Military and Veterans’ Health 
  The University of Queensland 
  288 Herston Rd 
  HERSTON  Qld  4006 
 
  P 07 3365 5045 
  F 07 3346 4749 
  E s.lambert@uq.edu.au 
 
Should you have any complaints or concerns about the manner in which this project is conducted, 
please do not hesitate to contact the Chief Investigator in person, or you may prefer to contact the 
Australian Defence Human Research Ethics Committee at the following address: 
 
  Executive Secretary 
  Australian Defence Human Research Ethics Committee 
  CP2 – 7 – 66 
  Department of Defence 
  CANBERRA  ACT  2600 
  P  02 6266 3837 
  F  02 6266 4982 
  E  ADHREC@defence.gov.au 
 
This study has been approved by ADHREC as the principle approving Human Research Ethics 
Committee. 
 
Additionally, this study adheres to the Guidelines of the ethical review process of The University of 
Queensland. Whilst you are free to discuss your participation in this study with project staff 
(contactable on the phone numbers above), if you would like to speak to an officer of the University 
not involved in the study, you may contact the Ethics Officer on 07 3365 3924. 
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Consent: 
 
 
I         give my consent to participate in: 
 
       The full study mentioned above (both the provision of a urine sample and  
   the administration of a sexual behaviour survey) 
 
   or 
 
             Provision of a urine sample for the study only 
 
   or  
 
     Administration of the sexual behaviour survey only. 
 
I give this consent on the following basis: 
 I have had explained to me the aims of this research project, how it will be conducted and 
my role in it. 
 I understand the risks involved as described above. 
 I am cooperating in this project on the condition that: 
- The information I provide will be kept confidential 
- The information will be used only for this project 
- The research results will be made available to me at my request and any 
published reports of this study will preserve my anonymity. 
- The urine sample will be tested for chlamydia only 
 
  I give my consent for the second urine sample to remain identifiable and   
  tested for Chlamydia trachomatis within Defence Health Pathology 
 
   or 
 
   I do not give my consent for the second urine sample to remain identifiable  
  and tested for Chlamydia trachomatis within Defence Health Pathology 
 
 
 
                                                                                                   Signatures over the page
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I understand that: 
 There is no obligation to take part in this study 
 If I choose not to participate there will be no detriment to my career or future health 
care 
 I am free to withdraw at any time with no detriment to my career or future health care 
 
I have been given a copy of the information and consent sheet, signed by me and the researcher 
to keep.  
 
I have been also given a copy of ADHREC’s Guidelines for Volunteers. 
 
 
 
              
Signature of Volunteer               Signature of Researcher 
 
 
              
Name in Full                Name in Full 
 
 
             
             
       Date 
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Appendix 2 
 
The survey instrument 
 
(logos, headers and footers removed) 
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Statement from ADHREC      
This study has been approved by Australian Defence 
Human Research Ethics Committee (ADHREC). Should 
you have any complaints or concerns about the manner in 
which this project is conducted, please do not hesitate to 
contact the Chief Investigator in person on 07 3365 5045, 
or you may prefer to contact ADHREC on 02 6266 3837.   
 
Statement from UQ Ethics 
Additionally, this study adheres to the Guidelines of the ethical review process of The University of 
Queensland. Whilst you are free to discuss your participation in this study with project staff 
(contactable on 07 3365 5045), if you would like to speak to an officer of the University not involved 
in the study, you may contact the Ethics Officer on 07 3365 3924. 
 
Introduction 
This survey is based upon a national survey of approximately 20 000 Australians, including those 
in your age group, who answered questions about their sexual behaviour and is part of a study of 
the prevalence of chlamydia in the Australian Defence Force.  Questions have been added for the 
military population. 
 
Completion of this survey is voluntary and anonymous.   Please note that you do not have to 
answer questions if you think the answers may potentially identify you. 
 
Your participation in this survey will assist the development of education and prevention efforts 
against this sexually transmissible infection. 
 
If you have volunteered to give a urine sample, this survey will be given the same code as the 
urine sample.  The results of the test for chlamydia will be analysed in conjunction with the 
information presented in this survey.  
 
On completion of the survey, make sure the code is on the survey and place it in the envelope 
addressed to The University of Queensland.  Post it yourself or give it to the investigator who gave 
you this survey. 
 
1. Your age today:     
  18 - 20  21 - 22  23 – 25   26 – 29  30 and above 
 
2. Gender:      Male  Female  
 
3a. In terms of legal relationship status, are you: 
   Married  De Facto Relationship  Widowed 
  Divorced  Separated but not divorced Single (Never Married) 
CODE: 
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3b. How long have you had this relationship status? 
  less than 12 months   more than 12 months 
 
 
4. How many children do you have?    
 
5. In which broad region / locality are you posted?       
  (eg: South East Queensland; Northern Victoria etc) 
 
6a. Are you in the  
  Navy  Army  Air Force  
 
6b. What is your rank?  
   Officer – Junior     Officer - Senior 
    Other Rank - Junior    Other Rank - Senior 
 
7. Are you:  Reservist  Permanent 
 
8. What year did you join the ADF?     (year) 
 
9a. How often do you have a drink containing alcohol? 
   Never (go to Question 11)  Monthly or less 
   Two to four times a month   Two to three times a week 
   Four or more times a week 
 
9b. How many standard drinks containing alcohol do you have on a typical day when  
 you are drinking? 
   One or two   Three or four 
   Five or six   Seven to nine 
   Ten or more 
 
9c. How often do you have six or more drinks on one occasion? 
   Never     Less than monthly 
   Monthly    Weekly 
   Daily or almost daily 
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10a. Thinking about the last time you participated in any sexual activity with another   
 person, had you had anything to drink? 
   Yes    No (go to Question 11) 
 
10b. Thinking about the last time you participated in any sexual activity with another   
 person, how many standard drinks did you have? 
   One or two   Three or four 
   Five or six   Seven to nine 
   Ten or more 
 
11. How many different people have you had sex with in the last 12 months? 
 
      (number of people) 
 
Question 12 asks about your regular partner. 
 
12a. Do you have a main regular partner that you have an ongoing sexual relationship  
 with? 
   Yes  No (go to Question 13) 
 
12b. How long have you been in the relationship with your current main regular   
  partner? 
 
      (months and years) 
 
12c. If you have vaginal or anal sex with your regular partner, how often is a condom   
 used? 
   Always  Often  Occasionally    Never   
 
12d. How often have you had sex with your regular partner in the last twelve months? 
   Daily    Weekly   Monthly            
   Every few months   Yearly   Not in the last 12 months      
 
12e. In the past 12 months, how many other people, other than a regular partner   
 have you had sex with? 
 
      (number of people, if 0 go to Question 14) 
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Question 13 asks about any casual encounters 
 
13a. If you have vaginal or anal sex with your casual encounters, how often is a   
 condom used? 
   Always  Often  Occasionally    Never   
   I don’t have vaginal or anal sex with my casual encounters 
 
13b. How often have you had sex with casual encounters in the last twelve months? 
   Daily    Weekly   Monthly            
   Every few months   Yearly   Not in the last 12 months      
 
13c. What was the relationship status of your last casual sexual encounter? 
   Married   De Facto Relationship   Widowed 
   Divorced   Separated but not divorced  Single (Never Married) 
   Don’t know 
 
Questions 14 & 15 ask about your last sexual contact. Tick all that apply for both questions. 
 
14. What was the gender of your last sexual contact?       
  Male  Female   Don’t know 
 
15. During your last sexual contact, which of the following did you engage in?  
   Oral Sex with a condom (or dam) and I was the inserting partner 
   Oral Sex with a condom (or dam) and I was the receiving partner 
   Oral Sex without a condom (or dam) and I was the inserting partner 
   Oral Sex without a condom (or dam) and I was the receiving partner 
   Vaginal Sex with a condom (or dam) 
   Vaginal Sex without a condom (or dam) 
   Anal Sex with a condom (or dam) and I was the inserting partner 
   Anal Sex with a condom (or dam) and I was the receiving partner  
   Anal Sex without a condom (or dam) and I was the inserting partner 
   Anal Sex without a condom (or dam) and I was the receiving partner
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16.    During the last twelve months have you experienced any of the following?  
  (tick all that apply) 
  Female  discomfort when urinating 
     unusual vaginal discharge 
    genital itch 
     painful ulcers in genital area 
    painless ulcers in genital area 
 
  Male   unusual discharge from the penis 
     pain while urinating 
     pain or irritation in the urethra 
     pain in the scrotum 
    genital itch 
     painful ulcers in genital area 
    painless ulcers in genital area 
 
17a. During the last 12 months have you been diagnosed with any of the following?  
     Chlamydia 
     Genital Herpes 
     Genital Warts 
     Gonorrhoea 
     Pubic Lice or crabs 
     Syphilis 
     Abnormal pap smear 
     Don’t know 
     Have not been tested 
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17b. In the last 12 months have you sought testing and treatment for an Sexually   
 Transmitted Infection at a Defence Health Service? 
   Yes    No  
 
17c. In the last 12 months have you sought testing and treatment for an Sexually   
 Transmitted Infection at a service / clinic other than a Defence Health Service? 
   Yes    No  
 
18. What is your history of overseas deployment within the last 12 months? 
 
  Which Country?   When?    Length?   
 
  Which Country?   When?    Length?   
 
  Which Country?   When?    Length?   
   
  Which Country?   When?    Length?   
   
  Which Country?   When?    Length?   
 
19. The approximate number of times deployed overseas in total during your entire   
 time in the ADF?         (number) 
 
20a. How many months in the last 12 months have you been prescribed doxycycline? 
 
      (number of months) 
 
20b. How many months in the last 12 months have you actually taken doxycycline? 
 
      (number of months) 
 
21a. If you have been on overseas deployment in the last 12 months did you engage   
 in any  sexual practices with someone else during this deployment? 
   Yes  No (go to Question 22)  
   No deployment in last 12 months (go to Question 22) 
 
21b. How many different people did you engage in sexual practices with   
  while on overseas deployment in the last 12 months? 
 
      (number of people) 
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21c. Of the number of people indicated in Question 21b, did they include:  
  (indicate all that apply) 
     A stranger (but not a sex worker) 
     A sex worker 
     A member of the Australian Defence Force 
     A member of another Defence Force 
     A person known to you other than any of the above 
 
21d. During your last overseas deployment (within the previous 12 months), which of   
 the following did you engage in?  
   Oral Sex with a condom (or dam) and I was the inserting partner 
   Oral Sex with a condom (or dam) and I was the receiving partner 
   Oral Sex without a condom (or dam) and I was the inserting partner 
   Oral Sex without a condom (or dam) and I was the receiving partner 
   Vaginal Sex with a condom (or dam) 
   Vaginal Sex without a condom (or dam) 
   Anal Sex with a condom (or dam) and I was the inserting partner 
   Anal Sex with a condom (or dam) and I was the receiving partner  
   Anal Sex without a condom (or dam) and I was the inserting partner 
   Anal Sex without a condom (or dam) and I was the receiving partner  
 
21e. Indicate the city and country where your last sexual encounter while on overseas  
 deployment occurred? 
 
      (city and country) 
 
22a. Have you been overseas in the last 12 months other than with the ADF (eg   
 holiday)? 
   Yes  No (go to Question 23)
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22b. How many different people did you engage in sexual practices with while on   
 your last overseas trip (other than on deployment)? 
 
      (number of people) 
 
22c. Of the number of people indicated in Question 22b, did they include:  
  (indicate all that apply) 
     Your regular partner  
     A stranger (but not a sex worker) 
     A sex worker 
     A member of the Australian Defence Force 
     A member of another Defence Force 
     A person known to you other than any of the above 
 
22d. Indicate the city and country where your last sexual encounter while overseas   
 (other than on deployment) occurred? 
 
      (city and country) 
 
23. Have you paid for sex in the last 12 months on any occasion? 
   Yes  No 
 
24. Have you received payment for sex in the last 12 months on any occasion? 
   Yes  No 
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Appendix 3 
 
Fact sheet on the use of the gel 
 
(logos, headers and footers removed) 
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For the Participant 
 
 
 
Step One:  
Three quarters fill the yellow topped jar with ‘first catch’ urine. 
 
 
 
Step Two: 
Check the crystals in the ‘orange topped tube’.  There should 
be about ½ - 1 ml of crystal in the bottom.  If the crystal has 
solidified in any way tap or shake the tube so the crystals can 
move up and down the tube.  
 
 
 
 
Step Three: 
Using the plastic dropper (bubble topped device), squeeze the 
‘bubble’ firmly to draw up a urine sample.   
 
 
Step Four: 
Squeeze the ‘bubble’ again to gently drip the sample into the 
orange topped tube (the one containing the crystals).   
 
Fill to the 3 ml mark - approximately 
 
 
 
 
 
Step Five: 
Replace the orange lid on the tube and shake gently 
 
Wait for a minute ….. the crystals will turn into a gel.  
 
 
Step Six: 
If you have given consent for a second test to be completed 
(so you can be treated if the test is positive) keep the 
remaining urine to return to the health officer.   
 
If you do not consent to the second test, empty any urine left in 
the yellow topped jar down the toilet and discard or return the 
jar as instructed by the health officer.    
 
Return the orange tube (and the urine jar if needed) to the 
health officer 
 
 
Warning: 
Do not 
consume 
crystals 
from 
orange 
tube 
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For the Health Officer 
 
 
 
Place the tube containing the gel inside the white 
cardboard sleeve (to help protect it during postage) and 
close securely. 
 
 
 
 
Place the cardboard sleeve containing the sample and the 
coded pathology slip inside the pathology bag and press 
seal.  
 
 
 
Put the pathology bag and into the ‘return addressed’ 
envelope (along with the survey if completed) and either 
arrange for collection by the Chief Investigator or drop it 
into any Australia Post post-box (yourself or the 
participant) within 5 days of taking the sample. 
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ADHREC ethics approval 
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UQ MREC ethics approval 
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ADHREC ethics variation approvals 
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Budget 
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Year One:  2006 
No Item Amount Funding 
Option 1 
Funding 
Option 2 
Funding 
Option 3 
1.1 Project Officer Wage @ 
2 days per week 
$31 488 National 
Chlamydia 
Campaign 
Other 
grant 
HIV & HCV 
Ed Proj 
1.2 Administration 
Assistance 
$8 000 National 
Chlamydia 
Campaign 
Other 
grant 
CMVH 
1.3 Travel $6 000 National 
Chlamydia 
Campaign 
Other 
grant 
CMVH 
1.4 Photocopying & Printing $3 000 National 
Chlamydia 
Campaign 
Other 
grant 
HIV & HCV 
Ed Proj 
1.5 Phone / Fax / Email /Internet $2 500 National 
Chlamydia 
Campaign 
Other 
grant 
HIV & HCV 
Ed Proj 
1.6 Medical and Nursing 
Staff training (wage 
component) 
In kind ADF   
1.7 Medical and Nursing 
Staff training (resources) 
$2 500 National 
Chlamydia 
Campaign 
CMVH  
1.8 Insurance In kind CMVH 
 
  
1.9 IT hardware and 
software 
$5 000 National 
Chlamydia 
Campaign 
Other 
grant 
CMVH 
      
Year Two:  2007 
No Item Amount Funding 
Option 1 
Funding 
Option 2 
Funding 
Option 3 
2.1 Project Officer Wage @ 
2 days per week 
$31 488 National 
Chlamydia 
Campaign 
Other 
grant 
HIV & HCV 
Ed Proj 
2.2 Administration 
Assistance 
$8 000 National 
Chlamydia 
Campaign 
Other 
grant 
CMVH 
2.3 Travel $6 000 National 
Chlamydia 
Campaign 
Other 
grant 
CMVH 
2.4 Photocopying & Printing $3 000 National 
Chlamydia 
Campaign 
Other 
grant 
HIV & HCV 
Ed Proj 
2.5 Phone / Fax / Email /Internet $2 500 National 
Chlamydia 
Campaign 
Other 
grant 
HIV & HCV 
Ed Proj 
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2.6 Medical services In kind ADF 
 
  
2.7 Nursing services In kind ADF 
 
  
2.8 Pathology @ 700 tests x 
$25.00 
$17 500 National 
Chlamydia 
Campaign 
CMVH Pharma 
2.9 Specimen transport 
through Australia post 
@ $5.00 per specimen 
$3 500 National 
Chlamydia 
Campaign 
CMVH Pharma 
2.10 Treatment In Kind ADF 
 
  
2.11 Insurance In kind CMVH 
 
  
      
Year Three:  2008 
No Item Amount Funding 
Option 1 
Funding 
Option 2 
Funding 
Option 3 
3.1 Project Officer Wage @ 
2 days per week 
$31 488 National 
Chlamydia 
Campaign 
Other 
grant 
HIV & HCV 
Ed Proj 
3.2 Administration 
Assistance 
$8 000 National 
Chlamydia 
Campaign 
Other 
grant 
CMVH 
3.3 Travel $6 000 National 
Chlamydia 
Campaign 
Other 
grant 
CMVH 
3.4 Photocopying & Printing $3 000 National 
Chlamydia 
Campaign 
Other 
grant 
HIV & HCV 
Ed Proj 
3.5 Phone / Fax / Email /Internet $2 500 National 
Chlamydia 
Campaign 
Other 
grant 
HIV & HCV 
Ed Proj 
3.6 Medical services In kind ADF 
 
  
3.7 Nursing services In kind ADF 
 
 
  
3.8 Pathology @ 700 tests x 
$25.00 
$17 500 National 
Chlamydia 
Campaign 
CMVH Pharma 
3.9 Specimen transport 
through Australia post 
@ $5.00 per specimen 
$3 500 National 
Chlamydia 
Campaign 
CMVH Pharma 
3.10 Treatment In kind ADF 
 
  
3.11 Insurance In kind CMVH 
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Year Four:  2009 
No Item Amount Funding 
Option 1 
Funding 
Option 2 
Funding 
Option 3 
4.1 Project Officer Wage @ 
2 days per week 
$31 488 Other 
grant 
CMVH HIV & HCV 
Ed Proj 
 
4.2 Administration 
Assistance 
$8 000 Other 
grant 
CMVH  
4.3 Travel $6 000 Other 
grant 
CMVH  
4.4 Photocopying & Printing $3 000 Other 
grant 
CMVH HIV & HCV 
Ed Proj 
4.5 Phone / Fax / Email /Internet $2 500 Other 
grant 
CMVH HIV & HCV 
Ed Proj 
4.6 Statistical Advisor In kind  CMVH 
 
  
4.7 Insurance In kind CMVH 
 
  
      
Year Five:  2010 
No Item Amount Funding 
Option 1 
Funding 
Option 2 
Funding 
Option 3 
5.1 Project Officer Wage @ 
2 days per week 
$31 488 Other 
grant 
CMVH HIV & HCV 
Ed Proj 
 
5.2 Administration 
Assistance 
$8 000 Other 
grant 
CMVH  
5.3 Travel $6 000 Other 
grant 
CMVH  
5.4 Photocopying & Printing $3 000 Other 
grant 
CMVH HIV & HCV 
Ed Proj 
5.5 Phone / Fax / Email /Internet $2 500 Other 
grant 
CMVH HIV & HCV 
Ed Proj 
5.6 Statistical Advisor In kind  ADF 
 
  
5.7 Insurance In kind CMVH 
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Appendix 8 
 
Changes to data collection tools resulting from piloting 
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The first land-based site that agreed to be involved in the study provided personnel for 
focus testing of both the survey instrument and the urine collection methodology. Focus 
testing was undertaken on Friday, 14 December 2007 from 8.30 am to 11.00 am.  
 
Inclusion criteria comprised being between 18 and 29 years of age and being a member of 
the RAN. Nineteen RAN personnel participated in the focus test and were recruited from 
the crews of four Admiral Class Patrol Boats in port at the time. The focus test was 
conducted by Mr Steve Lambert and Dr Joe Debattista.    
 
These 19 volunteers comprised 6 females and 13 males, with ages ranging from 18 to 32 
years with the mean age being 24. The median was 24. Females were, on average slightly 
older than males (F=24.7 to M=23.7). As shown in the table below, only one person 
present did not meet the age criteria for the study (18–29); however, this person was still 
included in the focus testing. Of the remaining 18, 14 met the criteria for the component of 
the study funded by the Australian Government Department of Health and Ageing (i.e. 
aged 18–25) and four were in the broader age range of 26–29. 
 
Total No. Age Range No. in Range M F 
19 
18–25 14 12 2 
26–29 4 2 2 
Over 29 1 1 0 
 
Length of time in the RAN ranged from 1 year to 13 years, with the mean being 5.2 years.  
Length of time posted at the site of the focus test ranged from 3.5 months to 5 years, with 
the mean being 1 year and 4 months.  
 
Results on the Information and Consent Form 
 
The participants understood the purpose of the form and there was no confusion amongst 
any of the participants about the dual consent for the survey and/or the urine sample.  
There was also no apparent confusion about the subsequent consent for the sample to be 
split into two components, namely, one to be used in the study and one to be tested 
locally.  
 
Suggestions for changes to wording in the information and consent form included:  
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1. The word “prevalence” should be clarified by including a bracketed explanation (that 
it means how much of something there is in a population) 
2. The phrase “will be de-identified (that is, it will be anonymously coded)” should be 
switched to read: “will be anonymously coded (that is, it will be de-identified). 
3. In the section on Risks of Participating, “partner/s as they may need to be offered 
treatment” should be changed to “partner/s as they may need to seek treatment”. 
4. The name of the Chief Investigator should be noted in the Statement of Privacy as 
well as over the page.   
 
Results on the Survey 
 
The survey took participants between 6 and 10 minutes to complete. Overall, the survey 
was well understood by the focus test participants. As well as minor changes, the 
participants indicated that the group of questions could narrow down the identity of the 
person who completed the survey to one and the participants felt this would prevent 
personnel from completing the survey honestly as anonymity may be compromised. (Of 
note, this issue was also raised by ADHREC in a review of the survey.)  It was noted that 
the participants understood that the word “intoxicated” asked whether or not they were 
drunk. The participants’ use of the word “drunk” generally meant they were unable to drive 
a vehicle. The participants found the terminology “casual partners” difficult to comprehend. 
The word “partner” implied someone they were seeing regularly and the word “casual” 
implied a one-night stand. The best terminology agreed by the group was “casual 
encounter”.  
 
Members in the focus test group raised the issue that they may not know the gender of 
their last sexual encounter and therefore suggested the inclusion of a “don’t know” tick 
box. When queried about this, the example given was picking up a person in a city in 
Southeast Asia who then performed sexual acts without their gender being apparent. It 
was also noted that a respondent may have had sex with more than one person on the 
last occasion they had sex and therefore a “tick all that apply” statement needs to be 
added to the survey. (It is noted that these responses were offered in the context of 
serious and genuine discussion about the survey questions.) 
 
The use of the words “receptive” and “insertive” were difficult for the participants to follow.  
The suggestion was to change these to “receiving” and “inserting”. In addition, there was 
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strong comment that the questions were written from a “male point of view”. The changes 
to the words noted above alleviated this to some extent; however, it was also suggested 
that the wording be changed from “condom” to “condom (and dam)”. 
 
The suggested changes to the survey are summarised as follows: 
 Q3—Add the word “single” next to the wording “never married”. 
 Q6, Q7, Q8, Q9—The participants indicated that this group of questions could 
narrow down the identity of the potential person who completed the survey to one 
and the participants felt this would prevent personnel from completing the survey 
honestly as anonymity may be compromised. The following changes were 
suggested to alleviate this: 
a) Change Q6 to: “What locality are you posted at” leaving the opportunity to name 
a town rather than a base. 
b) Leave Q7 and Q9 the same and remove Q8. This would mean that the type of 
employment information would not be gathered in the survey and may limit 
some of the findings. 
 Q12a (now newly-numbered Q11a) —The participants understood that the word 
“intoxicated” asked whether or not they were drunk. The participants’ use of the 
word “drunk” generally meant they were unable to drive a vehicle.  
 Q14a & b (now newly-numbered Q13a & b) —Insert the word “main” when talking 
about regular partners as the group noted that people may have more than one 
regular partner. 
 Q14c (now newly-numbered Q13c) —Remove the box titled N/A as it is not needed 
 Q15 (now newly-numbered Q14) —The participants found the terminology “casual 
partners” difficult to comprehend. The best alternative terminology agreed by the 
group was “casual encounter”.  
 Q15c (now Q14c) —It was noted by the group that people most probably don’t 
know the answer to this question but that it should be kept in the survey. The 
suggestion was also made to add the word “single” next to “never married” as per 
the previous questions.  
 Q16 (now Q15) —Members in the group raised the issue that they may not know 
the gender of their last sexual encounter and therefore suggested included a “don’t 
know” tick box.   
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 It was noted that a respondent may have had sex with more than one person on the 
last occasion they had sex and therefore a “tick all that apply” statement should be 
added.   
 Q17 (now Q16) —The use of the words “receptive” and “insertive” were difficult to 
follow and should be changed to “receiving” and “inserting”. This alleviated, to some 
extent, the concern that the questions were written from a “male point of view”. It 
was also suggested that the wording be changed from “condom” to “condom (and 
dam)”. 
 Q18 (now Q17) —It was suggested that the “tick all that apply” option should be 
included. In addition, the phrase “discharge from the penis” should be altered to 
“unusual discharge from the penis” as urine is a discharge.  
 Q19a (now Q18a) —Add two more tick box options:  “Don’t know” and “Not tested”.  
 Q19b & c (now Q18b & c) —Include the word “testing” when asking if the 
respondent had sought treatment, so that it reads “sought testing and treatment”. 
 Q20 (now Q19) —Add rows for possible deployments. 
 Q21 (now Q20) —Indicate “overseas deployment” rather than simply “deployment”.  
Ask for approximate number, as the group felt most respondents would not be able 
to recall.  
 Q22 (now Q21a and Q21b) —The group found this question confusing. They asked 
if the question meant how many months they had been prescribed doxycycline or 
how long they actually took it. The group indicated there was a difference in these 
two answers. It was agreed to include both questions.  
 Q23a (now Q22a) —Include the word “overseas” when talking about deployment. 
 Q23d (now Q22d) —Change the wording as per previous questions. 
 
Results on Instructions for Collecting Urine Specimens 
 
When focus testing the instruction sheet for collecting urine specimens, the participants 
did not need to provide a urine sample but rather were asked to simulate the process 
using water. This allowed the researchers to determine the clarity of the instruction sheet 
by following the steps in a practical exercise. The participants were divided into two 
groups with one group asked to return samples for anonymous testing only and the other 
group to return samples for both the anonymous study and for an identified test so they 
may find out if they have C. trachomatis. The participants were then asked to read the 
instruction sheet and go to the bathroom to gather the sample.  
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All the participants correctly handed in the appropriate samples. This indicated that the 
participants understood the instruction sheet and did not need prompting as to how to 
provide the sample.   
 
The participants were easily able to understand the instructions and were able to provide a 
specimen appropriately. This focus testing illustrated that potential volunteers were 
cognisant of the issues in sexual health and were accepting of this study.  
 
Two suggestions for improvement of the instruction sheet were received: 
1. Include the statement “Return the orange capped lid” in the third instruction section 
as some participants waited until the gel had set before putting the lid back onto the 
tube.  
2. Add a statement saying “Do not consume crystals” somewhere on the instruction 
page as a couple of participants reported that they wanted to “taste the crystals”.  
 
The use of information and consent form was also included in this pilot.  Participants 
understood the purpose of the form and there was no confusion amongst any of the 
participants about the dual consent for the survey and / or the urine sample.  There was 
also no apparent confusion about the subsequent consent for the sample to be split into 
two components – one for the study and one to be tested locally.  
 
Suggestions for changes to wording included:  
5. The word ‘prevalence’ be clarified by including a bracketed statement (how much 
there is in a population) 
6. The phrase: “will be de-identified (that is, it will be anonymously coded)” be switched 
around to read: “will be anonymously coded (that is, it will be de-identified)" 
7. In the section on Risks of Participating, change “partner/s as they may need to be 
offered treatment” to “partner/s as they may need to seek treatment”. 
8. Note the name of the Chief Investigator in the Statement of Privacy.  
APPENDICES 
Page 227 of 256 
 
 
 
Appendix 9 
 
Consultation flowchart 
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To Start:   You will have received individual kits containing:  
 Information and Consent Sheet (x2) 
 The Survey 
 Pathology bag 
 50 ml urine container (x2) 
 
 
 Pre-printed pathology slip 
 pre-printed coded labels (x3) 
 pre paid self addressed envelope 
 Guidelines for Volunteers 
Step one:  Information and Consent Sheet 
Personnel waiting to undergo the Annual Health 
Assessment (or other appointment) are given a copy 
of the I & C Sheet and the ‘Guidelines for Volunteers’ 
prior to their appointment. 
 
Step Four:  Coding 
Participant is given one (or two) of the 50 ml yellow-
capped specimen containers.  As the container is 
given, place the first pre-printed coded label on 
container and while the participant is collecting the 
sample, place the second preprinted coded label on 
the pathology slip and the third at the top of survey. 
 
 
Step Five:  Urine Sample 
Participant takes a specimen 
container and, in a private location, 
provides a sample of first catch urine.  
If the participant has given consent for 
a second identifiable sample to be 
tested within Defence Health 
Pathology (to possibly access 
treatment), they are to be asked to 
divide the first catch urine sample into 
the two available specimen containers 
and return containers to the health 
officer. 
 
 
Step Six:  Completing the 
Survey 
The coded survey is given to the 
participant on collection of the 
urine samples and they are 
invited to complete the survey 
anonymously and confidentially in 
a private area.  Instruct participant 
that once survey is completed, to 
place the survey in the self 
addressed envelope. 
 
 
Step Seven:  Sending the Survey 
Once the survey is placed in the self addressed 
envelope, the participant may choose to deposit this 
envelope in the mail themselves or may give it to the 
health officer to post. 
 
Step Eight:  Sending the Urine samples 
See second flowchart on ‘Testing the sample’. 
Anonymous (de-identified) and identified samples to 
be sent to different services. 
 
Step two:   
Routine Appointment 
Personnel undertake AHA or 
routine appointment 
 
Step Three:  Consent 
At the end of the appointment, the health officer asks personnel if they have any questions about the 
I & C Sheet and if they would like to participate in the study.  The health officer may take the 
opportunity to explain the study in more detail.  If the person wishes to participate in the study, they 
sign the consent forms and tick those components in which they wish to participate.  The authorised 
researcher signs the consent forms and a copy is given to the participant and a copy is sent to the 
Chief Investigator listed on page 3 of the form. 
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Step Eight (a):   Preparing the 
anonymous Urine Sample 
Once the specimen has gelled, follow the 
instruction sheet provided and place tube in 
cardboard box; place in coded pathology 
bag and placed in self addressed envelope. 
Instruct participant that once survey is 
completed, to place the survey in the same 
self addressed envelope. Once the survey 
and gelled urine sample is placed in the 
self addressed envelope, the participant 
may choose to deposit this envelope in the 
mail themselves or may give it to the health 
officer to post. 
 
Step Ten (a):  Register and Testing 
The anonymous coded urine sample is 
registered at specimen reception at RBWH 
and then tested via PCR for Chlamydia 
trachomatis at the pathology laboratory of 
the RBWH 
 
 
Step Eleven (a):  Results 
Results printed and forwarded to chief 
investigator for correlation with Survey data 
utilising the code placed on samples and 
survey in step four. 
 
 
Step Nine (a):  Send 
The gelled urine sample and the survey are 
sent to the chief investigator using the self 
addressed envelope provided. The chief 
investigator forwards the urine specimen to 
the Royal Brisbane & Womens Hospital 
(RBWH) pathology services 
Step Ten (b):  Testing 
The identified urine sample to be tested 
via PCR for Chlamydia trachomatis at 
local site 
 
 
Step Eleven (b):  Results 
Results of the identified specimen 
reported directly to the health facility. 
 
Step Twelve (b):  Informing the 
Participant & Treatment 
The health officer informs the participant of 
the result of the identified test and if 
positive, offers treatment as per standard 
protocols. 
 
Step Nine (b):  Send 
The identified urine sample is sent via the 
standard pathway to the local pathology 
provider 
 
Step Eight (b):   Preparing the 
identified Urine Sample 
Identified sample and slip are placed into a 
separate pathology bag that is used by 
local pathology provider 
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Appendix 10 
 
Calculation of weighting to compare study population to Australian population 
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Basis of weighting calculations 
 
The design weights for gender and age were calculated using the following information.   
 
Calculation of design weights for ADF sample 
 ADF 
Ni 
Study sample 
ni 
Design weight 
ni ÷ Ni = Wi 
Male 87% 77.21% 1.13 
Female 13% 22.79% 0.57 
>25 60.77% 65.85% 0.923 
≤25 39.23% 34.15% 1.155 
 
Combining these, a calculation was able to be made for age- and gender-adjusted findings 
that are generalisable to the ADF population (for the age ranges covered in this study). 
 
Calculation of age and gender combined design weights 
 Calculation Design weight 
Female younger 0.57 x 0.923 0.526 
Female older 0.57 x 1.155 0.658 
Male younger 1.13 x 0.923 1.043 
Male older 1.13 x 1.155 1.305 
 
C. trachomatis (Chapter 4, Section 4.6.1) 
 
The unadjusted C. trachomatis prevalence reported in this study was 1.95%. Adjusted for 
gender and age to the ADF population (18–29 years), the rate was 1.87% as follows: 
 
Application of design weights using C. trachomatis 
 Design 
weight 
C. trachomatis positive 
Original Adjusted 
Female younger 0.526 2 1.052 
Female older 0.658 1 0.658 
Male younger 1.043 10 10.430 
Male older 1.305 1 1.305 
  14 13.445 
 
13.445 ÷ 719 x 100 = 1.869 
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Male condom use with casual partners (Chapter 4, Section 4.6.2.3, Table 4.6.3) 
 
Two hundred and eighty-three males in the ADF sample provided information about 
condom use with casual partners. 
 
 Design 
weight 
Sex with casual partners 
Original Adjusted 
Always used a 
condom 
Male younger 1.043 113 117.86 134.83 
Male older 1.305 13 16.97 
Not always 
used a condom 
Male younger 1.043 117 122.03 174.23 
Male older 1.305 40 52.20 
   283  309.06 
 
134.83 ÷ 309.06 x 100 = 43.63% for the ADF sample. 
 
The calculation for the ASHR sample was based on the following % of each age group 
reported in the study and a reported male sample of 601 having sex with casual partners: 
 16–19  9.2% of study 55 males 
 20–24  11.5% of study 69 males 
 25–29  12.5% of study 75 males 
 
This equated to 199 males in the ASHR in this age range. The reported male condom use 
for each age group was: 
 16–19  9.2% of study 55 males 65.2%  36 males 
 20–24  11.5% of study 69 males 43.6%  30 males 
 25–29  12.5% of study 75 males 43.6%  33 males 
 
Ninety-nine males in the study used condoms with casual partners. This was 49.75%.  
 
 
Female condom use with casual partners (Chapter 4, Section 4.6.2.3, Table 4.6.3) 
 
Sixty-seven females provided information about condom use with casual partners. 
 
 Design 
weight 
Sex with casual partners 
Original Adjusted 
Always used a 
condom 
Female 
younger 
0.526 19 
9.99 11.31 
Female older 0.658 2 1.32 
Not always used 
a condom 
Female 
younger 
0.526 39 
20.51 25.12 
Female older 0.658 7 4.61 
   67  36.43 
 
11.31 ÷ 36.43 x 100 = 31.05% for the ADF sample. 
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The calculation for the ASHR sample was based on the following % of each age group 
reported in the study and a reported female sample of 324 having sex with casual 
partners: 
 16–19  9.2% of study 30 females 
 20–24  11.5% of study 37 females 
 25–29  12.5% of study 41 females 
 
 
This equated to 108 females in the ASHR in this age range. The reported female condom 
use for each age group was: 
 16–19  9.2% of study 30 females 43.9%  13 females 
 20–24  11.5% of study 37 females 37.3%  14 females 
 25–29  12.5% of study 41 females 37.3%  15 females 
 
Forty-two females in the study used condoms with casual partners. This was 38.89%.  
 
 
Male condom use with most recent event of vaginal intercourse (Chapter 4, Section 
4.6.2.3, Table 4.6.5) 
 
Four hundred and twenty-nine males in the ADF sample provided information about 
condom use with most recent event of vaginal intercourse.  
 
 
Design 
weight 
Most recent vaginal 
intercourse 
Original Adjusted 
Used a condom Male younger 1.043 188 196.08 246.98 
Male older 1.305 39 50.89 
Not used a 
condom 
Male younger 1.043 143 149.15 226.14 
Male older 1.305 59 76.99 
   429  473.12 
 
246.98 ÷ 473.12 x 100 = 52.29% for the ADF sample. 
 
The calculation for the ASHR sample was based on the following % of each age group 
reported in the study and a reported male sample of 7575 having had vaginal intercourse: 
 16–19  9.2% of study 697 males 
 20–24  11.5% of study 871 males 
 25–29  12.5% of study 947 males 
 
This equated to 2,515 males in the ASHR in this age range. The reported male condom 
use at time of last vaginal intercourse for each age group was: 
 16–19  9.2% of study 697 males 80.3%  560 males 
 20–24  11.5% of study 871 males 42.8%  373 males 
 25–29  12.5% of study 947 males 42.8%  405 males 
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One thousand, three hundred and thirty-eight males in the study used condoms at the time 
of last vaginal intercourse. This was 53.20%.  
 
Female condom use at time of last vaginal intercourse (Chapter 4, Section 4.6.2.3, 
Table 4.6.5) 
 
One hundred and thirty females provided information about condom use on the last 
occasion of vaginal intercourse. 
 
 Design 
weight 
Last vaginal intercourse 
Original Adjusted 
Used a 
condom 
Female 
younger 
0.526 42 
22.09 26.70 
Female older 0.658 7 4.61 
Not used a 
condom 
Female 
younger 
0.526 56 
29.46 45.91 
Female older 0.658 25 16.45 
   130  72.61 
 
26.70 ÷ 72.61 x 100 = 36.77% for the ADF sample.  
 
The calculation for the ASHR sample was based on the following % of each age group 
reported in the study and a reported female sample of 7,231 having vaginal intercourse: 
 16–19  9.2% of study 665 females 
 20–24  11.5% of study 832 females 
 25–29  12.5% of study 904 females 
 
This equated to 2,401 females in the ASHR in this age range. The reported female 
condom use at the time of last vaginal intercourse for each age group was: 
 16–19  9.2% of study 665 females 54.1%  360 females 
 20–24  11.5% of study 832 females 30.9%  257 females 
 25–29  12.5% of study 904 females 30.9%  279 females 
 
Eight hundred and ninety-six females in the study used condoms with casual partners. 
This was 37.32%.  
 
Male number of partners when in a relationship (Chapter 4, Section 4.6.2.2, Table 
4.6.1) 
 
One hundred and fifty-seven males who were in a relationship provided information about 
sex with casual partners.  
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Design 
weight 
In a relationship for more 
than 12 months 
Original Adjusted 
One partner 
only in last 12 
months 
Male younger 1.043 88 91.78 158.34 
Male older 
1.305 51 66.56 
More than one 
partner in last 
12 months 
Male younger 1.043 13 13.56 19.09 
Male older 
1.305 5 
6.53 
   157  178.43 
 
19.09 ÷ 178.43 x 100 = 10.69% for the ADF sample. 
 
The calculation for the ASHR sample was based on the following % of each age group 
reported in the study and a reported male sample of 2,169 having had more than one 
sexual partner in the last 12 months while indicating being in a relationship for more than 
12 months: 
 16–19  9.2% of study 601 males 
 20–24  11.5% of study 751 males 
 25–29  12.5% of study  males 
 
This equated to 2,515 males in the ASHR in this age range. The reported male partner 
configuration was: 
 16–19  9.2% of study 601 males 21.4%  129 males 
 20–24  11.5% of study 751 males 9.6%  72 males 
 25–29  12.5% of study 817 males 9.6%  79 males 
 
Two hundred and eighty males in the study reported being in a relationship for more than 
12 months and having more than one partner in that time. This was 12.91%.  
 
Female number of partners when in a relationship (Chapter 4, Section 4.6.2.2, Table 
4.6.1) 
 
Forty-nine females in a relationship provided information about sex with casual partners.  
 
 
Design 
weight 
In a relationship for more 
than 12 months 
Original Adjusted 
One partner 
only in last 12 
months 
Female 
younger 
0.526 30 
15.78 25.65 
Female older 0.658 15 9.87 
More than one 
partner in last 
12 months 
Female 
younger 
0.526 4 
2.10 2.10 
Female older 0.658 0 0 
   49  27.75 
 
2.10 ÷ 27.75 x 100 = 7.57% for the ADF sample.  
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The calculation for the ASHR sample was based on the following % of each age group 
reported in the study and a reported female sample of 2,231 having had more than one 
sexual partner in the last 12 months while indicating being in a relationship for more than 
12 months: 
 16–19  9.2% of study 618 females 
 20–24  11.5% of study 773 females 
 25–29  12.5% of study 840 females 
 
This equated to 2,401 females in the ASHR in this age range. The reported female 
configuration was: 
 16–19  9.2% of study 618 females 8.0%  50 females 
 20–24  11.5% of study 773 females 5.6%  43 females 
 25–29  12.5% of study 840 females 5.6%  47 females 
 
One hundred and forty females in the study reported being in a relationship for more than 
12 months and having more than one partner in that time. This was 6.28%. 
 
Gender of last sexual partner (Chapter 4, Section 4.6.2.4) 
 
Four hundred and sixty-five males in the ADF sample provided information about sex with 
same sex partners.  
 
 
Design 
weight 
Gender of last partner was 
same as self 
Original Adjusted 
Yes Male younger 1.043 12 12.52 16.43 
Male older 1.305 3 3.92 
No Male younger 1.043 347 361.92 496.38 
Male older 1.305 103 134.42 
   465  512.81 
 
16.43 ÷ 512.81 x 100 = 3.20% for the ADF sample. 
 
One hundred and forty-three females in the ADF sample provided information about sex 
with same sex partners.  
 
Design 
weight 
Gender of last partner was 
same as self 
Original Adjusted 
Yes Female 
younger 
0.526 1 
0.53 1.85 
Female older 0.658 2 1.32 
No Female 
younger 
0.526 109 
57.33 77.73 
Female older 0.658 31 20.40 
   143  79.58 
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1.85 ÷ 79.58 x 100 = 2.32% for the ADF sample. 
 
The ASHR sample had three percentages noted for each gender. The same sex 
experience for the entire sample (16–59 years) was directly reported. In order to develop a 
percentage for the 16–29 age range, the following calculations were undertaken for males 
and females separately.   
 
For males, 1.7% of those aged 16–19 years indicated any same sex experience and this 
age group represented 9.2% of the sample. Therefore, 1.7 x 9.2 x 9723 = 15 individuals. 
Also, for those aged 20–29, they indicated 6.9% same sex experience and represented 
24% of the sample. Therefore, 6.9 x 24 x 9723 = 161. Therefore, 176 males in the age 
group indicated any same sex experience. This was 5.45% of the total sample. 
 
For females, 10.2% of those aged 16–19 years indicated same sex experience and this 
age group represented 9.2% of the sample. Therefore, 10.2 x 9.2 x 9576 = 90 individuals. 
Also, for those aged 20–29 years, they indicated 11.9% same sex experience and 
represented 24% of the sample. Therefore, 11.9 x 24 x 9576 = 273. Therefore, 363 
females in the age group indicated any same sex experience. This was 11.40% of the total 
sample. Developing the percentage of same sex partners in the last 12 months was more 
difficult. This was not achievable with the available data for the 16–29 age range and was 
only undertaken with the full dataset.   
 
Males 
Self-identified 
sexuality 
% who indicated sex with same gender in 
last 12 months 
The sample % x the sample 
Straight 0.2 9475 18.95 
Bisexual 48.7 89 43.34 
Gay 79.5 154 122.43 
Total number of individuals (adjusted figures) who indicated sex with same 
gender in last 12 months 
185 
185 ÷ 9729 x 100 1.90% 
 
Females 
Self-identified 
sexuality 
% who indicated sex with same gender in 
last 12 months 
The sample % x the sample 
Straight 0.3 9355 28.07 
Bisexual 42.3 138 58.37 
Gay 73.6 77 56.67 
Total number of individuals (adjusted figures) who indicated sex with same 
gender in last 12 months 
143 
143 ÷ 9578 x 100 1.49% 
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Males who engaged services of a sex worker (Chapter 4, Section 4.6.3, Table 4.6.8) 
Four hundred and seventy-one males provided information about payment for sex in the 
ADF sample. 
 
 
Design 
weight 
Paid for sex in the last 12 
months 
Original Adjusted 
Yes Male younger 1.043 52 54.24 72.51 
Male older 1.305 14 18.27 
No Male younger 1.043 312 325.42 446.78 
Male older 1.305 93 121.37 
   471  519.29 
 
72.51 ÷ 519.29 x 100 = 13.96% for the ADF sample. 
 
The calculation for the ASHR sample was based on the following % of each age group 
reported in the study and a reported male sample of 9,337 who answered these questions: 
 16–19  9.2% of study  859 males 
 20–24  11.5% of study 1074 males 
 25–29   12.5% of study 1167 males 
 
This equated to 3,100 males in the ASHR in this age range. The reported engagement of 
sex workers was: 
 16–19  9.2% of study  859 males 1.2%  10 males 
 20–24  11.5% of study 1074 males 3.1%  33 males 
 25–29   12.5% of study 1167 males 3.1%  37 males 
 
Eighty males in the study reported having engaged the services of a sex worker. This was 
2.58%.  
 
Received payment for sex (Chapter 4, Section 4.6.3) 
 
Four hundred and sixty-seven males in the ADF sample provided information about being 
paid for sex.  
 
 
Design 
weight 
Had been paid for sex in 
last 12 months 
Original Adjusted 
Yes Male younger 1.043 3 3.23 7.15 
Male older 1.305 3 3.92 
No Male younger 1.043 358 373.39 507.81 
Male older 1.305 103 134.42 
   467  514.96 
 
7.15 ÷ 514.96 x 100 = 1.39% for the ADF sample. 
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One hundred and forty-nine females in the ADF sample provided information about being 
paid for sex. 
 
 
Design 
weight 
Had been paid for sex in the 
previous 12 months 
Original Adjusted 
Yes Female 
younger 
0.526 0 
0 0.69 
Female older 0.658 1 0.658 
No Female 
younger 
0.526 115 
60.49 82.20 
Female older 0.658 33 21.71 
   149  82.89 
 
 
0.69 ÷ 82.89 x 100 = 0.84% for the ADF sample. 
 
 
Attendance at health services (Chapter 4, Section 4.4) 
 
The raw figure was 19% (135/710 x 100). 
 
Adjusted figure: 
 
Male younger 59 x 1.043 = 61.537 
Female younger 32 x 0.526 = 16.832 
Male older  32 x 1.305 = 41.76 
Female older  10 x 0.658 = 6.580 
Missing data   2 
 
Total = 128.709 
 
Adjusted figure: 18.12% (128.709/710 x 100). 
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Appendix 11 
 
Power Calculations 
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The original power calculations were conducted at the beginning of this study based on the 
originally proposed study sample and an assumed infection rate of 7% in the deployed 
population and 2.5% in the non-deployed population. These calculations were based on a 
power of 90% and a significance level of 5%. A study sample of 468 deployed personnel 
(within the last 12 months) and 468 non-deployed personnel was required. 
 
Due to the number of participants recruited in total (733) and to the lower than expected 
infection rate (1.89%), some calculations failed to reach significance. In addition, where a 
calculation did reach significance, a further test of power was undertaken in an attempt to 
avoid a Type I error, that is, the rejection of the null hypothesis when it was true. This was 
not a retrospective test on data that did not reach significance, but rather an analysis of the 
required sample size needed for data that did reach a level of significance in order to 
ensure that the finding was valid based on the sample size used.    
 
In the analysis where there is a level of significance noted, if no mention is made of power, 
it is assumed that the calculation of power showed that the sample was large enough to 
make this determination. Where the sample size was not large enough, this is noted in the 
text. A sample size calculator comparing two proportions was used with 80% power rather 
than the 90% calculation used to determine the original sample size.  For example, the 
calculation relating to safe sex practice and C. trachomatis in Chapter 4, Section 4.2.1, 
showed that a sample of 466 who practised safe sex and a sample of 221 who did not 
practise safe sex was needed. These sample sizes were derived using the following 
variables: 
- significance level of 0.05 for a two-sided test 
- Power of the test of 0.2 (or 80% desired power) 
- Proportion in Sample 1 of 1.73% 
- Proportion in Sample 2 of 2.70% 
- Ratio of the two samples at 0.48 (222 / 462). 
Using the formula below found at  www.cct.cuhk.edu.hk/statproportion/Casagrande.htm 
             
   Where  
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Appendix 12 
 
Trial of recruitment methodologies 
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Three methodologies for recruitment were employed in the pilot phase in 1998. 
 
1. Using the AHA 
 
This methodology involved attaching the study to the AHA and asking those who 
presented for the AHA if they were willing to be included in this study. This continued to 
happen at HMAS Coonawarra and the Submarine and Underwater Medical Unit (SUMU). 
However, the use of the AHA is varied and the future of the use of the AHA is not certain. 
 
2. Health service active recruitment by study personnel 
  
The second methodology involved requesting participation in the study of all who arrived 
at a health service who matched the sample criteria (i.e. aged 18–29 and in the RAN) by 
personnel not employed within the health service. This was the methodology undertaken 
at HMAS Kuttabul as a ‘test of process’ in the week beginning Monday, 18 August 2008 
and concluding Friday, 22 August 2008. The following aspects of this methodology were 
noted: 
 Based on a count of personnel accessing the health service at the time and 
observation of the number within the sample criteria (50%), the recruitment rate 
was between 12% and 15% each day. This netted 27 samples in total.   
 However, two personnel were required to be present at all times (one at the front 
entrance of the service and one in the screening/survey room). Once costs were 
taken into consideration, this method of screening was seen to be unworkable.   
 Different methodologies were tested:  
 In uniform or not in uniform 
 Male or female 
 Active or passive recruitment (that is, leaving the briefing pages 
where visitors to the health service were able to pick them up without 
being approached by study personnel). 
 
3. Health service passive recruitment by administration staff 
  
The third methodology involved requesting participation in the study of all who arrived at a 
health service who matched the sample criteria (i.e. aged 18–29 and in the RAN) by 
personnel within the health service. This was the method utilised at HMAS Stirling from 
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Monday, 8 September 2008 to Friday, 26 September 2008. Two health staff were involved 
in the study recruitment: one (Leading Seaman Medic Reservist) was tasked specifically 
with recruiting participants for the study, and a second (full-time staff member of the 
service) acted as the backup when the first person was not available. This method netted 
12 samples over the three week period.  
 
Testing the different methodologies presented a picture of what works, what does not 
work, and what appears to make no difference in recruitment.  
 
What worked: 
 Use of dedicated and involved personnel. The majority of samples received from 
HMAS Coonawarra were from one member of the health team. 
  Attaching the screen to the AHA (where it occurred). 
 The use of the gel for transport and storage. There were no reported misuses of 
this medium. 
 
What did not make a difference: 
 Being in uniform or not in uniform; it did not make a difference for either initial 
recruitment or for presenting the consent, survey and urine screening tools. 
 The gender of the person recruiting. 
 
What did not work: 
 Passive recruitment—During the times that the briefing notes were left for passive 
‘pick up’, the recruitment rate was zero.  
 Using ‘point of contact’ personnel from the health service/base known to the base—
‘Point of contact’ refers to the first health service staff member whom the participant 
met at arrival to the reception area. Potential participants were reluctant to return 
completed surveys to people they knew, even though assurances and practices of 
confidentiality were noted and carried through. The participants thought the health 
service personnel ‘might take a peek’. 
 
The testing recruitment processes showed that the original methodology of using the AHA 
to present the request to be involved in the study was the best way to maximise 
recruitment. In addition, the methodology of having participants place their completed 
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survey in a sealed envelope and immediately posting it ensured that confidentiality 
concerns were addressed.   
 
From the trial of the methodologies, it was agreed that for the full screening year of 2009, 
health sites that undertook an AHA (or similar health assessment) were to be approached 
to assist the study. This resulted in eight sites being recruited into the full screening 
program of the study in 2009. In addition, involvement of the women’s health service at 
HMAS Kuttabul was sought to increase the participation rate of women in the study. This 
was successful and did not compromise the recruitment methodology, as women who 
presented for a routine cervical screening appointment were asked to volunteer for the 
study.  
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Appendix 13 
 
Analysis of samples without enough Power for determination of significance 
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This appendix contains the analysis of: 1) C. trachomatis prevalence; 2) STI diagnosis in 
the previous 12 months; and 3) safe sex. For these topics, the sample size of the 
subpopulation was too small to generate enough power to make a determination of 
significance. These findings are also presented in the summary table at the beginning of 
Sections 4.2 and 4.3 where they are highlighted in yellow.   
 
Rank 
 
No difference between officers and non-officers in C .trachomatis positivity was able to be 
determined.  
 
Table A4.2.1: C. trachomatis positivity and rank 
Rank Positive Ct 
Negative Ct Total 
n % 95% CI 
Officer 1 1.41% (0.15–6.39) 70 71 
Non-officer 13 2.08% (1.07–3.43) 613 626 
Total 14  689 697 
 
The x2 statistic was 0.145 (p=0.703). Checking with Fisher’s Exact Test confirmed p=1.00. 
The odds ratio comparing non-officers to officers was 1.48 (0.19–11.52 at 95% CI). 
However, the sample size needed for the officer group was 307 to enable a determination 
of significance. The same was found for STI diagnosis. 
 
Table A4.2.2: STI diagnosis in last 12 months and rank 
Rank STI in the last 12 months 
No STIs Total 
n % 95% CI 
Officer 3 4.23% (1.20–10.85) 68 71 
Non-officer 39 6.07% (4.41–8.11) 604 643 
Total 42  672 714 
 
The x2 statistic was 0.391 (p=0.532). The odds ratio comparing non-officers to officers was 
1.46 (0.44–4.86 at 95% CI); however, there was almost enough statistical power (at 80%) 
to determine any level of difference (sample required was 69 and 608). Analysis of 
seniority also did not have a large enough sample.  
 
Table A4.2.3: STI diagnosis in last 12 months and seniority 
Seniority STI in the last 12 months 
No STIs Total 
n % 95% CI 
Senior 3 6.67% (1.91–16.73) 42 45 
Junior 39 5.83% (4.24–7.80) 630 669 
Total 42  672 714 
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The x2 statistic was 0.053 (p=0.818). The odds ratio comparing those of senior rank to 
those of junior rank was 1.15 (0.34–3.89 at 95% CI). There was not enough statistical 
power to determine any difference on the basis of seniority regarding STI diagnosis in the 
previous 12 months (the sample size of senior members required was 293).The safe sex 
analysis also did not generate a sample size large enough for the determination of 
statistical significance.  
 
Table A4.2.4: Safe sex practice and rank 
Rank Not practising safe sex Practising 
safe sex 
Total 
n % 95% CI 
Officer 22 31.88% (21.80–43.45) 47 69 
Non-officer 199 31.84% (28.28–35.57) 426 625 
Total 221  473 694 
 
The x2 statistic was 0.0005 (p=0.994). The odds ratio comparing non-officers to officers 
was 1.00 (0.59–1.71 at 95% CI). However, there was not enough statistical power to 
determine if there was any difference in safe sex practices among different ranks. 
 
Table A4.2.5: Safe sex practice and seniority 
Seniority Not practising safe sex Practising 
safe sex 
Total 
n % 95% CI 
Senior 6 13.33% (5.76–25.43) 39 45 
Junior 215 33.13% (29.59–36.82) 434 649 
Total 221  473 694 
 
The x2 statistic was 7.597 (p=0.006). The odds ratio comparing those who were junior to 
those who were senior was 3.22 (1.34–7.72 at 95% CI); however, there was not enough 
statistical power to determine any significant difference in safe sex practices between 
seniority levels. The sample of senior personnel required was 53.   
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Deployment 
 
Table A4.2.6: C. trachomatis positivity, STI diagnosis in last 12 months and deployment at 
the time of the study 
On deployment 
at time of study 
C. trachomatis STI diagnosis in last 12 months 
Positive 
Negative Total 
Yes No Total 
n % 95% CI n % 95% CI 
Deployed at 
time of study 
2 1.09% (0.64–3.61) 182 184 9 4.74% (2.37–8.47) 181 190 
Previous 
deployment in 
last 12 months 
3 2.65% (0.75–6.91) 113 116 9 7.56% (4.01–14.03) 113 122 
Not deployed 
in last 12 
months 
9 2.34% (1.17–4.23) 375 384 23 5.94% (3.91–8.63) 364 387 
Total 14  670 684 43  658 699 
 
The x2 statistic for C. trachomatis positivity was 1.18 (p=0.554). Differentiating between 
those who undertook the study while on deployment compared to those who had not been 
deployed or those who had previously been deployed in the last 12 months did not 
generate any level of significance as the sample size needed for the deployed group was 
286. The x2 statistic for STI diagnosis was 0.947 (p=0.623). Differentiating between those 
who undertook the study while on deployment compared to those who had not been 
deployed or those who had previously been deployed in the last 12 months did not 
generate any level of significance.     
 
Those on current deployment may have had a protective factor against C. trachomatis. 
The odds ratio for those who were on current deployment compared to the remainder of 
the sample was 2.24 (0.50–10.10 at 95% CI). Those not currently on deployment were 
more than two times more likely to test positive for C. trachomatis than those on 
deployment. Similar to C. trachomatis positivity, those on current deployment may have 
had a protective factor against being diagnosed with an STI within the previous 12 months. 
The odds ratio for those who were on current deployment compared to the remainder of 
the sample was 1.35 (0.63–2.88 at 95% CI).   
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Casual partners and relationship status 
 
Table A4.2.7: C. trachomatis positivity, sex with casual partners and current relationship 
status 
Sex with casual partner 
and relationship status 
Positive Ct 
Negative Ct Total 
n % 95% CI 
Single 5 2.33% (0.89–3.02) 210 215 
In a relationship less 
than 12 months 
2 1.89% (0.39–5.91) 104 106 
In a relationship more 
than 12 months 
3 2.56% (1.28–11.47)) 64 67 
Total 10  378 388 
 
The x2 statistic was 1.219 (p=0.543). The odds ratio for people who had had sex with 
casual partners and who were single compared to those with casual partners who had 
been in a relationship for more than 12 months was 1.97 (0.46–8.46 at 95% CI). As the 
sample size needed for those who had been in a relationship for more than 12 months was 
3,736 to enable a determination of significance, any difference in C. trachomatis positivity 
between those in a relationship and those who were single among those who had had sex 
with a casual partner was not able to be determined. 
 
Table A4.2.8: STI diagnosis in last 12 months, relationship status and sex with casual 
partners 
Sex with casual partner 
and relationship status 
STI in the last 12 months 
No STIs Total 
n % 95% CI 
Single 18 8.37% (5.22–12.63) 197 215 
In a relationship less 
than 12 months 
8 7.34% (3.53–13.37) 101 109 
In a relationship more 
than 12 months 
7 10.00% (4.59–18.63) 63 70 
Total 33  361 394 
 
The x2 statistic was 0.393 (p=0.822). The odds ratio for people who had had sex with 
casual partners and who were single compared to those with casual partners who had 
been in a relationship for more than 12 months was 1.33 (0.53–3.32 at 95% CI). However, 
there was not enough statistical power to make a determination of STI diagnosis in the 
previous 12 months between those in a relationship and those who were single among 
those who had had sex with a casual partner. 
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Gender of last sexual contact 
 
Seventeen males and four females indicated that the gender of their last sexual contact 
was the same as their own. Although a small sample, this group was compared to the 
larger cohort for C. trachomatis positivity.    
 
Table A4.2.9: C. trachomatis positivity and gender of last sexual partner 
Gender of last 
sexual partner 
Positive Ct 
Negative Ct Total 
n % 95% CI 
Same 0 0.00% - 17 17 
Opposite 14 2.13% (1.23–3.45) 643 657 
Total 14  660 674 
 
The x2 statistic was 0.369 (p=0.543). The odds ratio (when a numeral of ‘1’ was substituted 
for zero) for those who had had sex with the opposite gender compared to those who had 
had sex with the same gender was 2.70 (0.33–21.74 at 95% CI). Although those who had 
had sex with the opposite gender were almost three times more likely to be positive, a 
significant difference in C. trachomatis positivity among those who had had sex with the 
same gender and those who did not was not able to be determined because the sample 
size needed in the same gender group to generate statistical power was 248. 
 
Table A4.2.10: STI diagnosis in the last 12 months and gender of last sexual partner 
Gender of last 
sexual partner 
STI in last 12 months 
No STIs Total 
n % 95% CI 
Same 1 4.76% (3.86–8.52) 20 21 
Different 42 6.30% (4.26–10.15) 625 667 
Total 43  645 688 
 
The x2 statistic was 0.082 (p=0.775). Checking with Fisher’s Exact Test confirmed p=1.00. 
The odds ratio for those who had had sex with a person of a different gender at the time of 
their last sexual contact compared to those who had had sex with a person of the same 
gender was 1.34 (0.18–10.26 at 95% CI). However, there was not enough statistical power 
to determine the difference in STI diagnosis in the last 12 months among those who 
indicated they had had sex with a person of the same gender and those who had had sex 
with a person of a different gender (the sample required of those who had had sex with a 
person of the same gender was 88). 
 
The practice of safe sex was also examined for participants who provided information on 
the gender of their last sexual contact.  
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Table A4.2.11: Safe sex practice and gender of last sexual partner 
Gender Not practising safe sex Practising 
safe sex 
Total 
n % 95% CI 
Same 7 33.33% (16.32–54.60) 14 21 
Opposite 215 33.08% (29.54–36.76) 435 650 
Total 222  449 671 
 
The x2 statistic was 0.0006 (p=1.00). The odds ratio for participants whose last sexual 
partner was the same gender compared to those whose last sexual partner was of the 
opposite gender was 1.02 (0.40–2.54 at 95% CI). The sample of those who had had sex 
with a person of the same gender at the time of their last sexual contact was too small to 
generate enough statistical power.   
 
Sex while overseas 
 
Table A4.2.12: STI diagnosis in the last 12 months and sex while overseas other than 
deployment 
Sex while on 
holiday (only) 
STI in the last 12 months 
No STIs Total 
n % 95% CI 
No 2 2.99% 0.64–9.51 63 65 
Yes 6 5.61% 2.52–11.83 95 101 
Total 8  158 166 
 
For this subgroup, the x2 statistic was 0.646 (p=0.422). Checking with Fisher’s Exact Test 
confirmed p=0.479. The odds ratio for those who had had sex while overseas, while on 
travel other than work, compared to those who hadn’t was 1.99 (0.39–10.17 at 95% CI). 
While there was not enough statistical power to determine a significant difference in STI 
diagnosis in the last 12 months among those who had had sex while overseas for reasons 
other than work and those who hadn’t, those who did engage in sexual practices overseas 
were almost twice as likely to have been diagnosed with an STI in the previous 12 months.  
 
Of the 409 who provided all the required information about deployment, overseas travel, 
and sex while overseas, 312 had travelled overseas on deployment and 179 had travelled 
overseas for reasons other than work. Eighty-two participants had done both. These 82 
are analysed in the following table. 
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Table A4.2.13: STI diagnosis in the last 12 months and sex while overseas, both while on 
deployment and while on other travel 
Sex while on 
holiday and on 
deployment 
STI in the last 12 
months No STIs Total 
n % 95% CI 
No 1 4.35% 0.47–18.58 22 23 
Yes 5 8.47% 3.31–17.58 54 59 
Total 6  76 82 
 
For this subgroup, the x2 statistic was 0.416 (p=0.520). Checking with Fisher’s Exact Test 
confirmed p=1.00. While the odds ratio for those who had had sex while overseas both 
while deployed and while on travel other than work compared to those who hadn’t was 
2.04 (0.22–18.45 at 95% CI), there was not enough statistical power to determine any 
level of significance. 
 
Sex work 
 
Table A4.2.14: C. trachomatis positivity and sex work (paid for sex) 
Paid for sex in last 
12 months 
Positive Ct 
Negative Ct Total 
n % 95% CI 
Yes 0 0.00% (~0.00–4.00) 75 75 
No 14 2.26% (1.36–3.76) 605 619 
Total 14  680 694 
 
The x2 statistic was 1.73 (p=0.188). The odds ratio (when a numeral of ‘1’ was substituted 
for zero) for those who had paid for sex in the last 12 months compared to those who had 
not was 1.71 (0.22–12.21 at 95% CI). Although those who had paid for sex within the last 
12 months were almost twice more likely to be positive, there was not enough statistical 
power to determine a significant difference in C. trachomatis positivity among those who 
had paid for sex and those who had not (the sample needed in the group who had paid for 
sex was 226). 
 
Table A4.2.15: C. trachomatis positivity and sex work (being paid for sex) 
Received 
payment for sex in 
the last 12 months 
Positive Ct 
Negative Ct Total 
n % 95% CI 
Yes 0 0.00% - 7 7 
No 14 2.05% - 669 683 
Total 14  676 690 
 
No analysis was attempted because of the small sample.  
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Table A4.2.16: STI diagnosis in the last 12 months and sex work (paid for sex) 
Paid for sex in last 
12 months 
STI in the last 12 months 
No STIs Total 
n % 95% CI 
Yes 3 4.00% (1.14–10.29) 72 75 
No 38 5.98% (4.34–8.03) 597 635 
Total 41  669 710 
 
The x2 statistic was 0.485 (p=0.486). Checking with Fisher’s Exact Test confirmed 
p=0.609. The odds ratio for those who had paid for sex in the last 12 months compared to 
those who had not was 1.53 (0.46–5.07 at 95% CI). Although those who had not paid for 
sex within the last 12 months were 1½ more likely to be diagnosed with an STI in that time 
period, there was not enough statistical power to determine difference among those who 
had paid for sex and those who hadn’t. 
 
A very small number of participants also indicated they had been paid for sex in the last 12 
months.   
 
Table A4.2.17: STI diagnosis in the last 12 months and sex work (been paid for sex) 
Received 
payment for sex in 
the last 12 months 
STI in the last 12 months 
No STIs Total 
n % 95% CI 
Yes 2 28.57% (6.47–64.77) 5 7 
No 40 5.72% (4.18–7.63) 659 699 
Total 81  664 706 
 
The x2 statistic was 6.467 (p=0.011). Checking with Fisher’s Exact Test confirmed 
p=0.060. The odds ratio for those who had been paid for sex in the last 12 months 
compared to those who had not was 6.59 (1.24–35.03 at 95% CI). The sample size of 
those who had paid for sex was too small to generate statistical power.  
 
Safe sex practice was also analysed comparing those who had engaged the services of a 
sex worker and those who hadn’t.  
 
Table A4.2.18: Safe sex practice and payment for sex 
Payment for sex Not practising safe sex Practising 
safe sex 
Total 
N % 95% CI 
Yes 36 48.65% (37.56–59.91) 38 74 
No 203 31.87% (28.34–35.56) 434 637 
Total 239  442 691 
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The x2 statistic was 8.37 (p=0.0038) for payment of sex. The odds ratio for participants 
who paid for sex within the previous 12 months compared to those who hadn’t was 2.03 
(1.25–3.29 at 95% CI). Those who had engaged the services of a sex worker within the 
previous 12 months prior to participation in the study were twice as likely to be practising 
unsafe sex over that period than those who had not engaged the services of a sex worker. 
However, the sample was not large enough to generate statistical power. A sample of 78 
who had paid for sex was required.  
 
Table A4.2.19: Safe sex practice and being paid for sex 
Being paid for sex Not practising safe sex Practising 
safe sex 
Total 
n % 95% CI 
Yes 3 42.86% (13.88–76.55) 4 7 
No 218 32.66% (28.63–33.64) 462 680 
Total 221  466 687 
 
The x2 statistic was 0.370 (p=0.543) for being paid for sex. The Fisher’s Exact test 
confirmed p=0.687. The odds ratio for participants who had been paid for sex within the 
previous 12 months compared to those who hadn’t was 1.59 (0.35–7.16 at 95% CI).  
Considering the small sample size and the large confidence limits for the proportions and 
the odds ratio, the data was insufficient to determine significance levels. A sample of 183 
of individuals who had been paid for sex was required to generate enough statistical 
power.  
 
Change in relationship status and safe sex 
 
Table A4.2.20: Safe sex practice and change in relationship status 
Change in relationship status Not practising safe sex Practising 
safe sex 
Total 
n % 95% CI 
Single Changed status 
within last 12 mths 
8 21.62% (10.79–36.69) 29 37 
Same status 22 11.28% (7.42–16.29) 173 195 
Total 30  202 232 
      
In a 
relationship 
Changed status 
within last 12 mths 
39 37.14% (28.35–46.63) 66 105 
Same status 114 41.15% (35.48–47.02) 163 277 
Total 153  229 382 
 
For those who were single, the x2 statistic was 2.95 (p=0.086). The odds ratio for 
participants who were single who had changed their relationship status within the previous 
12 months compared to those who were single for the entire 12 months (or more) was 
APPENDICES 
Page 256 of 256 
2.17 (0.88–5.33 at 95% CI). Single participants who had changed their relationship status 
within the previous 12 months (that is, become single after finishing a relationship) were 
more than twice more likely to have engaged in unsafe sexual practices than those who 
had been single for more than 12 months. There was not, however, enough statistical 
power to determine any level of significance. A sample of 121 was required for the 
‘changed status’ group. 
 
The x2 statistic was 0.51 (p=0.475) for those who were in a relationship compared to those 
who had changed their status (that is, moved from being single to being in a relationship) 
and those who had been in that relationship for more than 12 months. The trend was that 
being in the relationship had a protective effect (OR 0.84, 0.53–1.34 at 95% CI). However, 
there was not enough statistical power to make a determination about significance.  
 
 
 
 
 
